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Abstract 
A single eukaryotic gene can give rise to a variety of protein forms (proteoforms) as a result 
of genetic variation and multi-level regulation of gene expression. In addition to alternative 
splicing, an increasing line of evidence shows that alternative translation contributes to the 
overall complexity of proteomes. Identifying the repertoire of proteins and micropeptides 
expressed by alternative selection of (near-)cognate translation initiation sites and different 
reading frames however remains challenging with contemporary proteomics. Mass 
spectrometry enabled identification of proteoforms is expected to benefit from 
transcriptome and translatome data by the creation of customised and sample-specific 
protein sequence databases. Here, we focus on contemporary integrative omics approaches 
that complement proteomics with DNA and/or RNA oriented technologies to elucidate the 
mechanisms of translational control. Together, these technologies enable to map the 
translation (initiation) landscape and more comprehensively define the inventory of 
proteoforms raised upon alternative translation, thus assisting in the (re-)annotation of 
genomes.  
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Introduction 
Gene expression, especially in higher eukaryotes, is subject to multilevel regulation including 
gene transcription, mRNA processing, mRNA stability, mRNA translation and finally, protein 
modification. Contemporary mass spectrometry (MS) based proteomics is indispensable for 
understanding the outcome of gene expression by providing information complementary to 
genome and transcript sequencing [1, 2]. The continuous improvement of MS 
instrumentation and procedures for processing proteome samples lead to a more 
comprehensive mapping of proteomes in less time [3, 4]. Judged from recently published 
yeast and mammalian proteome studies [3-6], a complete eukaryotic proteome could soon 
become accessible, making proteomics a standard practice for gene expression profiling.  
Integration of proteomics and transcriptomics for 
comprehensive gene expression profiling 
Contemporary proteomic studies provided estimates on the number of proteins expressed 
by different cell types from the available collection of about 20,300 human protein-coding 
genes (according to the GRCh38 GENCODE 20 annotation). Very recently, comprehensive 
proteome analyses of 30 histologically normal human cell and tissue types resulted in the 
identification of proteins encoded by 17,294 human genes [6]. From this vast collection, 
1,537 genes were found to be tissue-specific [6]. Similarly, the ProteomicDB repository 
provided proteomics evidence for 18,097 human genes [5]. Overall, a saturation of 
proteome coverage at 16,000 – 17,000 proteins was demonstrated, consistent with RNA-seq 
coverage of the transcriptome. Surveying ProteomeDB led to the postulation that the human 
core proteome consists of at least 10,000 – 12,000 expressed gene products [5] in line with 
several earlier studies [7-9]. These results indicate that the expressed proteome is 
omnipresent and the variability between cell types is often achieved by tuning expression 
levels rather than by the absence or presence of specific proteins [7, 10]. Hence, a 
quantitative comparison of proteomes under study is needed as protein levels shape cell 
phenotypes and functions. Recent estimates of protein absolute abundance report on 
similar dynamic ranges of detectable proteins in mouse fibroblasts [11, 12] and human cells 
[4, 7-9, 13] spanning six to seven orders of magnitude, with median protein abundance 
estimated at 10,000 to 21,000 protein copies per human cell [4, 8, 9]. Emerging lines of 
evidence however, demonstrate that the global proteome diversity might be much larger 
than originally anticipated and that proteomics has not yet delivered the complete set of 
expressed molecular forms of protein products - proteoforms [14, 15] (Fig. 1). 
MS-based protein identification depends on the completeness of protein sequence 
databases and is thus largely restricted to annotated proteins. Only now we begin to 
understand just how many proteoforms can result from allelic variations, different 
transcripts raised by (epigenetically-controlled) alternative promoter usage, alternative 
splicing and mRNA editing, upon alternative translation (initiation) and various co- and post-
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Figure 1 - A single term – proteoforms – may be used to describe the molecular forms of 
proteins derived from individual genes, thus capturing the complete biological variability 
and all possible modifications of primary protein structure [14]. 
translational protein modifications (Fig. 1), amongst others. As an example, our recent N-
terminomics studies on mouse and human proteins highlighted the underestimated 
prevalence of database non-annotated translation start sites [15-17]. Furthermore, N-
terminal proteoforms were also found in yeast [18, 19] and fruit fly [20]. Depending on the 
cell or tissue type, we found that 10-20% of all identified protein N-termini result from 
alternative translation initiation events, point to incorrectly annotated protein start sites or 
to alternative splicing. In specific cases, (premature) protein termination may be 
circumvented by a stop codon readthrough mechanism [21, 22], recently shown to produce 
C-terminally elongated proteoforms in fly, yeast and human [21]. Ribosomal frameshifting
was found to be another mechanism potentially leading to the generation of distinct
proteins from one genomic locus [23, 24]. Further, mRNA-seq revealed the enormous
diversity of splice junctions used and showed that tissue-specific splicing events occur [25].
Integration of transcriptome data from different sources further suggested that alternative
splicing may affect about 95% of all multi-exonic human genes [25]. Importantly, cases of
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non-synonymous and cell-specific genetic variation next to RNA editing can be detected by 
combining proteomics with sample-specific genome and transcriptome-derived database 
searches [2]. 
Hence, it is fair to state that all proteoforms expressed under different conditions in a cell 
type or tissue-specific manner are not yet annotated. An integration of proteomics and 
transcriptomics data to narrow the search space to a selected set of genes [16, 17, 26] may 
help to overcome this as we will discuss below. 
Proteome data are increasingly integrated with other omics data, thereby opening up new 
possibilities to discover the relationship between the transcriptome and the proteome. 
Numerous studies showed that mRNA levels only moderately correlate with protein levels 
[2, 9, 11, 27, 28]. Instead, individual proteins appear to have a conserved intrinsic rate of 
mRNA to protein conversion [2, 5]. Also, the remodelling of proteomes in response to 
various perturbations seems to be largely orchestrated at the post-transcriptional level. In 
multiple model systems, changes in mRNA levels often poorly correlate with changes in 
protein levels [28-34], even more so in the parasitic protist Trypanosoma brucei where 
transcriptional control is lacking and functionally distinct proteins are simultaneously 
expressed from long polycistronic transcription units [35]. These findings suggest an 
important role for post-transcriptional regulation of gene expression, including mRNA decay, 
translational control of protein synthesis and protein degradation. Several integrative omics 
studies complemented with computational modelling were conducted to assess the 
accumulation of such effects. In Mycoplasma pneumoniae, regulation of gene expression 
was found to be largely decoupled from protein dynamics as high protein numbers and long 
protein half-lives effectively buffer against spikes in gene expression [28]. In T. brucei, 
translational control and mRNA stability were both found to vary over two order of 
magnitude and thus to contribute equally to gene expression [35]. In human cells, 
estimations of the impact of protein turnover on gene regulation [36] revealed that protein 
synthesis and degradation rates are conserved in functional protein classes and similar 
among most components of individual protein complexes. Nonetheless, the protein 
synthesis rate is extensively regulated upon cell differentiation whereas the protein 
degradation rate overall poorly contributes to protein expression control [36]. In summary, 
studies in both prokaryotes and eukaryotes show that mRNA translation rates are likely the 
predominant regulators of protein abundance [11, 28, 36, 37] and have an overall higher 
impact than transcriptional regulation of mRNA [11], protein turnover [11, 28, 36] and mRNA 
degradation [11, 37].  
Alternative translation increases the complexity of 
eukaryotic proteomes 
Molecular mechanisms of translation have been extensively studied [38-42] and showed 
that translation of most eukaryotic mRNA molecules is initiated by a scanning mechanism. 
7 
INTRODUCTION 
Mature mRNA molecules are recognised and circularised by a complex of eukaryotic 
initiation factors (eIFs) 4F, composed of eIF4E, 4A, 4G and 4B, accompanied by the poly(A)-
binding protein (PABP). Simultaneously, the ternary complex (composed of an initiator 
methionyl-tRNA (iMet-tRNA) and eIF2) associates with the 40S ribosome subunit and eIFs 1, 
1A, 3 and 5. In this way the pre-initiation complex (PIC) is formed. Once assembled, PIC is 
recruited to an activated mRNA molecule. The whole complex, referred to as the 48S 
initiation complex, begins scanning along the 5’ leader until an AUG triplet embedded in a 
Kozak consensus context is encountered. A series of interactions, initiated by eIF1 
dissociation, triggers hydrolysis of GTP bound to eIF2, thereby promoting the release of the 
initiation factors. This allows the 60S ribosomal subunit to join and proceed to the 
elongation phase of translation. Synthesis of the polypeptide chain is terminated at stop 
codons, upon which ribosomal subunits can be recycled.  
Translational control involves deviations from this canonical ribosomal scanning, such as 
leaky scanning, reinitiation and internal ribosome entry [41, 42]. It is presumed that most 
regulation is exerted during translation initiation [41] via the selection of different start sites, 
including AUG and near cognate start codons. As for the latter, triplets such as CUG or GUG 
may interact with the anticodon of iMet-tRNA by an incomplete Watson-Crick interaction 
[43, 44]. As such, protein biogenesis by ribosomes can generate multiple proteoforms from 
one mRNA molecule by utilizing alternative translation initiation sites and reading frames 
(Fig. 1). 
Different in-frame initiation sites in the 5’ leader or inside the coding sequence may be 
selected, leading to increased complexity of proteomes. For instance, proteoforms with N-
terminal extensions or truncations may serve different functions [17, 45]. Such N-terminally 
distinct proteins may lose or gain targeting signals and several proteins were thus reported 
to reside in different cellular organelles as a consequence of alternative translation initiation 
[46-51]. In particular, both N-terminally truncated and elongated proteoforms may acquire 
mitochondrial localisation due to the exposure of a full-length cryptic target signal [51] or by 
gaining a new targeting sequence at their N-terminus [49], respectively. Other truncated 
isoforms, which lost their mitochondrial targeting signal, may instead end up in the nucleus 
[43]. Several of these N-terminal proteoforms are iso-functional but active in different 
compartments [47, 48]. Others acquire altered properties such as altered sodium 
permeability in case of the N-terminally truncated form of the potassium channel, subfamily 
K, member 2 (K2P2.1), which changes neuron responsiveness in specific brain tissues and 
developmental stages [52]. Alternative translation initiation can also cause a loss of function, 
like the dominant negative effect of truncated CCAAT/enhancer binding protein beta (C/EBP 
β) [53], or can functionally modulate growth factors and oncogenes (including fibroblast 
growth factor (FGF) [45], vascular endothelial growth factor (VEGF) [54] and V-myc avian 
myelocytomatosis viral oncogene homolog (c-Myc) [55]). Moreover, N-terminal proteoforms 
may have different cellular stabilities as is the case for the opioid receptor mu 1 (OPRM1) 
[56]. All of these findings are further enforced by the recent demonstration that alternative 
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translation start sites at AUG and near-cognate codons are often conserved among 
eukaryotes, further hinting to a possible functional importance [57, 58].  
Tools for the comprehensive mapping of proteoforms 
Proteomics is indispensable to study the products of mRNA translation as it provides the 
ultimate evidence for the existence of proteins. Novel N-terminal proteoforms are most 
efficiently identified by enriching protein N-terminal peptides prior to LC-MS/MS analysis. 
Our lab pioneered such N-terminomics studies by introducing the N-terminal COmbined 
FRActional DIagonal Chromatography (COFRADIC) approach [59]. When combined with 
proteome labelling (e.g. SILAC) and mass tagging of in vivo primary amines, it becomes a 
powerful tool to study alternative translation, as N-termini together with their in vivo 
modification status directly hint to translation initiation events [18, 19, 60, 61] (Fig. 2A). 
Using the known rules of initiator methionine (iMet) processing by methionine 
aminopeptidases (MetAPs) and N-terminal acetylation, one of the most common co-
translational protein modifications in eukaryotes, N-terminal COFRADIC data allow to judge 
if N-terminal peptides can serve as proxies for mRNA translation events or rather are 
indicative of proteolysis [60, 62]. 
Of note is that the annotation of protein-coding genes is still incomplete as many such 
proteoforms are missing in databases, thus hindering comprehensive proteomics and N-
terminomics studies. Gene models rely on ab initio gene prediction, cDNA sequence 
determination and sequence conservation amongst others and benefit from proteogenomics 
strategies to delineate protein-coding sequences and splice junctions [63-65]. 
Proteogenomics using 6-frame genome translation (6-FT) in combination with splice site 
predictions allowed for remarkable advances in decoding small genomes such as A. thaliana 
(i.e. by discovering 778 new protein-coding genes) [64]. On the other hand, reducing the 
complexity of the overall search space is deemed necessary for large genomes to reduce 
sequence redundancy and to avert the increased false discovery rate [65, 66]. Therefore, in 
organisms such as mouse, rat and human, further refinement of gene models may be 
facilitated by partitioning of 6-FT databases [66], accurate prediction of protein-coding loci 
[2, 65] or by confining the analyses to protein sequences derived from transcriptome 
databases and RNA-sequencing experiments [2, 26, 67]. Recently, Branca et al. [66] 
combined peptide fractionation by high resolution isoelectric focusing (HiRIEF) and 
rationalized database searches to achieve an extensive (over 70 fold) reduction of the 6-FT 
tryptic search space by implementing a isoelectric point (pI) restriction. Overall, their 
proteogenomics workflow led to the identification of 224 human and 122 mouse peptides as 
proxies for the expression of previously uncharacterized proteoforms. More specifically, 24 
human and 22 mouse peptides pointed to N-terminal protein extensions, 5 human and 5 
mouse peptides were derived from upstream open reading frames (uORFs) in mRNA 5’ 
leaders. Combined with numerous products of frame-shifting in both species, these hint to 
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Figure 2 – Identification and quantification of proteoforms. A. N-terminomics (i.e. N-  
A 
B 
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terminal COFRADIC) combined with ribosome profiling and mRNA sequencing allow for the 
comprehensive identification of protein translation events [17, 61]. Differential protein 
labelling of free primary amines with heavy acetyl groups (highlighted in red), next to in vivo 
N-terminal (Nt-)acetylation (in black), results in blocking of all protein amino termini.
Further, diagonal reverse-phase chromatography in combination with specific peptide
modifications allows for the isolation of proteome-representative N-terminal peptides,
excluding internal and carboxy-terminal peptides. As such, N-terminal COFRADIC allows to
study translation initiation and N-terminal protein modifications in a quantitative manner.
Ribosome profiling is based on deep sequencing of ribosome-protected mRNA fragments
and thereby enables the study of (alternative) translation with sub- to single-codon
resolution [68-70]. Treating cells with translation inhibitors provides a snapshot of different
translational events: cycloheximide (CHX) halts elongating ribosomes, thus reflecting the
landscape of all translated mRNA regions; harringtonine (HARR) [69] and lactimidomycin
(LTM) [70] immobilize initiating ribosomes and allow to map translation start sites.
Polysomes (mRNA molecules with attached ribosomes) are digested to yield monosomes
and are further isolated by density centrifugation. In parallel, the corresponding mRNA pool
is subjected to random fragmentation. Subsequently, ribosome-protected footprints (~30 nt)
and mRNA fragments are extracted by PAGE, incorporated into cDNA libraries, deep
sequenced and mapped onto the reference genome. The accumulation of ribosomes on
initiation sites (upon LTM or HARR treatment) allows delineating the exact translation
frames, subsequently converted into customised protein databases that enable the MS-
based discovery of yet uncharacterized proteoforms [16, 17].
B. Quantification of gene expression using ribo-seq and mRNA-seq. Ribosome footprints
detected upon CHX treatment (blue) are used to quantify translation and thereby estimate
gene expression levels. The frequency of ribosomal footprints vs. the overall expression level
of mRNA (red) is indicative for the translation efficiency (TE). The right panel shows an
upregulated TE of Gene X in Condition 2 as compared to Condition 1. The left panel depicts
how TE may deviate between ORFs. Here, translational upregulation of two upstream ORFs
(uORFs) in Condition 2 inhibits translation of the annotated protein-coding sequence (CDS)
and thus a reduced TE of the CDS as compared to Condition 1.
alternative translation events including the use of non-AUG codons [66]. Another 
proteogenomic strategy was used by Kim et al. [6]. MS/MS spectra acquired from 30 human 
tissue types, unmapped to conventional protein databases, were searched against 
conceptual translation of genes and transcripts, databases of theoretical protein N-termini 
and predicted signal peptides. This analysis revealed 216 new (splice) variants caused by 
gene/protein/exon extension and incorporation of new exons. Furthermore, 198 new 
protein N-termini were identified, pointing to 3 upstream and 195 downstream translation 
initiation sites. Apart from refining known gene models, Kim et al. [6] identified translation 
evidence for 44 new ORFs including uORFs, several of which were previously reported [71, 
72]. In addition, numerous peptides originating from the so-called pseudogenes and long 
noncoding RNAs were identified. 
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Recently, ribosome profiling (or ribo-seq) revolutionised the genome-wide annotation of 
protein-coding regions by deep sequencing of ribosome-protected mRNA fragments (Fig 2A-
B). The comprehensive delineation of (alternative) translation frames by ribosome profiling 
can further be used to create customized, sample-oriented sequence databases which can 
serve as reference datasets for the proteome under study (Fig. 2A). Such integrative 
strategies were already successfully applied to cytomegalovirus, Trypanosoma, zebrafish, 
mouse and human samples [16, 17, 35, 73, 74] and enabled more efficient discovery of 
proteins and micropeptides and helped to overcome limitations in identifying N-terminal 
extensions and non-AUG initiated proteoforms. A recent N-terminomics study reported 
more than 1,700 alternative translation events in mouse and human [17], of which N-
terminally truncated proteoforms represented the largest group with 1,231 and 465 
downstream translation initiation sites (dTIS) detected in human and mouse, respectively. 
Supplementing the MS search space with protein products of reading frames identified by 
ribosome profiling enabled the identification of additional proteoforms not contained within 
the Swiss-Prot database [17]. Indeed, 17 N-terminally extended proteoforms, 2 overlapping 
out-of-frame uORFs and 4 truncated proteoforms were discovered in human. In mouse, 17 
N-terminally extended proteoforms, one uORF and one new truncated proteoform were
found. Overall, these studies provided evidence at the proteome level that near-cognate
start codons, such as GUG, CUG and ACG, are decoded to methionine, instead of their
canonical amino acid (valine, leucine and threonine respectively). Further, numerous dTIS
pointed to translation initiation events raised upon ribosomal leaky scanning; a scanning
model which assumes that ribosomes may omit start codons embedded in poor Kozak
consensus sequences and continue scanning until a more favourable translation initiation
site is encountered [40]. In many cases where the conventional protein start site was
surrounded by a suboptimal Kozak context, translation was initiated at a downstream AUG
codon, likely ensuring the effective expression of an isofunctional protein. Of note,
alternative N-termini were often positioned in close proximity to the database-annotated
initiation sites, consistent with the observations of Kim et al. [6]. Importantly, conservation
of dTIS between vertebrate genomes was equally high as conservation of canonical initiation
sites, while significantly distinct from a decoy set of putative translationally inactive AUG
start sites (based on ribosome profiling and proteome analysis). An observation which was
further supported by the identification of 200 orthologous pairs of mouse and human dTIS
indicative N-termini [17].
Translational control by short ORFs from a proteomics’ point-
of-view 
As explained before, the canonical model of translation does not explain the full diversity of 
proteins expressed in vivo, and besides truncated or elongated N-terminal proteoforms, a 
remarkable high prevalence of short open reading frames (sORFs) has been postulated 
throughout eukaryotic genomes, inferred from both in silico predictions as well as studies of 
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translated RNA regions (further referred to as the translatome) [68, 69, 75-78]. Proteomics 
may help to verify whether such alternative translation events give rise to detectable 
peptides or merely serve a regulatory role, being rapidly degraded after emerging from the 
ribosome, if at all resulting in peptide production [79].  
The diversity of the documented proteome has clearly expanded over the past years, 
amongst others by the discovery of sORFs that potentially give rise to polypeptides less than 
100 amino acids long [80], classified as micropeptides [81]. sORFs are generally well 
conserved among species [77, 82] and can reside in many genomic locations [81]. Amongst 
others, they are found upstream, overlapping or downstream of mRNA coding sequences 
(CDS) and non-coding RNAs (ncRNA) as well as in intergenic regions. Upstream (overlapping) 
sORFs (uORFs) play an acknowledged role in steering eukaryotic translation. They reduce the 
accessibility of the canonical CDS to ribosomes by engaging them for translation in the near 
proximity of the translation initiation site of the canonical CDS, thus interfering with or 
completely attenuating synthesis of its corresponding protein [40, 42, 83] (see also Fig. 2B). 
Both leaky scanning and reinitiation are involved in this type of regulation and allow for 
multiple different initiation sites to be selected on the same mRNA molecule. Moreover, 
sORFs may induce ribosome stalling and activate nonsense-mediated decay (NMD) of mRNA 
molecules [42, 83] to further attenuate protein synthesis. In contrast to the well understood 
role of sORFs in translation, limited evidence is available on the coding potential of sORFs 
and the biological activity possibly exerted by their encoded short peptide products [80, 84, 
85]. 
Contemporary proteomics may assist in validating the expression of sORF-derived peptides 
as new constituents of the proteome [6, 16, 17, 66, 67, 72, 74]. Several features of sORFs 
may however impede identification of sORF-derived peptides: such short peptides can be 
rapidly degraded [67, 86] and may thus generally be too scarce. Peptidomic workflows that 
employ tailored isolation procedures preventing unwanted protein/peptide degradation [71, 
86, 87], may here be of use. However, the sequences of sORF-derived peptides are not 
annotated in sequence databases and alternatives are needed such as customized protein 
libraries based on translation of genomes [6, 66] or transcriptomes [6] supplemented with 
RNA-seq [67], using (s)ORF prediction [72] or ribo-seq data [16, 17, 74]. The majority of sORF 
translation is essentially presumed to be initiated at non-AUG codons [69] translated to 
methionine [16, 17], thus introducing a mismatch between mRNA and amino acid sequences 
that needs to be accounted for. 
Recently, Slavoff et al. used MS to detect the expression of 90 peptides with an average size 
of 67 amino acids derived from human sORFs [67], 4 of which were reported in a previous 
study of Oyama et al. [71]. Conservation analysis in mammalian species indicated that sORFs 
located in known/expressed transcripts undergo stronger evolutionary selection than 
introns, but are less conserved than annotated CDSs. In line with previous reports, 
translation of 57% of sORFs was initiated at near-cognate codons. The expression levels and 
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range of sORF products (10-2,000 copies per cell) were low compared to human proteins [4, 
8, 9]. Using immunofluorescence, the cytoplasmic expression of 10 sORFs localised in 
presumed 5’ untranslated regions (UTRs) was confirmed, thereby showing that uORFs 
potentially give rise to peptides while controlling translation of downstream genes. 
Interestingly, no products of sORFs located in 3’UTRs or internal frame-shifts were observed, 
the latter proposed to only be expressed from truncated splice variants. Moreover, their 
dataset provided scarce evidence for translation of long intergenic ncRNAs (lincRNAs), in 
contrast to the reported translational activity on lincRNAs detected by ribosome profiling 
[69] and peptide evidence of over 100 lincRNAs in the human proteome draft [6].
Nonetheless, it is important to note that a recent revised opinion on ribo-seq demonstrated
that ribosome occupancy alone does not hold sufficient evidence of translation [79],
therefore stressing the need for proteome-oriented approaches to univocally establish
coding potential.
Additional evidence for short protein and micropeptide synthesis from alternative ORFs 
(altORFs), residing in UTRs or (partially) overlapping with canonical CDS in different reading 
frames, was recently provided by Vanderperre et al. [72], who verified AUG translation 
initiation of unconventional reading frames encoding polypeptides of minimum 40 amino 
acids. When applied to samples of human cell lines and tissues, their proteogenomics 
strategy resulted in the detection of 210 alternative proteins, mainly shorter than 100 amino 
acids. Unexpectedly, these altORFs were rarely found in 5’UTRs, in contrast to other reports 
[67]. Immunofluorescence and immunoblotting showed that altORFs and reference ORFs 
were co-expressed to various extents and, in analogy to canonical proteins, were often 
targeted to different subcellular organelles. The discovery that alternative reading frames 
might be present in the majority of mammalian mRNAs [69, 72] is especially important when 
expressing exogenous cDNA constructs, as co-expression of different protein and peptide 
products may remain unnoticed but might obscure experiments. Strikingly, the identification 
rate of alternate proteins increased from about 2% when analyzing cells and tissues, to over 
50% when analyzing body fluid samples, overall leading to a grand total of 1,259 detected 
altORF translation products. Upon closer inspection of the data, notable observation was 
that without any N-terminal enrichment strategy, 889 out of 1,259 altORFs (i.e. 70%) 
identified, were represented by N-terminally acetylated peptides [72]. This finding might 
partially be explained by the higher overall chance of identifying N-terminal peptides of 
alternative proteins with a median size of 57 amino acids compared to 344 amino acids for 
conventional proteins. However, only 53% of these acetylated peptides were fully compliant 
with the rules of iMet cleavage and N-terminal acetylation, while 27% peptides violated 
these rules (including many acetylated proline residues [20]) and 20% were rare cases. For 
example, in the case of Met-Ser- starting human protein N-termini, iMet processing is 
expected in more than 95% of the cases [60], however for the alternative proteins identified 
here, iMet processing was observed in only 28% of the cases. These unexpected findings 
either hint to alternative modes of translation or potentially, false positive peptide-to-
spectrum matches. 
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A novel ribosome profiling data analysis strategy employed by Bazzini et al. [74] led to the 
identification of potential sORFs in ncRNAs as well as 5’UTR and 3’UTR regions of protein-
coding transcripts in zebrafish and human. sORFs with coding potential were distinguished 
from non-coding ORFs by a triplet periodicity of ribosome footprints, corresponding to the 
stepwise translocation of translating ribosomes along reading frames. Matching MS studies 
in zebrafish could further confirm the expression of 98 Ensembl/RefSeq annotated sORFs, 6 
newly predicted sORFs located on ncRNAs in addition to 17 and 10 sORFs in 5’UTR and 
3’UTR, respectively [74]. 
Overall, integrative omics approaches including proteomics and peptidomics provide 
evidence for sORF translation in a multi-cistronic manner from numerous mRNAs encoding 
conventional proteins. Likely, alternative translation initiation at sORFs using AUG (or near-
cognate) codons is a common mechanism implicated in translational control of neighbouring 
proteins by regulating ribosome availability (action in cis) but also gives rise to short 
peptides, potentially exerting their biological functions in trans (see Results Chapter 4). 
Translation regulation by miRNAs 
Another level of post-transcriptional gene repression is orchestrated by microRNAs 
(miRNAs). These short noncoding RNA species of about 21-23 nucleotides, processed from 
hairpin-shaped precursors, are widely spread across genomes and involved in the 
development and metabolism of multicellular organisms, cell differentiation and 
proliferation, cancer and viral infection [88, 89]. Data repositories like miRBase have 
collected miRNA loci from 206 different species including algae, plants, animals and viruses 
[90]. Following the discovery of miRNA targets and pathways responsible for miRNA 
biogenesis and processing [88, 89], different molecular mechanisms of gene repression by 
miRNAs were proposed, either via translation repression or mRNA degradation [91]. 
Quantitative proteomic studies have been used to determine miRNA’s modes of action [92, 
93]. Selbach et al. revealed the early and late effects of different miRNAs overexpressed in 
HeLa cells using pulsed SILAC (pSILAC) labelling in order to distinguish pre-existing proteins 
from newly synthesised ones [92]. Changes in protein synthesis were measured in parallel 
with microarray mRNA expression profiling. Individual miRNAs were found to modulate the 
synthesis of hundreds of proteins, corresponding to the prevalence of miRNA recognition 
motifs in the 3’UTR of their corresponding mRNAs. However, the impact of miRNA on 
individual protein levels was generally low and only in rare cases resulted in a 4-fold or 
higher repression, pointing to the role of miRNAs in the fine-tuning of gene expression. 
Further, comparing proteomic and mRNA data at early time points of miRNA expression 
showed that miRNAs first repress translation before they induce mRNA decay. 
In another miRNA study, Baek et al. confirmed that miRNAs have an overall modest effect on 
proteomes despite the fact that a single miRNA may have many target genes [93]. 
Additionally, this study explored the hierarchy of miRNA efficiency, showing that longer 
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complementary sequences (8-mers) impact stronger the mRNA target as judged by both 
mRNA and protein changes. Further, a limited cooperative effect was observed for mRNAs 
with multiple recognition sites for the same miRNA. Overall, only few proteins displayed 
translation-only regulation and the degree of this regulation was modest (less than 33% 
change in expression). In contrast, targets undergoing more substantial regulation were 
usually destabilized at the mRNA level, putting forward mRNA decay as the proposed 
primary mechanism of miRNA-induced gene repression. 
Further insight into miRNAs’ modes of action was gained by alternative methods, such as 
ribosome profiling [94, 95] and polysome profiling based on microarray determination of 
ribosomal occupancy of mRNAs bound to polysomal fractions resolved by density 
centrifugation [96]. These studies came to the same conclusion that translational control by 
miRNAs, to whatever extent it occurs, is probably executed during or shortly after 
translation initiation. Also, the impact of miRNAs on translation and on mRNA degradation 
might be linked and exerted simultaneously [95, 96]. Especially, studies on the short term 
miRNA effect [95] suggested that, in line with [92], translation down-regulation is the early 
response, prior to mRNA deadenylation and thus mRNA decay.  
Quantitative proteomics identifies targets of translational 
control 
Translational control of gene expression is involved in the regulation of cellular metabolism 
and biological responses to stress stimuli, leading to a reduction in global translation, 
concomitantly allowing for reprogrammed gene expression of stress response proteins [97]. 
Mediated e.g. by the phosphorylation of eIF2 and eIF4E and their binding partners, such 
control is mainly executed at the initiation phase of protein synthesis via the efficiency of 
ternary complex formation and mRNA 5’-cap recognition [42, 97]. Overexpression or 
continuous activation of various eIFs perturb translational control and are associated with 
malignant transformation of cells, enhanced cancer progression and poor prognosis [98-
104]. 
Kinase mediated eIF2 phosphorylation (eIF2~P) is elicited upon viral infection (PKR), ER 
stress (PERK), heme deficiency (HRI) or amino acid deprivation (GCN2) [97]. By reducing 
translation reinitiation, eIF2~P activates the translation of uORF-repressed genes, including 
transcription factors GCN4 [105] and ATF4 [106]. The efficiency of cap-dependent translation 
is further modulated by mTOR-(S6K) signalling and the Ras-MAPK pathway through the 
phosphorylation of 4E-BP, eIF4G and 4B [42, 107]. Mass spectrometry accompanied by 
transcriptome and translatome profiling hold promise to study and characterize the 
coordinated proteome-wide response elicited by these molecular networks. 
In this context, transcription and protein synthesis have recently been assessed in yeast 
subjected to oxidative, heat, DNA damage, rapamycin and osmotic-induced stress [30-32]. 
Despite the overall concordance between mRNA and translation, changes in protein 
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expression were usually delayed in time compared to mRNA changes, probably reflecting the 
time required for new translation to affect the steady-state levels of proteins [30-32]. As 
reported by Fournier et al. [31], in response to rapamycin, yeast cells engage the TOR 
pathway to induce translation arrest by repressing ribosome biogenesis and reducing the 
activity of eIFs (especially eIF4E), inducing cell cycle arrest at G1/G0 transition and enhanced 
autophagy. Under these harsh cellular conditions of protein biosynthesis shut-down, several 
proteins increased in abundance while no change in their mRNA levels was observed. An 
analogous manner of translational regulation of gene groups linked to stress was observed 
by Lackner et al. [30]. Interestingly, ribosome biogenesis was temporarily unaffected at 
translation level in heat stress, in contrast to the observed down-regulation during oxidative 
stress [30]. Only selected ribosomal proteins were subjected to this regulation [30], hinting 
to the proposed specialization of ribosomal proteins described in other yeast species [108]. 
The notion that a heterogeneous ribosome composition may constitute yet another level of 
translation regulation was hypothesized to occur throughout several kingdoms of life [108-
112]. Paralogous genes encoding ribosomal proteins are often exclusively expressed in 
specific tissues, developmental stages or in response to environmental stress. Presumably, 
when incorporated into ribosome particles, these ribosomal constituents might confer 
altered translational properties to the affected particles (i.e. specificity towards mRNAs 
harboring certain regulatory elements) [108-110, 112, 113].  
In higher eukaryotes, quantitative studies of circadian rhythm revealed another important 
post-transcriptional mechanism regulating translation [114] that is reflected in the daily 
oscillations in the composition of the mouse liver proteome. The phase of rhythmic changes 
in protein abundance was correlated with protein function and often delayed compared to 
mRNA cycling or even independent of transcript levels [114]. Interestingly, several energy 
consuming metabolic processes were limited to periodical activity and nutrient consumption 
by mice. In this context, coordinated expression patterns were observed for a network of 
translation initiation factors (eIF1, eIF4A2, eIF4G1, eIF5) and co-cycling translation 
elongation factors (eEF2 and eEF1A1). The peak abundance of translation factors in the 
nocturnal period coincided with increased translation efficiency of many mRNAs, mainly 
ribosomal proteins, findings supported by an independent polysome profiling study in 
mouse liver [115]. Additionally, translation initiation factors were temporally activated by 
regulatory kinase pathways, such as TOR and AKT, to further enhance translation of 
ribosomal proteins [115]. Taken together, these studies hint to an autoregulatory feedback 
mechanism established by the synergic regulation of activity and expression levels of various 
translation machinery components, thereby controlling protein synthesis independent of 
mRNA expression [114, 115]. 
Translational control may also occur in response to chemotherapy, as recently shown in a 
clinically relevant model of human multiple myeloma [37]. In order to identify drug 
resistance mechanisms, the researchers performed an advanced system-wide analysis of the 
transcriptome, translatome, proteome and N-terminome. Upon proteasomal inhibition by 
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bortezomib, cancer cells try to evade apoptosis by translational upregulation of components 
of the unfolded protein response (UPR) and endoplasmic reticulum transport system 
followed by increased mRNA degradation and translational downregulation of ribosomal 
proteins. Moreover, enhanced translation activities were reported in the 5’UTR mRNA region 
of several chaperones, proteasomal subunits, translation elongation and initiation factors as 
well as ribosomal proteins, hinting to their translational regulation by uORFs, often initiated 
at non-AUG codons [37].  
Recent proteomics studies gave another indication of feedback between UPR and mRNA 
decay that regulates translation readthrough of premature termination codons (PTC) [22]. 
Nonsense or frameshift mutations in various hereditary disorders introduce PTC and drug-
induced readthrough has been utilized to restore functional full-length protein synthesis. In 
response to such therapy, UPR triggers translational attenuation via the phosphorylation of 
eIF2 and reduces nonsense-mediated decay thereby increasing the availability of mRNAs 
affected by PTC to readthrough treatment [22]. 
Eukaryotic stress responses have been extensively studied at the transcriptome level, but 
until recently they were rarely complemented with proteomics data. Increasing lines of 
evidence support the observation that transcript and protein levels do not always correlate 
and adaptation to stress is partially mediated by translational regulation. Moreover, some 
functional groups of proteins seem to be affected in response to a variety of stress stimuli, 
indicating that mechanisms and targets of translational control are often shared. The 
preferentially targeted ribosomal proteins and translation factors likely orchestrate 
downstream translational control pathways specifically engaged to counter certain stimuli.  
Future perspectives 
Studies investigating the steady-state of proteomes provide valuable information on the 
repertoire of expressed proteins and changes in protein levels upon cellular perturbations. 
Identification of numerous novel N-terminal proteoforms is supported by a strong line of 
evidence from ribosome profiling and N-terminomics data. However, the dynamic and 
spatial aspects of protein expression cannot be overlooked. Advances in (post)metabolic 
strategies of protein labelling enable, amongst others, large-scale studies of protein turnover 
and subcellular localization [116, 117]. Combining such technologies with N-terminomics 
may verify the differential regulation of stability and subcellular targeting of such 
proteoforms on a proteome-wide scale. Enhanced knowledge on protein degradation rates, 
cellular localisation as well as (co-translational) protein modifications is indispensable for a 
comprehensive biological description of proteoforms, complementing the systemic view of 
translation regulation. 
Novel proteomic technologies can further advance studies of protein synthesis by 
monitoring the immediate effect of translational regulation on newly synthesised 
polypeptides. A recently developed method called puromycin-associated nascent chain 
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proteomics (PUNCH-P) combines the isolation of nascent polypeptide chains with mass 
spectrometry [118, 119]. Here, polysome associated nascent polypeptides are recovered 
from cells and treated with biotin-puromycin conjugates, which leads to premature 
translation. C-terminally labelled conjugates can subsequently be recovered by streptavidin 
affinity purification and subjected to MS. As such, PUNCH-P monitored changes in 
translation of ~5,000 human proteins during cell cycle progression. Further, PUNCH-P 
provided evidence for the translational coordinated expression of functionally related 
proteins, in addition to identifying novel players in cell cycle progression [119].  
In contrast to metabolic pSILAC requiring longer duration of pulses to obtain sufficient 
labelling of proteins and thus reliable SILAC ratios, PUNCH-P monitors translation in a narrow 
time frame [119]. Protein abundances measured with pSILAC are therefore affected by 
degradation rates, potentially hampering the capture of unstable proteoforms including 
micropeptides. In contrast to pSILAC, the ex vivo nature of puromycin labelling is compatible 
with any type of cell and tissue, thus offering the unique possibility to study temporal 
proteome remodelling in response to stress or treatment in a tissue-specific manner. An 
exciting perspective on translation can be inferred by complementing PUNCH-P with shotgun 
and N-terminomics as well as RNA-seq and ribosome-profiling [119]. Further, targeting 
selective populations of ribosomes based on their localisation and/or interaction partners by 
such integrative approaches gives a true possibility to capture a more comprehensive 
collection of proteoforms and interrogate biological models on a system-wide level. 
Nonetheless, some aspects of translation remain difficult to tackle by integrative omics 
studies. Fidelity of translation elongation may be impaired by defects in loading of tRNAs 
with cognate amino acids [120, 121] and by mutations in ribosomal subunits that decrease 
the accuracy in codon-anticodon pairing [122]. The incorporation of incorrect amino acids 
may also occur by chance (although with low frequency) [121] and was shown to be 
regulated by eukaryotic elongation factors [123] as well as enhanced under nutritional (such 
as amino acid starvation) or environmental stress [121]. In such cases, the ambiguity of 
protein sequence may in principle only be resolved by de novo protein sequencing. 
Importantly, amino acid availability may have additional consequences for protein synthesis 
by modulating translation elongation, leading to ribosome pausing or even translation 
abortion at rate-limiting codons [124]. Natural differences in cellular tRNA levels also left 
their evolutionary mark on protein coding sequences as evident from the correlation 
between tRNA abundance and codon frequency [125]. However, the effect size of tRNA 
availability on protein synthesis during homeostasis is highly debated [124, 126] and needs 
further elucidation. 
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The canonical mechanism of eukaryotic protein translation assumes that initiation of protein 
synthesis occurs at the 5’ proximal AUG codon of an mRNA molecule when recognized by a 
scanning ribosome subunit [1]. However, a certain degree of flexibility in start codon usage 
appears to be tolerated, leading to the recognition of suboptimal start sites, including near-
cognate non-AUG codons [2]. Hence, competition between different start codons within a 
single mRNA molecule, (extracellular) stimuli and regulatory factors may influence the 
outcome of the translation process and thereby the repertoire of expressed open reading 
frames. Combined, and in addition to alternative splicing and protein modifications, such 
alternative (non-canonical) translation initiation events lead to the generation of multiple 
proteoforms, adding another, yet poorly studied level of complexity to the proteome.  
Alternative translation initiation in eukaryotes is largely controlled by eukaryotic translation 
initiation factors and involves processes such as leaky scanning and translation re-initiation 
[3, 4]. However, the biological targets and regulatory modes of action of particular eIFs are 
insufficiently understood and the scarce available literature on eukaryotic proteoforms 
arisen from alternative translation initiation indicates that such N-terminal proteoforms may 
be differentially regulated and localized, display altered stabilities and functionalities [5, 6 , 
7]. 
Over the past few years, a rapid development of several state-of-the-art technologies 
provided the necessary tools for explaining the full diversity of protein variants expressed in 
vivo. In our laboratory, a positional proteomics technology called N-terminal COFRADIC [8, 
9] that enriches for N-terminal peptides, allowed for the first global analysis of protein N-
termini as proxies for translation initiation events and stressed the highly underestimated
occurrence of alternative translation start sites [10, 11]. By deep sequencing of ribosome-
protected mRNA fragments, ribosome profiling further confirmed the omnipresence of
alternative translation initiation sites and the existence of novel ORFs throughout genomes
[12-14].
In this work we aimed at the: 
1. Discovery of novel N-terminal proteoforms
During the course of my PhD project, and building upon our acquired expertise in positional 
proteomics, we aimed at a comprehensive discovery and systems-level characterization of 
alternative N-terminal proteoforms. As the analysis of the N-terminome and ribosome 
profiling data provide complementary information, we further suggested integrating both 
types of data to expand our current understanding of translation initiation. 
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2. Assessment of N-terminal proteoform stability
Next, at the proteome-wide level, we pursued to supplement the annotation of (novel) N-
terminal proteoforms with measurements of their cellular stability using dynamic SILAC 
pulse-chase experiments. Since stability has the capacity to reflect certain functional 
properties of proteins, investigation of isoform-specific protein dynamics might reveal yet 
another mechanism for biological diversification of the proteome.  
3. Deep integration of OMICS data
Our long-term goal is to explore (human) proteome plasticity by incorporating translatomic 
data into conventional proteomics analysis pipelines. These ambitions were tackled in 
collaboration with Dr. Gerben Menschaert and his group at BioBix, who provided the 
necessary knowhow for developing specialized bioinformatics tools which greatly aided in 
the integration of OMICS endeavors hereby undertaken. 
4. Novel insights into translational control
Finally, we aimed at elucidating translation control mechanisms driven by eIF1, an initiation 
factor considered as a potential molecular switch in the stringency of start codon selection. 
Overall, we anticipate that proteome-wide discovery of N-terminal proteoforms, studies on 
their abundance, stability and regulation are essential to improve our understanding of gene 
expression and proteome diversity, which may in the longer term facilitate the assignment 
of biological functions to N-terminal proteoforms 
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Abstract 
Usage of presumed 5’UTR or downstream in-frame AUG codons, next to non-AUG codons as 
translation start codons contributes to the diversity of a proteome as protein isoforms 
harboring different N-terminal extensions or truncations can serve different functions. 
Recent ribosome profiling data revealed a highly underestimated occurrence of database 
non-annotated, and thus alternative translation initiation sites (aTIS) at the mRNA level. N-
terminomics data in addition showed that in higher eukaryotes around 20% of all identified 
protein N-termini point to such aTIS, to incorrect assignments of the translation start codon, 
translation initiation at near-cognate start codons or to alternative splicing. We here report 
on more than 1,700 unique alternative protein N-termini identified at the proteome level in 
human and murine cellular proteomes. Customized databases, created using the translation 
initiation mapping obtained from ribosome profiling data, additionally demonstrate the use 
of initiator methionine decoded near-cognate start codons besides the existence of N-
terminal extended protein variants at the level of the proteome. Various newly identified 
aTIS were confirmed by mutagenesis, and meta-analyses demonstrated that aTIS reside in 
strong Kozak-like motifs and are conserved among eukaryotes, hinting to a possible 
biological impact. Finally, TargetP analysis predicted that the usage of aTIS often results in 
altered subcellular localization patterns, providing a mechanism for functional 
diversification. 
Discovery of novel N-terminal proteoforms 
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Introduction 
Eukaryotic protein-coding genes can give rise to multiple translation products of which the 
expression is regulated at multiple levels. In contrast to transcriptional regulation, protein 
translational regulation permits for more immediate effects to take place. Initiation, 
elongation, termination and ribosome recycling constitute the different phases of the 
eukaryotic translation process, with translation initiation acting as the gate-keeping step by 
the successive steps of ternary complex recruitment, scanning, AUG codon selection and 
ribosomal subunit joining. Overall, this process requires over 30 different proteins including 
the eukaryotic initiation factors (eIFs) [1]. In eukaryotes, the translation start codon is 
typically found by ribosome scanning, referred to as the canonical mechanism of translation 
initiation. Here, the 43S pre-initiation complex (PIC) composed of the initiator Met-tRNA 
(Met-tRNAi) pre-loaded onto the small (40S) ribosomal subunit, binds near the 5’ end of the 
mRNA molecule in a m7G-cap structure/eukaryotic initiation factors 4 (i.e., eIF4E, 4G and 4A; 
jointly referred to as the eIF4F complex) mediated fashion. This complex then starts to scan 
successive triplets of the 5’ untranslated region (5’UTR) in the 3’ direction until an AUG start 
codon or, alternatively, a near-cognate start codon entered the P (peptidyl) decoding site of 
the ribosome. Start codon recognition requires base-pairing with the anticodon loop of Met-
tRNAi and triggers a scanning arrest and GTP hydrolysis of the eIF2-GTP-Met-tRNAi ternary 
complex, ultimately leading to the formation of the 48S initiation complex. The latter is then 
followed by factor displacement, enabling the joining of the large (60S) subunit and 
assembly of the elongation-competent 80S initiation complex which can now accommodate 
the second amino acid encoding aminoacyl-tRNA into the aminoacyl site (A-site) and thus 
formation of the first peptide bond in the process of translation elongation upon 
recruitment of translation elongation factors. 
Secondary RNA structures might influence the processivity and efficiency of scanning and as 
such regulate translation initiation. mRNAs that contain secondary structures in their 5’UTR 
require ATP proportional to the degree of secondary structure [2] in addition to helicase 
activity to enhance 43S PIC binding and scanning. 
Although the scanning mechanism of translation initiation is used by most mRNAs, an 
alternative manner of translation initiation of a specific subset of mRNAs is mediated by 
internal ribosomal entry sites (IRES). Viruses use internal ribosomal entry as a mechanism of 
translation, engaging host cell ribosomes while bypassing the need for (a subset of) the 
limiting eIFs. Internal ribosomal entry sequences are typically long and highly structured 
elements that mimic the functions of eIFs while requiring trans-acting factors such as the 
polypyrimidine tract binding protein PTB or the La autoantigen [3]. Several IRESes were also 
discovered in various cellular mRNAs expressed during apoptosis or mitosis or following cell 
stress, when cap-dependent translation is known to be impaired [4, 5]. Moreover, other 
specific mechanisms of translation initiation exist, such as the structural mRNA element 
driven, cap-dependent and IRES-like mechanism of histone H4 translation initiation, related 
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to the fact that the non-canonical histone H4 mRNA features - such as its short 5’ UTR - 
prevent conventional scanning and translation initiation [6]. 
Besides IRES, a second common type of alternative translation is leaky ribosomal scanning. 
Here, the sequence context surrounding the first encountered AUG is sub-optimal, leading to 
leaky scanning and translational initiation at both this first AUG codon and additional 
downstream AUG codons [7].  
Further, translation reinitiation after a short upstream ORF (uORF) is another common 
regulatory control mechanism of translation initiation [8, 9] (see also Results Chapter 4). In 
fact, up to 50% of all mammalian genes encode mRNAs that have at least one short uORF 
residing upstream of the main protein-encoding ORF and that consists of about 30 codons 
on average [10]. Here, some translation factors remain associated with the ribosome, 
thereby enabling scanning after translating the uORF and thus enabling reinitiation of 
translation at downstream sites.  
Finally, 5’ mRNA leader sequence recapping can also give rise to alternative translates [11, 
12], and thus contributes to the translational initiation landscape. Cis-acting sequence 
elements steer recognition of the correct initiation codon to ensure the fidelity of translation 
initiation. Usually, this AUG triplet resides in an optimal context (i.e., gcc[A/G]ccAUGG(not 
T)), with a purine at position -3 and a guanine at position +4 relative to the A of the AUG 
codon which is designated as +1 [7]. Control of translation initiation codon recognition and 
thereby translation initiation can additionally be exerted through various trans-acting factors 
such as eIFs, where the conserved eIF1 acts as a key determinant. eIF1 mutations resulting in 
premature eIF1 dissociation were shown to increase initiation rates at near-cognate start 
codons [13] and are thus key in maintaining the fidelity of initiation [14] (see also Results 
Chapter 4). Further, eIF1A thought to occupy the A-site, regulates start codon selection in a 
dual fashion as its N-terminal region decreases the initiation accuracy and promotes eIF1 
dissociation at AUG codons, whereas its C-terminal region increases the stringency of start 
codon selection and promotes continued scanning at non-AUG codons [15]. Further, eIF2 
and eIF5 also help to ensure the fidelity of initiation codon selection. In general, 
phosphorylation of the alpha subunit of eIF2 (eIF2αP) is known to reduce translation 
initiation, contradictory however, translational induction of GCN4, a yeast transcriptional 
activator, has been observed by reducing translation initiation at four uORFs [16], thereby 
overcoming the inhibitory effect of these uORFs on reinitiation at the GCN4 ORF [17]. 
Ribosome profiling, a recently developed genomics-based strategy, enables systematic 
monitoring of protein translation events by deep sequencing of ribosome-protected mRNA 
fragments. To date, this methodology was applied to study the translatomes and the 
changes thereof in human [18-21], mouse [22], zebrafish [23], nematode [24], plants [25, 
26], yeast [17, 27, 28], bacteria (Escherichia coli [29, 30] and Bacillus subtilis [30]), human 
cytomegalovirus [31] and bacteriophage lambda [32]. 
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When used in combination with initiation-specific translation inhibitors, this technique 
allows for the study of (alternative) translation (initiation) with subcodon or even single-
nucleotide resolution, the latter referred to as Global Translation Initiation sequencing or 
GTI-seq [22, 33]. As such, ribosome profiling provided a wealth of information on the mRNA 
engagement of (initiating) ribosomes and revealed the omnipresence of alternative 
translation initiation events in human and mice as nearly half the transcripts harbor multiple 
translation initiation sites or TIS in their sequence [22, 33]. Besides a handful of cases for 
which alternative TIS selection leads to (functionally) distinct proteins isoforms due to their 
N-terminal heterogeneity (i.e. protein stability [34], localization [35-39], function [40], etc.),
the overall functional outcome of alternative mRNA engagement, the factors and
mechanisms involved in TIS selection, and the overall outcome of expanding the proteome
diversity remain largely elusive.
Upon ribosome emergence, nascent protein chains (i.e. 30 to 50 amino acid long protein N-
termini) can be subjected to various co-translational modification events, including 
proteolysis (removal of the initiator methionine (iMet) by the MetAPs (methionine 
aminopeptidases) [41, 42]) and N-terminal (de)blocking modifications (N-terminal 
acetylation (Nt-acetylation) [43-46] or deformylation [47]); ubiquitous modifications in 
eukaryotes and prokaryotes respectively. 50% of all soluble yeast proteins and 80-90% of all 
soluble human proteins are modified by acetylation of the α-amino group of the amino-
terminal residue (Nt-acetylation) [48-51]. The utmost N-terminal amino acid(s) identity is the 
major determining factor whether or not a given protein is Nt-acetylated and by which N-
terminal acetyltransferase (NAT) this occurs [52], although some redundancy amongst the 
different NATs can be observed [50, 53]. Since Nt-acetylation is considered to mainly occur 
co-translationally [54], in vivo acetylated protein N-termini can thus be considered as proxies 
of translation initiation, though read out at the proteome-wide level.  
In this study N-terminal proteomics was used to map the TIS landscape in human and mouse 
cells. Overall, more than 20% of all identified protein N-termini point to aTIS and we report 
on more than 1,700 unique alternative protein N-termini next to the more than 4,500 
database annotated protein N-termini identified in the proteomes of study, thereby linking 
about one-third of the uniquely identified protein N-termini to alternative translation 
initiation events. 
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Results 
Mapping of the translation initiation landscape in human and mice using N-terminomics 
reveals numerous alternative translation initiation events. 
In this study, a proteome-wide map of the translation initiation landscape in human and 
mouse was created by mass spectrometry assisted analysis of protein N-termini isolated by 
N-terminal COFRADIC [55]. A TIS compilation was made from previously generated N-
terminal proteomics data ([50, 56-58] and unpublished data) derived from the proteomes of
the human HeLa, HCT116, A-431, THP-1, K-562 and Jurkat cell lines in addition to primary B-
cells as well as the mouse cell lines Mf4/4 and YAC-1 next to primary dendritic mouse cells.
Here, prior to tryptic digestion, all primary amines, and thus free protein N-termini, were
mass tagged by acetylation using non-natural, stable isotope encoded groups such as
trideutero-acetate. In this way, in vivo Nt-acetylated and in vivo free N-termini can be
distinguished and the degree of Nt-acetylation determined [59]. After tryptic digestion, all
protein N-termini will thus be blocked, while all other internal peptides will have a newly
generated primary α-amine. Subsequently, N-terminal peptides are enriched for by means of
strong cation exchange (SCX) step at low pH and further segregated from remaining internal
peptides using a diagonal chromatography strategy. Selected protein N-termini are
subsequently identified following LC-MS/MS analysis [60]. Identified protein N-termini were
grouped by their TIS context. First, protein N-termini with a Swiss-Prot database annotated
protein start position (i.e., N-termini starting at protein position one or two in the protein
sequence) are referred to as database annotated TIS or dbTIS. Overall, 2,879 human and
1,771 mouse dbTIS-indicative N-termini originating from 2,723 and 1,708 unique Swiss-Prot
protein entries were identified (Appendix Table I.1).
Second, based on the co-translational nature of N-terminal acetylation of protein N-termini 
[48] by the NATs, the near universal requirement of a Met-encoding initiator codon (iMet)
and the co-translational processing of iMet by methionine aminopeptidases (MetAPs), all in
vivo free and/or Nt-acetylated peptides with start positions downstream the database
annotated TIS were grouped. In this way, 1231 human (1060 proteins) and 465 mouse (418
proteins) N-termini hinted to protein N-termini originating from the usage of in-frame,
downstream TIS (dTIS), thus giving rise to N-terminal truncated protein isoforms. The N-
termini hinting to dTIS were further subdivided into two sub-categories (See Table 1 and
Experimental procedures); the high confident dTIS encompassing all (partially) in vivo Nt-
acetylated peptides amongst others. In vivo unmodified dTIS compliant with the rules of
iMet-processing and Nt-acetylation (the latter for example considering that, without
exception, (X)-Pro-starting N-termini are unmodified [61]) were withheld as low confident
dTIS and this only when their protein start position did not overlap with any proteolytic
cleavage event reported in public repositories [62-65] (i.e., protein signal processing sites or
reported proteolytic cleavage sites after or before a Met residue). Finally, and whenever
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ribo-seq or orthologue mapping hinted to translation initiation events, low confident dTIS 
were re-catalogued as high confident dTIS (see below and Appendix Table I.1).  
Human dTIS Mouse dTIS 
confidence level Total confidence level Total 
H L H L 
identified peptides 858 373 1231 
274 191 465 
mapped peptides 850 370 1220 
Ensembl TIS exon 1 41 4 45 25 4 29 
exon >1 146 32 178 39 3 42 
subtotal 187 36 223 64 7 71 
no Ensembl TIS exon 1 301 47 348 128 48 176 
exon >1 362 287 649 82 136 218 
subtotal 663 334 997 210 184 394 
Swiss-Prot isoform TIS 17 1 18 36 1 37 
no Swiss-Prot isoform TIS 833 369 1202 238 190 428 
TrEMBL TIS 159 32 191 43 6 49 
no TrEMBL TIS 691 338 1029 213 185 416 
ribo-seq TIS 96 9 105 57 12 69 
no ribo-seq TIS 754 361 1115 217 179 396 
identified 
peptides(+meta) 900 331 1231 298 167 465 
mapped peptides(+meta) 892 328 1220 
Table 1 - All experimentally observed alternative translation initiation sites (aTIS: 1231 
human, 465 mouse) were mapped onto their corresponding reference genomes (Ensembl 
human GRCh37 and mouse NCBIM37). The dTIS locations were detected throughout several 
mass spectrometry analyses (i.e. data obtained from previously generated N-terminal 
proteomics data ([50, 56-58] and previously unpublished data) and a compilation was 
extracted from the in-house ms-lims system [66] (Appendix Table I.1). The overlap with 
annotated Ensembl, Swiss-Prot or TrEMBL annotated TIS is also provided. For the Ensembl 
mapping an extra subdivision was done based on TIS location in the first (Exon1) or the 
consecutive exons (Exon>1). Also, a comparison was made with the TIS identified in two 
ribosome profiling studies on HEK293 and mESC cell lines (18,19). See the “selection of N-
termini” paragraph within the material and methods section for more explanation on the 
subdivision based on confidence level (either H or L). ‘(+ meta)’ indicates that isoform, 
transcript, ribo-seq and/or orthologues dTIS metadata is available for dTIS originally assigned 
as low confidence (see also Appendix Table I.1). 
For dbTIS, the discrepancy between the numbers of identified protein N-termini and the 
actual proteins is only due to the observed incompleteness of iMet-processing (i.e., cases 
where both the iMet processed and unprocessed N-termini were identified) and thus 
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heterogeneity of the N-terminal proteoforms, while in the case of dTIS, multiple dTIS were 
observed for several proteins. 
Further, the identified N-termini were grouped by mapping them to the first or a subsequent 
exon, with the former category hinting to alternative translation events by leaky scanning or 
reinitiation, whereas the latter, besides representing putative dTIS, might point to TIS 
originating from alternative splicing (Table 1 and Appendix Table I.1). Overall 1,220 human 
dTIS (out of the 1,231 Swiss-Prot N-termini identified) and all 465 mouse dTIS N-termini 
could be mapped onto their corresponding reference genome and their confidence level is 
given in Table 1 and Appendix Table I.1. Meta data related to these d(b)TIS identifications 
are made available as visualization tracks in the H2G2 genome browser 
(http://h2g2.ugent.be/biobix.html, see also Appendix File I).  
Of the dTIS N-termini identified, 18% (n=223) and 15% (n=71) of the Swiss-Prot non-
annotated human and mouse TIS mapped to Swiss-Prot isoform entries and/or indicative 
transcripts in TrEMBL and/or Ensembl, validating our selection strategy for identifying dTIS, 
as these have been experimentally proven to give rise to N-terminally truncated protein 
isoforms (Appendix Table I.1). Overall these numbers are indicative for the fact that our 
dataset is of high quality and thus holds numerous hitherto unreported dTIS sites, here 
discovered at the level of the proteome. 
TIS sequence context analyses 
A survey of the sequence context flanking the dbTIS and dTIS of the Exon1 and Exon>1 
categories using WebLogo [67] revealed a preference of the most crucial Kozak context 
elements being a purine at position -3 and guanine at position +4 [68] in the Kozak motif 
gcc[A/G]ccAUGG(not U) with the dbTIS and dTISexon1 equally well conserved, followed by the 
dTISexon>1 category. Only d(b)TIS locations were taken into account where the complete 
flanking region does not span any splice junction. For the dbTIS, additionally the higher GC 
content in the flanking nucleotide context becomes noticeable [69, 70] (see Figure 1 A. and 
B.).  
A detailed analysis of the human Swiss-Prot dbTIS for which we report an alternative start 
site located in the first exon (i.e. the dTISexon1 category) additionally revealed an increased 
occurrence of suboptimal start codon contexts (with a pyrimidine in position -3 upstream of 
AUG instead of purine [71]). As compared to the start codon contexts of all identified dbTIS, 
an increased suboptimal versus optimal measure of 35.2% versus 19.5% is observed (as 
deduced from input data used in Fig. 1 and Appendix Fig. I.1). According to the leaky 
scanning model [72], the 40S ribosomal subunits can miss an AUG codon in a suboptimal 
context and initiate translation at downstream AUG(s) which is in corroboration with the 
data obtained from GTI-seq data, showing that the strongest Kozak consensus sequence was 
observed in the gene group with no detectable dTIS but with dbTIS initiation, while this 
context was largely absent in the group of genes lacking a detectable translation initiation at
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Figure 1 - A. Homo sapiens TIS WebLogos. The flanking sequences (12 bases upstream, 9 
bases downstream) of the corresponding dbTIS for which a dTIS has been identified, the 
experimentally observed dTIS, located in exon 1 (n = 374), and the experimentally observed 
dTIS, located in subsequent exons (n = 791) are used to create WebLogos. B. Mus musculus 
TIS WebLogos. The flanking sequences (12 bases upstream, 9 bases downstream) of the 
corresponding dbTIS for which a dTIS has been identified, the experimentally observed dTIS, 
located in exon 1 (n = 197), and the experimentally observed dTIS, located in subsequent 
exons (n = 251) are used to create WebLogos. Both the probability and bits values are 
plotted. The discrepancy between the numbers given above and the numbers in Table 1 are 
because splice site spanning flanking sequences were not used to create the WebLogo 
analysis. 
dbTIS [33]. The downstream flanking sites of these downstream start sites in both the 
dTISexon1 and dTISexon>1 categories were further investigated using the AUG_Hairpin software, 
enabling the prediction of downstream secondary structure influencing translation start site 
recognition [71, 73-75]. Following the strategy of Kochetov et al., only those dTIS that show 
a stable stem-loop structure (Etot < -20 kcal/mol) located between 13 and 19 nucleotides 
downstream from the start site were retained. Average energies of eligible stem-loop 
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structures (Etot) were -32.2 kcal/mol and -32.6 kcal/mol for the dTIS with suboptimal and 
optimal start codon contexts respectively (also the distributions of Etot values proved not to 
be significantly different according to a Kolmogorov-Smirnov two-sample test). Overall, the 
presence of the Kozak sequence context in all categories is further indicative for real TIS 
events.  
Conservation analysis 
To assess the possibility of evolutionary conservation of the identified dTIS and their flanking 
sequences as compared to their corresponding dbTIS, the orthologous positions in various 
vertebrate genomes were extracted using phastCons [76, 77] and scored in a multiple 
sequence alignment, thereby generating a metagenic conservation plot (Fig. 2). Also, an 
analysis was made between the identified dTIS and a set of 5,000 randomly chosen, BioMart 
[78] annotated complete CDS (CCDS) translation initiation sites (serving as a proxy for the
global dbTIS landscape, Appendix Fig. I.2). Only d(b)TIS locations were taken into account
where the complete flanking region does not span any splice junction. In general, the
phastCons score (between 0 and 1) gives a probability that each nucleotide belongs to a
conserved element (see Material and Methods for detailed explanation). Overall, the human
and mouse conservation plot indicated that the dTIS are highly conserved, with a mean
conservation score of 0.97 (+/- 0.002, 95% confidence interval) and 0.97 (+/- 0.005) for
respectively the Exon1 and Exon>1 groups compared to the dbTIS with a mean conservation
score of 0.96 (+/- 0.01) and are thus indicative for the fact that the dTIS translation start sites
are very well conserved within eukaryotic genomes in analogy to what was previously
reported by Bazykin et al. [79] using in silico predictive analyses and using in vivo GTI-seq
experiments [33].
Further, the conservation scores of the dTIS flanking regions of both the Exon1 and Exon>1 
groups are high, ranging from 0.9 to 1. Here, next to the translation start codon, other Kozak 
hallmarks such as the guanine at position +4 and purine at position -3 are well conserved. 
Also notable in the dTIS conservation plots - and expected given the higher coding potential 
of the first two nucleotides - is the slightly higher conservation of the first two nucleotides of 
the coding triplets in the translated sequence [80]. This feature is most pronounced in the 
human dTISexon>1 plot. As opposed to the dTIS plots, the flanking 5’ upstream sequences in 
the dbTIS plots score significantly lower as these presumably contain untranslated sequence 
(UTR) in contrast to the 5’ upstream region of the dTIS that contain translated sequence 
encoding for N-terminal protein extensions. No significant differences are obvious between 
the dTIS conservation plots of the Exon1 and Exon>1 groups.  
Statistical testing was performed to assess the sequence conservation surrounding the Kozak 
motif and to increase confidence that the identified sites (dTIS) are genuine translation 
initiation sites. For that purpose we compiled a dataset of decoy sites meeting the following 
criteria: (I) Consensus Coding Sequences (CCDS) were scanned for downstream Kozak 
sequence motifs [A/G]ccAUGG, (II) the identified Kozak sequence motif sites that overlap 
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Figure 2 - Conservation plots for the flanking exonic regions of human and mouse TIS. 
Conservation plots for the flanking (12 bp upstream, 9 bp downstream) exonic regions of 
human (left pane) and mouse d(b)TIS (right pane) are plotted. The conservation measure 
averages the phastCons score at every position of all flanking sequences within the 
subgroups (corresponding dbTIS, dTIS located in exon 1 (Exon1 subgroup), and dTIS located 
in subsequent exons (Exon>1 subgroup)) after alignment based on their translation start site. 
For all flanking positions, the mean is provided together with its 95% confidence interval. 
The upper panels show the conservation plot of the flanking region of corresponding dbTIS 
for which a dTIS has been identified. The middle and lower panel are respectively based on 
flanking regions of dTIS of the Exon1 (n = 374 for human, n = 197 for mouse) and Exon>1 (n = 
791 for human, n = 251 for mouse) subgroups. Only d(b)TIS locations were taken into 
account where the complete flanking region does not span any splice junction 
with dTIS identified in the Nt-COFRADIC mass spectrometry analysis described in this study 
were discarded,  (III) the ones showing an overlap with dTIS identified within the ribosome 
profiling experiments re-analyzed in this study (human (33) and mouse (22)) were also 
discarded. This group of decoy sites was compared with the different categories of TIS 
described in the study: database annotated TIS (dbTIS), downstream TIS located in exon1 
(dTISexon1) and downstream TIS located in further downstream exons (dTISexon>1). The 
PhastCons conservation scores at positions (-3,+1,+2,+3,+4), the most crucial Kozak context 
positions, were averaged for further calculation. A low P-value (4.701e-12 and <2.2e-16 for 
respectively the human and mouse datasets) in a Welsh one-way ANOVA is indicative for a 
difference amongst the four TIS groups (after testing for heteroscedasticity using the 
Levene’s test). In order to determine which particular group of TIS deviates the most, a 
Tukey’s Honestly Significant Difference (Tukey-HSD) post-hoc test (accounting for 
heteroscedasticity by using a heteroscedastic consistent covariance estimation) was 
performed showing a clear difference between the decoy group and the three other sets 
(dbTis, dTISexon1 and dTISexon>1, p-value < 0.001) at a 95% confidence level. 
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Finally, and to further analyze the degree of conservation of dTIS between our human and 
mouse datasets, the experimentally identified mouse and human dTIS were compared. In 
total, of 200 orthologous dTIS pairs, both the human and mouse N-termini could be 
identified (i.e. for 43% of all mouse dTIS identified, the human orthologous N-termini could 
be identified). 
Of these, 29 human and 31 mouse dTIS were originally classified as low confident dTIS. 
Interestingly, and based on the MS/MS-based evidence of Nt-acetylation of these 
orthologous N-termini, 3 human and 9 murine dTIS could now be re-catalogued under the 
reliability class 1 (Appendix Table I.1).  
TargetP analysis 
To have a first approximation of the functional impact of alternative TIS usage, a TargetP 
analysis was performed predicting the subcellular location of the full-length proteins (i.e. 
proteins translated starting from their dbTIS) versus their N-terminally truncated 
counterparts identified (dTISexon1 and dTISexon>1) [81]. Figure 3 (upper and lower panel for 
respectively human and mouse) show that although only a small percentage of the dbTIS 
protein products is predicted to contain a mitochondrial targeting or signal peptide (i.e., 
most likely an underrepresentation, since in most cases signal or transit peptide maturation 
has occurred), a noticeable decrease of secreted or mitochondrial targeted proteins can be 
observed when assessing their N-terminally truncated counterparts (see Figure 3 pie charts, 
Chi-squared test of Independency, p-value < 2.2e-16 for both the human and mouse 
datasets). The bar plots within Figure 3 give a more detailed view, making an extra 
subdivision based on (I) the reliability of the TargetP prediction (class 1 to 5) and (II) whether 
the dTIS is localized in exon1 or in an exon downstream exon1 (exon>1). The more detailed 
bar plots also show a significant drop for the mitochondrial and secretory pathway 
localization categories (“M” and “S”) independent of the reliability classes (1-5) in both the 
exon1 and exon>1 groups (green versus blue bars).  
Overall, the TargetP output strengthens the idea that dTIS usage has an impact on protein 
subcellular localization [35, 36, 82], which was also hypothesized and computationally 
investigated by Cai et al. [83] and in fact proven for a variety of N-terminal protein isoforms 
generated by means of alternative translation initiation. 
Ribosome profiling data provide independent experimental support for N-terminomics 
data 
Interestingly, of the here identified TIS, complementary ribo-seq TIS profiling data are 
available for 861 of the 1,755 transcript-matching mouse dbTIS (49%), 69 of the 465 mouse 
dTIS (15%), 1,150 of the 2,841 human dbTIS (40%) and 105 of the 1,220 human dTIS (9%) 
(Appendix Table I.1), thereby providing evidence that these represent genuine translation 
initiation sites in mouse and human transcripts [22], and thus that these N-termini are 
representative for N-terminal protein variants. 
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Figure 3 - TargetP analysis of the protein products generated by dbTIS versus dTIS usage. 
TargetP predicts both N-terminal mitochondrial targeting peptide (mTP) and signal peptides 
(SP) processing, respectively reflecting mitochondrial and secretory pathway localization. 
Both human (upper pane) and mouse (lower pane) are plotted. The pie charts depict the 
overall localization patterns of the dTIS and dbTIS translation products. The more detailed 
bar charts make an extra subdivision based on (I) the reliability of the TargetP prediction 
(class 1 to 5, where 1 indicates the strongest prediction) and (II) whether the dTIS is localized 
in exon1 or in an exon downstream exon1 (exon>1). The green and blue bars respectively 
correspond to N-terminal isoforms raised upon dbTIS and dTIS usage, dark and clear bars 
represent the Exon1 and Exon>1 group respectively. The X-axis shows the predicted 
localizations (“M” stands for mitochondrial, “S” for secretory pathway) and the reliability of 
that prediction (class 1 to 5). The rightmost bars depict the combination of all reliability 
classes (“All M” and “All S”). The Y-axis corresponds to the total number of TIS events falling 
within the groups depicted in the X-axis. 
As such, the experimental evidence obtained by ribosome profiling-assisted TIS identification 
categorizes 47 extra mouse dTIS and 66 extra human dTIS to reliability class 1, thereby 
increasing the percentage of validated dTIS to 27% (n=125) and 22% (n=272) in mouse and 
human respectively (Appendix Table I.1). 
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Overall, and when taking into account the available isoform, transcript, ribo-seq and 
orthologues dTIS metadata, 24 extra mouse dTIS and 42 extra human dTIS originally assigned 
as low confidence, are now classified as highly likely genuine dTIS, respectively summing up 
to 73% (n=900) and 64% (n=298) of all identified human and mouse dTIS having data that 
support their translation initiation potency (Appendix Table I.1). 
Since the translatome (i.e. the ORF delineation and the translation initiation landscape) can 
be specifically delineated using ribosome profiling data, usage of this type of data does not 
necessitate translation into its three reading frames, hence decreasing the search space 
tremendously. Alongside, non-canonical codons serving as alternate initiation codons are 
depicted. These near cognate translation initiation codons can either be decoded as the 
expected initiator methionine residue or alternatively to their coding-matching amino acid 
as for example leucine-decoded CUG starts of translation initiations have been reported [84, 
85]. For these reasons, customized sample-oriented and ribosome profiling derived protein 
databases were created which served as custom-made reference datasets for the proteomes 
under study [86].  
In the mouse proteomes, besides the additional full-length protein N-termini identified (i.e., 
N-termini not enclosed in the Swiss-Prot database), 17 N-termini indicating N-terminal
protein extensions were identified (Appendix Table I.1). Four N-terminal extensions were
generated upon translation initiation at an AUG codon, in addition, 13 were produced by
translation initiation at near cognate start codons; being GUG (6 N-termini), CUG (4) and
ACG (3) normally encoding for respectively Val, Leu and Thr, but decoded to Met as evident
from the iMet-retaining N-termini identified. Besides, the N-termini of an uORF and a dTIS
protein product could be identified using respectively GUG and CUG as start codon.
In human, 17, 4 and 2 N-termini respectively hinted to N-terminal protein extensions, N-
terminally truncated and overlapping uORF protein products, 22 of which were generated 
upon translation initiation at a near-cognate start codon (Appendix Table I.1). Besides, these 
database searches led to the identification of some additional dbTIS, not contained in the 
Swiss-Prot database (Appendix Table I.1). 
TIS mutagenesis analyses reveal that N-terminal protein isoforms of the class dTISexon1 are 
generated by means of leaky ribosomal scanning  
To further verify whether some of the alternative TIS products identified are raised by 
alternative translation initiation, in vitro translation studies of (mutagenized) dTIS holding 
coding sequences (CDS) flanked by (a part of) their presumed 5’UTR were performed using 
coupled in vitro transcription/translation assays. In general, mutation of AUG to CUG 
typically abolished or greatly diminished translation initiation at these sites. In all cases 
distinct protein bands corresponding to the short N-terminal protein isoform(s) (i.e. dTIS 
products), identified by proteomics means, and the database annotated variant could be 
observed (Fig. 4).  
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Figure 4 - In vitro translation of TIS-mutagenized constructs reveal the existence of the by 
proteomics identified N-terminal protein variants. Wild type and d(b)TIS mutagenized 
pOTB7 constructs encoding N-terminal variants of aminoacyl tRNA synthase complex-
interacting multifunctional protein 2 (AIMP2), inhibitor of kappa light polypeptide gene 
enhancer in B-cells kinase gamma (NEMO), Zinc finger protein 296 (ZN296), splicing factor 3a 
subunit 3 (SF3A3), cytoplasmic aspartate-tRNA ligase (SYDC), cytokine receptor-like factor 3 
(CRLF3), Nucleosome assembly protein 1-like 1 (NP1L1) and pyridoxamine 5'-phosphate 
oxidase (PNPO) were in vitro transcribed and translated. Following SDS-PAGE and 
electroblotting, radiolabeled proteins were visualized by radiography. Assignments of the 
precursor band corresponding to the database annotated protein sequences (black 
arrowhead) and protein products raised upon dTIS usage (orange and dashed arrowheads) 
were verified by mutating their respective initiator methionine. A grey arrow points to 
translation initiation events at dTIS which were not identified by proteomics means. An 
asterisk is indicative of an unspecific protein band produced in the control in vitro 
transcription and translation reaction (i.e. a reaction without input DNA). In each case the 
theoretical molecular weights of the identified N-terminal protein variants are indicated. 
Further, since the mutation of the canonical initiation site affected the production of the 
truncated isoform(s) and vice versa (i.e. some truncated N-terminal isoforms were only 
detected when the dbTIS were mutagenized), our results strongly indicate that the dTIS 
products are produced by alternative translation initiation via leaky ribosomal scanning at 
internal translation start sites. Besides, in some cases a deviation from the 5’ polarity of 
scanning could be observed for closely spaced AUG codons (up to 16-19 nt). As a result of 
the proposed reverse directionality of scanning (3’ to 5’), a lower initiation frequency at a 5’ 
proximal AUG could be observed in the presence of (a) nearby downstream AUG(s), 
suggestive of downstream nucleotides inferring a restricted relaxation to the forward 
directionality of scanning of the proximal AUG [87]. 
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Discussion 
The most acknowledged mechanism of protein diversification in mammalian genomes is 
alternative splicing, where different mRNAs are derived from the same nascent transcript. 
Only recently, alternative translation initiation from a single mature transcript was 
recognized as an important and wide-spread mechanism of protein diversification, further 
highlighting the importance of gene functionality [22, 33]. 
As previously postulated, targeted analysis of protein N-termini is ideally suited to study N-
terminal protein isoform diversity [35].  
In this study, we report on more than 1,700 alternative translation initiation events in mouse 
and human cell lines by applying stringent rules for mass spectrometric based identifications 
of N-terminal peptides. Besides, our detailed understanding of the specificity of the Nt-
acetyltransferases and co-translational processes in general assists in judging if such 
peptides indeed report protein translation events and thereby allow for the functional (re-
)annotation of genomes. For a significant fraction of the here reported TIS, available 
metadata from transcripts, ribosome profiling, TIS sequence context and conservation 
analyses served as evidence that our N-terminal selection provides a very powerful strategy 
to map the TIS landscape in higher eukaryotes. In addition, and as is the case for the high 
mobility group proteins HMGB1, HMGB2 and HMGB3, next to the orthologues matching dTIS 
sites, corresponding dTIS sites in all three homologues could be identified (Appendix 
Table I.1). These observations are further strengthened by the fact that previously reported 
dTIS products of the Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) [88], 
Glucocorticoid receptor (GCR) [89], Insulin-degrading enzyme [90], Regulator of G-protein 
signaling 2 [91] and the BAG family molecular chaperone regulator 1 [92] - of which the N-
terminal isoform expression was shown to display a stage- and site-specific expression 
profile during mouse development - were also identified in this study (Appendix Table I.1). 
Ribo-seq and GTI-seq in mammalian cells revealed that only half of the TIS codons made use 
of AUG as the translation initiation codon. However, in the study of Lee et al. [33], TIS codon 
usage was shown to be distinct when residing in the presumed 5’UTR (uTIS) as opposed to 
the annotated CDS. When outside the dbTIS/dTIS reading frame, uTIS are mostly associated 
with short ORFs and were mostly non-AUG codons, while dTIS, typically encoding for N-
terminal truncated protein variants predominantly made use of AUG codons, an observation 
which is in line with our data and the fact that only 37 protein products raised upon 
translation initiation at near-cognate start codons, typically giving rise to N-terminal protein 
extensions, were identified in our mouse and human datasets based on available ribo-seq 
datasets [22, 33]. Further, a recent computational analysis of ribosome profiling data 
calculating the efficiencies of individual translation initiation sites, revealed that despite the 
high frequency of non-AUG translation initiation sites identified by means of ribosome 
profiling, the probability of initiation at non-AUG codons was found to be considerably lower 
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than at AUG codons (data presented by Pavel Baranov at the EMBO Conference Series 
‘Protein Synthesis and Translational Control’, Heidelberg, Germany 2013 [93]), likely 
explaining their general underrepresentation in the N-terminomics datasets here presented. 
In addition to translation reinitiation for alternative translation initiation, GTI-seq 
demonstrated that leaky scanning was the major contributing mechanism leading to TIS 
selection since the strongest Kozak consensus sequences were observed in the gene group 
with dbTIS selection but no detectable dTIS, while dTIS selection was observed when a weak 
or no consensus sequence context of the dbTIS was present, enabling for an estimation of 
the leakiness of the first AUG codon and again confirming our proteome data.  
Our TargetP analyses as well as other multiple lines of evidence indicate that alternative 
translation initiation can give rise to iso-functional though localization-specific N-terminal 
protein variants making translation initiation a very attractive mechanism of regulating 
protein localization as previously reported for the p43 Component of the Multisynthetase 
Complex [37] where a mitochondrial targeting sequence is lost when translation initiation 
proceeds via a dTIS, while in contrast, translation initiation at a dTIS in Flap endonuclease 1 
(FEN-1) exposes a cryptic mitochondrial targeting signal [38], two cases contributing to the 
increased complexity of the mitochondrial proteome [39].  
Although translation initiation at dTIS found in close proximity to dbTIS are more likely to 
yield isofunctional and localization non-distinct N-terminal isoforms, thereby providing a 
potential fail-safe mechanism for translation initiation to occur, it is noteworthy that the N-
terminal identity of a protein is critically important in determining protein stability. More 
specifically, the N-end rule relates the regulation of the in vivo half-life of a protein to the 
identity of (the N-terminal modification of) its N-terminal residue. Therefore, the loss of 
even a single N-terminal amino acid or its modification can significantly impact protein 
stability [94] (see also Results Chapter 2 [95]), influence protein localization [96] and protein 
complex formation [97] amongst others. Finally, our TargetP analyses shows a clearly 
noticeable change in localization in both exon1 and exon>1 groups for both the human and 
mouse datasets (Fig. 3) indicative that the findings of altered subcellular 
localization/functional diversification also applies to the broader set of alternative 
translation events identified in this study. 
Besides steering protein localization and protein stability, TIS selection can also regulate 
protein expression levels. For example, hypo- or hypermorphic point mutations introducing 
premature translation termination codons in the first exon can result in the production of 
truncated protein variants through translation initiation at in-frame methionines 
downstream the nonsense mutation [98-100]. Two such examples for which various dTIS 
sites were identified in this study include the nuclear factor kappa B (NF-κB) essential 
modulator (IKKγ/NEMO) and the NF-κB inhibitor IκBα [98-100] (Fig. 4 and Appendix 
Table I.1). Premature translation termination codons in these genes - although leading to the 
residual production of a truncated variant sufficient for the non-lethality observed during 
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development - have been shown to underlie specific cases of the genetic disorder anhydrotic 
ectodermal dysplasia with immune deficiency. The (presumed) dTIS of both reported 
truncated protein variants have here been identified as being in vivo Nt-acetylated (Ac-
M38LHLPSEQGAPETLQR (NEMO) and Ac-M37KDEEYEQMVKELQEIR (IκBα)), indicative for the 
fact that, as demonstrated to be the case for wild type NEMO transfected cells, a (limited) 
translation initiation of IκBα at these alternative methionines can also occur under normal 
cellular conditions. The dTIS product of IκBα lacks the two amino-terminal IκB kinase (IKK) 
phosphorylation sites known to be essential for targeting IκBα for proteasomal degradation, 
and as a result the degradation-resistant variant acts as a dominant negative regulator of NF-
κB activity. The mutation in IKKγ/NEMO, the scaffolding subunit of the IKK complex, gives 
rise to a truncated but functional variant that is produced in limited, insufficient amounts for 
the development of protective immune responses. In vitro transcription/translation assays 
independently confirmed that the 44 kDa isoform of NEMO is the product of alternative 
translation initiation at the internal Met38. Here, close to the canonical start codon, other 
start codons are located downstream of the database annotated iMet1 (i.e. GxxAUGG and 
GxxAUGC), corresponding to the (surrounding) nucleotide motifs of methionines 13 and 38. 
The likelihoods of these AUG codons to act as translation initiation sites were estimated 0.29 
and 0.27 versus 0.54 for the first AUG codon (TxxAUGA) (translation initiation prediction at 
http://atgpr.dbcls.jp). As such, various mutagenized constructs were made (Fig. 4) in which 
the presumed initiator Met1, the internal Met13 and/or Met38 were mutagenized to 
monitor translation initiation at these sites. Expression from the coding sequence alone 
resulted in the production of two clearly distinct protein forms (Fig. 4, WT sample), of which 
the expression of shorter isoform was lower as compared to its full-length counterpart, 
indicative for leaky ribosome scanning. Further, mutagenesis of Met13 also resulted in two 
distinct bands of which the higher MW band runs approximately 1 kDa lower as compared 
the highest MW band of the WT construct and thus probably indicative for the fact that the 
higher MW band observed encompasses the products of translation at Met1 and Met13, an 
observation which is confirmed when Met 13 or alternatively Met 38 is mutated. The fact 
that translation initiation may occur at Met 1 and Met 13 is further supported by the 
observation that cellular expression of the WT and M38A mutant resulted in a somewhat 
smeared out precursor band [100] and that the TrEMBL and Ensembl databases hold 
preliminary entries of this Met13 initiated protein variant. The combined Met 13/38 mutant 
seems to express the 44 kDa form besides residual translation initiation at the first non-
canonical mutant CUG codon. Although, in vitro translation from the triple AUG to CUG 
mutant construct is significantly impaired, residual translation initiation (mainly at the near-
cognate start codon decoded to Met38) can still be observed. Overall, we observed 
translation at three different AUG codons in NEMO, of which the translation product starting 
with Met38 was identified using N-terminal proteomics in the proteomes of K562, THP-1 and 
B-cells.
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Figure 5 - Representation of the single exon encoding mouse and human JUNB protein in 
the H2G2 genome browser. Several information tracks are presented. From top to bottom: 
(I) Ensembl Gene annotation, (II) Ensembl Transcript annotation, (III) ribosome profile data
of control human HEK293t A. and mESC cell line sample B. showing profiles alongside the
CDS, (IV) ribosome profile data of lactimidomycin (LTM) treated human HEK293t A. and
harringtonine treated mESC cell line sample B. showing profiles alongside the CDS, (V) ribo-
seq predicted TIS, (VI) the translation product prediction based on the two aforementioned
tracks, (VII) TrEmbl annotated TIS, (VIII) Ensembl annotated TIS and (IX) dbTIS and (X)
alternative TIS identified using N-terminal COFRADIC. Two zoomed figures (in black boxes)
are also depicted, representing a more detailed view of the genomic region around the
translation initiation site of the N-terminal truncated JUNB protein isoform in human A. and
mouse B. identified using N-terminal COFRADIC, clearly demonstrating the use of an
alternative initiation site (ATG) and accumulated ribo-seq signals at this start site in human
and mouse. Furthermore an alignment of the mouse and human N-terminal protein
sequences of the transcription factor jun-B and d(b)TIS conservation is presented together
with the C. autoradiograph showing translation initiation of in vitro transcribed JUNB at the
AUG start codons encoding M1 and M5.
Further, ribosome profiling data where the utmost 5′ AUG triplet resides in a suboptimal 
context (absence of a purine at −3 and/or G at +4) suggested that more than one quarter of 
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the human transcripts showed clear evidence of downstream translation initiation and thus 
could display a bi- or multicistronic behavior [33], meaning that these mRNAs could produce 
more than one polypeptide through leaky scanning. Many of these hypothetical cases would 
be expected to involve the production of small peptides or N-terminal truncated protein 
isoforms that have routinely been excluded from database sequence annotations.  
Despite the multitude of alternative TIS here identified, linking over 30% of the protein N-
termini to alternative translation initiation, for the majority of them their spectral counts 
(Appendix Table I.1) hint to a general lower translation efficiency and thus likely lower 
concentration of protein products expressed from such secondary initiation codons. 
Nonetheless, potent functions of such possibly lower abundance dTIS protein products have 
been demonstrated,as in the case of the mitogenic osteogenic growth peptide (OGP) 
translated by leaky scanning from mammalian histone H4 mRNA [101]. Strikingly however, 
when TIS are relatively closely spaced (i.e. resulting in N-terminal protein isoforms differing 
less than about 6 amino acids), spectral counts and our in vitro translation results hint to a 
more balanced expression, likely linking this to a proximity effect previously shown to modify 
the strict sequential constraint of regular leaky scanning into a more competitive feature 
[87]. In this respect, it is important to note that such protein products can easily be 
overlooked by conventional detection technologies such as western blotting despite their 
potent expression, as here shown to be the case by mutagenesis studies enabling 
visualization of the N-terminal AIMP2, JUNB, UCHL1 and CRLF3 isoforms generated by 
translation initiation at closely spaced AUG start codons (Fig. 4-6).  
Further, the bioinformatics-assisted integration of positional proteomics and available 
ribosome profiling data enabled for a more sensitive and comprehensive protein discovery, 
thereby enabling a global (re-)annotation of the translation initiation landscape [31, 86]. 
Interestingly, the high overlap of alternative translation products identified in this 
comprehensive study with those from a previous positional proteomics study that focused 
on the TIS-landscape in mouse embryonic stem (mESC) cells, further hints to their functional 
importance and conservation. In contrast however to the majority of translation products 
linked to alternative translation initiation as observed in ribosome profiling, the repertoire 
reported in this study is mainly confined to translation products raised upon downstream 
AUG besides some upstream non-cognate codon usage, meaning that the products of uORF 
and out-of-frame translation generally remain undetected. Although the sensitivity of 
ribosome profiling to detect TIS sites and translation products remains unprecedented, the 
bioinformatics-oriented approaches used to assign TIS in ribosome profiling in some cases 
appear ineffective (e.g. the dTIS in JUNB here identified, clearly provided a discrete LTM and 
Harringtonin signal in the human and mouse ribo-seq datasets [22, 33], though remained 
undetected by the strict training algorithm used in the original Ingolia et al. study (Fig. 5)). 
This, as well as the occurrence of co-translational protein modification events and the recent 
finding that mRNA ribosome occupancy does not necessarily hints to effective translation 
[102], necessitate the need for proteomics endeavors to identify the (mature) translation 
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products. As such, we foresee that the complementary use of proteomics approaches and 
ribosome profiling will further assist in the comprehensive cataloguing of TIS ultimately 
leading to detectable and functional translation products. 
Figure 6 - Representation of the human UCHL1 protein in the H2G2 genome browser. A. 
Information tracks are presented as in Fig. 5. Furthermore an alignment of the N-terminal 
UCHL1 mouse and human protein sequences and d(b)TIS conservation is presented together 
with the autoradiograph (B.) showing translation initiation of in vitro transcribed ubiquitin 
carboxyl-terminal hydrolase isozyme L1 (UCHL1) at the AUG start codons encoding M1 and 
M6 and M12. 
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Materials and Methods 
Cell culture 
Human epithelial colon (HCT116) and human epidermoid (A-431) cells were grown in 
Dulbecco's Modified Eagle's Medium (DMEM) medium supplemented with 10% fetal bovine 
serum and penicillin/streptomycin. Human monocytic THP-1 cells and human primary B-cells 
were grown in HyClone Roswell Park Memorial Institute (RPMI) medium supplemented with 
10% fetal bovine serum and penicillin/streptomycin (all Invitrogen). Primary mouse dendritic 
cells [57], mouse macrophage Mf4/4 [58], mouse lymphoblast YAC-1, human lymphoblast K-
562 and Jurkat [56] and human epithelial cervix HeLa [50] cells were cultured as described 
previously. All cell lines were purchased from ATCC.  
N-terminal COFRADIC and LC-MS/MS analysis
N-terminal COFRADIC analyses were performed as described previously [103]. To enable the
assignment of in vivo Nt-acetylation events, all primary protein amines were blocked making
use of a (stable isotopic encoded) N-hydroxysuccinimide ester at the protein level (i.e. NHS
esters of 13C2D3 or D3 acetate).
LC-MS/MS analysis was performed as described previously ([50] and [48]). The generated 
MS/MS peak lists were searched with Mascot using the Mascot Daemon interface (version 
2.2.0, Matrix Science). Searches were performed in the Swiss-Prot database with taxonomy 
set to human or mouse (UniProtKB/Swiss-Prot database version 2012_03, containing 20,254 
human and 16,513 mouse entries (535,248 sequence entries in total)) or using custom 
databases (combination of UniProtKB/Swiss-Prot and ribo-seq derived translation sequences 
[86]).  
13C2D3- or D3-acetylation at lysines, carbamidomethylation of cysteine and methionine 
oxidation to methionine-sulfoxide were set as fixed modifications for the N-terminal 
COFRADIC analyses. Variable modifications were 13C2D3-acetylation, D3-acetylation and 
acetylation of protein N-termini. Pyroglutamate formation of N-terminal glutamine was 
additionally set as a variable modification. Endoproteinase Arg-C/P (Arg-C specificity with 
arginine-proline cleavage allowed) was set as enzyme allowing no missed cleavages. The 
mass tolerance on the precursor ion was set to 10 ppm, 0.2 Da and 0.5 Da, and on fragment 
ions to 0.5 Da, 0.1 Da, 0.5 Da for the Orbitrap, Q-TOF Premier and Ion Trap analyses 
respectively.  The peptide charge was set to 1+, 2+, 3+ and instrument setting was put to ESI-
TRAP for Orbitrap and Ion Trap analyses and to ESI-QUAD-TOF for Q-TOF Premier analyses. 
Only peptides that were ranked one and scored above the threshold score, set at 99% 
confidence, were withheld. The estimated false discovery rate by searching decoy databases 
(a shuffled version of the yeast Swiss-Prot database made by the DBToolkit algorithm [104]) 
was found to lie below 1.5% on the spectrum level. All annotated highest scoring spectra of 
the N-terminal peptides reported in Appendix Table I.1 are provided as supplemental data. 
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Selection of N-termini 
From the mouse and human N-terminal datasets, N-terminally blocked peptides were 
selected and classified. The high confident TIS encompass: i.) all (partially) in vivo Nα-
acetylated N-termini and in vivo unmodified N-termini of which the start position 
corresponded with a Swiss-Prot isoform, Ensembl and/or TrEMBL annotated TIS site, ii.) iMet 
processed or iMet retaining counterparts of in vivo Nα-acetylated N-termini, iii.) N-termini 
matching TIS previously identified by ribosome profiling, iv.) N-termini annotated as dbTIS in 
(a) prior Swiss-Prot release(s), v.) N-termini for which the iMet processed and/or iMet
retaining orthologous N-terminal peptide (HomoloGene) was identified as being (partially)
Nα-acetylated in vivo.
Sequence logo analysis 
All experimentally observed alternative N-termini were aligned based on their translation 
start codon. The N-terminal peptides lacking the initiator methionine (iMet) were preceded 
with the iMet to rule out codon shifts in the sequence logo creation. Afterwards, all peptides 
were mapped to their coding sequence (Perl scripting using the Ensembl API). Sequence 
logos were created based on the aligned transcript sequences (12 bp upstream and 9 bp 
downstream) using WebLogo 3 (http://weblogo.threeplusone.com, [105]). Sequence logos 
were plotted using both the residue probability and information content in bits as measure. 
Sequence logos were created for both the dTIS and corresponding dbTIS flanking regions. 
Also, an extra positive control to the dTIS sequence logos was generated based on 5,000 
randomly selected coding sequences corresponding to annotated translation initiation sites 
from CCDS [106] proteins were aligned for nucleotide context logo creation. 
Ribosome profiling and genome-wide visualization 
Raw sequencing reads of the mESC ribosome profiling data [22] were downloaded from the 
Gene Expression Omnibus (dataset GSE30839). All reads from the control (cycloheximide 
treated, also referred to as CHX treated, sample GSM765292) and harringtonine treated 
(sample GSM765295) were remapped using bowtie (v.0.12.7) on the mouse genome 
(assembly version 37) using the protocol described [107]. All HEK293 cell line GTI-seq data 
[33] was downloaded from the NCBI Sequence Read Archive (accessions: SRX172392,
SRX172361, SRX172360, SRX172315) and processed in the same way.
Genome-wide visualization of the experimental data, in combination with publicly available 
data, was accomplished using an in-house developed genome browser (H2G2, 
http://h2g2.ugent.be/biobix.html). Information tracks containing the ribosome profile/GTI-
seq mappings of the CHX treated samples (generating a translation profile all over the coding 
mRNA) and harringtonine/lactimidomycin treated samples (translation profile accumulation 
at the TIS) are available (see [22] for more information). Furthermore, an information track is 
constructed showing the predicted translation products, based on the TIS-predictions from 
Ingolia et al. [22] and Lee et al. [33] (for respectively the mESC and HEK293 cell line sample) 
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and the UCSC transcript annotation. The genomic locations of the N-terminal peptides 
identified by means of N-terminal COFRADIC are also visualized in the H2G2 browser. Other 
visualization tracks include genomic information from a local Ensembl [108] instance 
NCBIM37.66, transcript tracks holding the annotated TIS within the UniProtKB and Ensembl 
database and a conservation track based on the phastCons [76, 77] conservation scores 
amongst others. More information on how to use the H2G2 browser can be found in the 
Appendix File I.1.  
Genomic annotation of the identified dbTIS and aTIS 
All Swiss-Prot annotated N-termini (dbTIS) and alternative N-termini (aTIS) were mapped to 
their corresponding reference genome (GRCh37 for human and NCBIM37 for mouse) based 
on the UniProt-KB/Swiss-Prot accession number (or alternatively the Swiss-Prot gene name) 
and the N-terminal peptide sequence (PeptideMapper script based on the BioMart [78] and 
Ensembl [109] API, version 66). The genomic locations of the experimental aTIS and dbTIS 
locations were made available as a visualization track in the H2G2 genome browser (see 
above). Two projects are made available (named TIS Human and TIS Mouse) using a public 
login (see Appendix File I.1 for more details). These projects hold several visualization tracks 
(see fig 5 and 6 for examples): (A) an Ensembl gene track (B) an Ensembl transcript track 
(visible after mouse-click on the gene track), and tracks holding (C) the annotated TIS within 
the UniProtKB database split into Swiss-Prot and trEMBL (D) the annotated TIS within the 
Ensembl database (E) the reported aTIS and dbTIS locations (F) a conservation track based 
on the phastCons [76, 77] conservation scores based on alignment of 45 and 29 vertebrate 
genomes respectively for human and mouse. Furthermore all genes where an aTIS or dbTIS 
has been identified by means of the N-terminal COFRADIC experiments are listed in 
“GeneDigest” reports within the H2G2 genome browser environment.  
The aTIS “GeneDigest” report lists all genes wherefore an alternative start site is reported, 
whereas the dbTIS “GeneDigest” report lists all genes of which a Swiss-Prot database 
annotated TIS has been identified. A third “Genedigest” report lists extra translation start 
sites identified from the N-terminomics experiments searching a protein product database 
constructed based on ribosome profiling sequence information [22] (see above). Further, 
experimental ribo-seq data [22] are also presented as custom tracks, allowing manual 
inspection of co-occurrence of N-terminal COFRADIC and ribo-seq experimental evidence. 
Conservation analysis 
To assess the evolutionary conservation potential of the identified d(b)TIS and their flanking 
sequences as compared to 5000 randomly chosen, BioMart [78] annotated CCDS translation 
initiation sites, their orthologous positions in various vertebrate genomes were extracted 
using phastCons [76, 77] and scored in a multiple sequence alignment. The phastCons 
program computes conservation scores based on a phylo-HMM, a type of probabilistic 
model that describes both the process of DNA substitution at each site in a genome and the 
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way this process changes from one site to the next. The value plotted at each site is the 
posterior probability that the corresponding alignment column was “generated” by the 
conserved state of the phylo-HMM.  
TargetP analysis 
To categorize the subcellular location of the proteins translated from their annotated versus 
their alternative N-termini, a targetP prediction (v1.1b, [110]) was performed. The location 
assignment is based on a predicted N-terminal presequence: a mitochondrial targeting 
peptide, or a secretory pathway signal peptide. 
Generation of TIS mutagenized CDS and in vitro translation assays 
pOTB7 vectors (RZPD Imagenes, Germany) encoding aminoacyl tRNA synthase complex-
interacting multifunctional protein 2 (AIMP2), inhibitor of kappa light polypeptide gene 
enhancer in B-cells kinase gamma (NEMO), Zinc finger protein 296 (ZN296), splicing factor 3a 
subunit 3 (SF3A3), cytoplasmic aspartate-tRNA ligase (SYDC), ubiquitin carboxyl-terminal 
hydrolase isozyme L1 (UCHL1), transcription factor jun-B (JUNB), cytokine receptor-like 
factor 3 (CRLF3), Nucleosome assembly protein 1-like 1 (NP1L1) and pyridoxamine 5'-
phosphate oxidase (PNPO) served as templates for site-directed PCR-mutagenesis 
(QuickChange, Stratagene) according to the manufacturer’s instructions using the primer 
pairs indicated in Appendix Table I.2. The correctness of all (mutant) cDNA sequences 
generated was confirmed by DNA-sequencing. 
The mutagenized constructs were used as templates for in vitro coupled 
transcription/translation in a rabbit reticulocyte lysate system according to the 
manufacturer’s instructions (IVTT; Promega) to generate [35S]methionine labeled protein 
products. 5 µl of the translate reaction was diluted 10-fold in 10 mM Tris pH 8.0. NuPAGE 
LDS Sample Buffer (Invitrogen) was added and the samples heated for 10 min at 70 °C. 
Samples were separated on 4-12% NuPAGE Bis-Tris gradient gels (1.0 mm x 12 well) 
(Invitrogen) using MOPS Buffer. Subsequently, proteins were transferred onto a PVDF 
membrane, air-dried and exposed to a film suitable for radiographic detection (ECL 
Hyperfilms, Amersham Biosciences, Buckinghamshire, UK). Radiolabeled proteins were 
visualized by radiography.  
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Abstract 
To understand the impact of alternative translation initiation on a proteome, we performed 
a proteome-wide study on protein turnover using positional proteomics and ribosome 
profiling to distinguish between N-terminal proteoforms of individual genes. By combining 
pulsed SILAC with N-terminal COFRADIC we monitored the stability of 1,941 human N-
terminal proteoforms, including 147 N-terminal proteoform pairs that originate from 
alternative translation initiation, alternative splicing or incomplete processing of the initiator 
methionine. N-terminally truncated proteoforms were less abundant than canonical 
proteoforms and often displayed altered stabilities, likely attributed to individual protein 
characteristics, including intrinsic disorder, but independent of N-terminal amino acid 
identity or truncation length. We discovered that the removal of initiator methionine by 
methionine aminopeptidases reduced the stability of processed proteoforms, while 
susceptibility for N-terminal acetylation did not seem to influence protein turnover rates. 
Taken together, our findings reveal differences in protein stability between N-terminal 
proteoforms and point to a role for alternative translation initiation and co-translational 
initiator methionine removal, next to alternative splicing, in the overall regulation of 
proteome homeostasis.  
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Introduction 
Protein stability has been suggested to reflect the individual properties and biological 
functions of proteins [1, 2]. In eukaryotic cells, a wide variety of proteins with roles in cell 
cycle progression, signal transduction and metabolic regulation are quickly degraded by the 
proteasome [3], whereas some constituents of abundant protein complexes (such as the 
ribosome and the spliceosome) are extremely stable [1, 2]. Short-lived proteins are 
predicted to have an increased aggregation potential, which often places them central in 
protein deposition diseases correlated with ageing and reduced proteasome activity [4]. 
Estimations of the impact of protein turnover on gene regulation revealed that protein 
synthesis and degradation rates are comparable for proteins within functional protein 
classes and among individual components of macromolecular protein complexes [5]. As 
such, protein stability is undoubtedly a key component that regulates the outcome of gene 
expression and shapes cellular phenotypes. Large-scale studies of proteome dynamics in 
living cells were made possible by applying stable isotope labeling, including SILAC (stable 
isotope labeling by amino acids in cell culture), in combination with mass spectrometry. To 
measure protein turnover, cells are usually pulsed with media containing stable isotopic 
variants of essential amino acids and the rate of incorporation of these newly added 
isotopes then enables calculating the protein half-life [1, 6, 7]. 
In several recent N-terminomics analyses using mouse and human cell lines, we showed that 
the prevalence of translation start sites not annotated in protein sequence databases was 
underestimated. More specifically, we found that 10-20% of all protein N-termini resulted 
from alternative translation initiation events, pointed to inadequately annotated protein 
start sites or to alternative splicing [8-10]. Scarce evidence indicates that alternative 
translation initiation can produce proteins variants – proteoforms [11] – that differ in 
stability when compared to their database-annotated counterparts [12]. As an example, 
alternative translation initiation of the opioid receptor that results in an N-terminal protein 
extension rich in lysine residues and prone to ubiqitination, contributes to the high 
degradation rate of this proteoform [12]. 
Triggered by such atomistic studies, we set out to study on a more global scale if N-terminal 
proteoforms derived from the same gene showed different stabilities. In contrast to other 
proteome studies that do not distinguish between N-terminal proteoforms, we here 
combine SILAC pulse-labeling [2] (pSILAC) with N-terminal COFRADIC (COmbined FRActional 
DIagonal Chromatography) [13] to study the stability and turnover rates of proteoforms with 
heterogeneous N-termini. Important here is that we rely on known (previously identified [9]) 
N-terminal modifications to unambiguously assign an identified peptide as a proxy for a
protein’s N-terminus. Indeed, N-termini of eukaryotic proteins typically undergo co-
translational modifications, which can be used to discriminate N-termini pointing to
translation initiation events from those pointing to proteolytic cleavage using mass
spectrometry [14]. For example, methionine aminopeptidases typically remove the initiator
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Met (iMet) if the side chain of the next amino acid has a small gyration radius like found in 
alanine (Ala), valine (Val), serine (Ser), threonine (Thr), cysteine (Cys), glycine (Gly) or proline 
(Pro) [15]. Subsequently, the alpha-amino group of the resulting N-terminus, with the 
exception of Pro, are frequently modified by N-terminal acetylation (Nt-acetylation) 
catalysed by N-terminal acetyltransferases (Nt-acetyltransferases or NATs) [16]. iMet-
retaining N-termini may also be Nt-acetylated, largely depending on the sequence specificity 
of the NAT involved [17, 18]. Taken together, up to 90% of all human proteins undergo 
either partial or complete Nt-acetylation [19]. For several cases Nt-acetylation was shown to 
alter protein interactions, functions and structure [20-23]. Moreover, protein N-termini have 
other unique properties, such as increased disorder (the lack of a fixed dimensional 
structure) [24]. Surprisingly, the length of N-terminal disorder strongly correlates with the 
probability of protein Nt-acetylation, with highly disordered sequences being more 
frequently Nt-acetylated. As a consequence, it was suggested that Nt-acetylation may play a 
role in structural stabilization. More specifically, Nt-acetylation of alpha-synuclein was 
shown to stabilize the helicity of its N-terminus [22] and loss of Nt-acetylation seems to 
inhibit aggregation of prion proteins [24]. Moreover, Nt-acetylation may have important 
roles in protein stability. Although it was long believed that Nt-acetylation may prevent 
protein degradation by the ubiquitin system [25], other studies indicated that Nt-acetylated 
proteins are not significantly more stable or shielded from proteolytic degradation [26]. The 
N-end rule further explores the relationship between the in vivo protein half-life and the
identity of a protein’s N-terminal amino acid(s). In summary, the N-end rule links the
removal of protein substrates covering the whole spectrum of N-terminal identities, except
of Pro- and Gly-starting N-termini. Degradation signals encoded by N-terminal residues,
referred to as N-degrons, may be recognised by specialised E3 ubiquitin ligases and the N-
end rule consists of two major branches, being the Arg/N-end rule and the Ac/N-end rule
pathways. The Arg/N-end rule targets unmodified iMet-starting N-termini followed by a
hydrophobic amino acid [27] and neo-N-termini generated upon proteolytic cleavage [27,
28]. The acetylation-dependent branch of the N-end-rule (Ac/N-end rule) mediates a
targeted degradation of proteins with Nt-acetylated Met, Arg, Val, Ser, Thr and Cys residues
[29]. Interestingly, Nt-acetylation of two N-terminal proteoforms raised by alternative
initiation of SNC1 in Arabidopsis thaliana had an opossing effect on proteoform stability
dependent on the NAT involved [30]. The longest form was destabilised by NatA, whereas
NatB mediated Nt-acetylation increased the stability of the truncated proteoform. On the
other hand, recent studies of human Ogden syndrome caused by a NatA loss-of-funtion
mutation indicated that Nt-acetylation was involved in the increased stability of the NatA
substrate THOC7 [31]. Next to the N-end rule, additional mechanisms have been shown to
repress undesirable protein degradation. For example, N-degrons may be shielded by proper
folding of the mature protein or by integration into macromolecular complexes [21, 32, 33].
To summarize, alternative translation initiation and co-translational modifications seem to 
contribute substantially to the diversity of protein N-termini and are implicated in the 
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regulation of protein turnover. Evidently, a comprehensive characterisation of N-terminal 
proteoforms linked to their stability is of great importance. 
Results 
We combined N-terminal COFRADIC, a positional proteomics technology that enables the 
enrichment of N-terminal peptides, with pSILAC for the identification of N-terminal 
proteoforms and characterisation of their cellular stability in human Jurkat T-lymphocytes. 
Following database searching, we retained N-termini starting at position 1 or 2 that point to 
“database-annotated” translation initiation sites (dbTIS). Next, we inspected N-terminal 
peptides starting beyond position 2 and selected those peptides that comply with the rules 
of iMet processing and Nt-acetylation [16, 18]. Proteoforms linked to these N-terminal 
peptides were expected to be mainly derived from the use of alternative translation 
initiation sites (aTIS). 
Overall, we identified 2,578 N-terminal peptides (Appendix Table II.1A), including 2,135 
dbTIS and 443 aTIS. Our study demonstrates that N-terminal proteoforms raised upon 
translation initiation and alternative iMet processing contribute substantially to the diversity 
of the human proteome. Indeed, we identified 335 N-terminal proteoforms derived from 
133 genes displaying multiple N-termini raised from different translation initiation sites (Fig 
1A). Additionally, we observed 81 proteoforms resulting from partial iMet processing (Fig 
1A). Of note, 63% of all aTIS were identified in the absence of their canonical counterparts.  
Diversity of N-terminal proteoforms 
Deviations from the canonical translation mechanism such as ribosome leaky scanning and 
reinitiation [34, 35] allow for selection of alternative translation initiation sites within one 
transcript and, together with mRNA splicing, contribute to the N-terminal proteoform 
diversity observed in our study. Leaky scanning is a mechanism by which a fraction of 
ribosomes omits less favourable start codons to initiate translation downstream [36, 37]. 
Ribosome profiling previously demonstrated [38] that leaky scanning is responsible for most 
TIS selection events and that the efficiency of downstream initiation is heavily dependent on 
the strength of the translation initiation context surrounding dbTIS, a finding corroborated 
by our previously obtained N-terminomics data [9]. To study the contribution of (alternative) 
translation initiation and splicing to N-terminal proteoform expression in more detail, we 
performed ribosome profiling experiments in Jurkat cells. Additionally, the N-terminal 
peptides identified in our proteomics experiment in the Swiss-Prot database were mapped 
to alternative databases; human Swiss-Prot Isoform, UniProt TrEMBL and Ensembl.  
Ribosome profiling, or ribo-seq, enables studying in vivo protein synthesis by deep 
sequencing of ribosome-associated mRNA fragments, thereby providing a genome-wide 
snapshot of actively translated mRNAs. Additionally, (alternative) translation initiation can 
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be studied with sub-codon to single-nucleotide resolution through the use of antibiotics such 
lactimidomycin (LTM), which exclusively inhibit initiating ribosomes [38]. 
Figure 1 - The origin of N-terminal proteoforms. A. 2,578 proteoforms were identified 
including 2,135 dbTIS and 443 aTIS. For the majority of proteins we found a unique 
translation initiation site (grey). Additionally, 335 N-terminal peptides pointed to proteins 
with multiple N-termini created by alternative translation initiation (blue), whereas 81 N-
termini were generated by alternative iMet processing (green). B-C. Proteomics-derived 
translation initiation events were verified at the transcript level using ribo-seq data obtained 
in Jurkat cells and HCT116 cells (data unpublished). Although in this study, the degree of in 
vivo Nt-acetylation could not be directly determined, all retained N-termini were compliant 
with the rules of N-terminal processing [9]. In the case N-termini were found to be in vivo Nt-
acetylated (previous MS/MS-based evidence [9]) this information is indicated. dbTIS and aTIS 
peptides were further mapped to protein N-termini annotated in Swiss-Prot Isoform, 
UniProt TrEMBL and Ensembl databases and neo-N-termini (proteolytic products) of the 
knowledgebase TopFind 3.0. The number of matching N-termini is indicated in dark grey. N-
terminal peptides supported by at least one source of metadata pointing to translation (Nt-
acetylation, ribo-seq, Swiss-Prot Isoforms, TrEMBL or Ensembl) were classified as highly 
confident TIS (indicated in green). D. Using experimental and metadata, we assigned the 
most likely origin of aTIS peptides and confirmed that alternative translation initiation within 
the same transcript (leaky scanning) contributes to the majority of alternative TIS identified. 
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Using ribosome profiling, of the 2,578 N-terminal proteoforms identified by means of N-
terminomics, we were able to confirm translation initiation events for 89% of dbTIS (1,895 of 
2,135) and 29 % of aTIS (130 of 443 aTIS) in Jurkat cells (Fig 1B-C). Using a Mann-Whitney 
one sided test we further confirmed that aTIS detected by ribo-seq (130) had significantly 
lower translation initiation signal (RLTM-CHX) at the start codon compared to dbTIS (1,895) (p-
value= 0.011). The same was observed when directly comparing dbTIS to aTIS variants (31 
pairs) detected by ribo-seq and originating from the same gene (Wilcoxon signed-rank test 
for paired samples; p-value of 0.00068). Further, from the data mapping to Ensembl and 
Swiss-Prot Isoforms databases, we found that 23% of the aTIS proteoforms (101 out of 443) 
could likely be explained by a database annotated alternative splicing event (Fig 1D). 
Additionally, only 19 aTIS N-termini were annotated in the proteolytic knowledgebase of 
protein N-termini, TopFIND 3.0, as potential protease cleavage products [39] (Fig 1C). 
However, 7 of these 19 could be disregarded due to Nt-acetylation evidence and/or ribo-seq 
confirmed TIS selection. Overall, given the N-terminal selection strategies applied and the 
metadata at hand, only very few of the here reported N-termini can be considered as 
potential proteolytic products. The majority of remaining N-terminal proteoforms (330) is 
thus likely generated upon leaky scanning or other translation initiation mechanism as 
previously shown by others and us [9, 38]. Leaky scanning frequently results in initiation at a 
downstream start codon in the immediate proximity of the first AUG codon (Fig 2A) [9], 
however, supported by ribo-seq data, we found examples of translation initiation by means 
of leaky scanning at more distant start codons (Fig 2B). Relying on the current Ensembl 
human transcriptome annotation and splice variants present in the Swiss-Prot Isoform 
database, we were additionally able to confirm the expression of N-terminal proteoforms 
from alternatively spliced transcripts (Fig 2C). 
Interestingly, we found 12 aTIS proteoforms being exclusively expressed in the absence of 
dbTIS, judging from the lack of preceding ribo-seq and proteomics evidence [9] (Fig 2D). The 
two most likely scenarios leading to the creation of N-terminal proteoforms starting at two 
consecutive Met residues (for example at position 1 and 2), are leaky scanning or alternative 
iMet processing. Our proteomics data provides evidence of consecutive Met-starting N-
termini for 11 genes and matching ribo-seq data indicate that translation initiation may 
occur at both Met residues (Fig 2E-F). 
Protein turnover measurement 
To measure turnover times of N-terminal proteoforms we used human Jurkat T-lymphocytes 
that were pre-labelled with either light (Arg0) or medium (Arg6) isotopes of arginine and 
harvested 0.5, 1.5, 4, 8, 12, 24 or 48 hours after refreshing light medium or swapping the 
Arg6 label to heavy arginine (Arg10) (see Fig 3A). Note that arginine was used as the SILAC 
label given that by nature of the N-terminal COFRADIC procedure, all N-terminal peptides 
end on arginine. After mixing equal amounts of light and medium/heavy labelled proteome 
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samples taken at the 7 different time points, N-terminal COFRADIC analyses were 
performed. 
Figure 2 - Examples of translation initiation events confirmed by ribo-seq in Jurkat cells. A-
B. Alternative translation initiation due to leaky scanning. C. Alternative splicing. D. The 
preferential expression of an N-terminally truncated proteoform. E-F. Evidence for 
alternative translation initiation occurring at two consecutive AUG codons. Grey arrows 
mark the identified TIS. Transcripts were colored accordingly: coding sequence in green, 5’ 
leader in red and introns in grey. Jurkat LTM and Jurkat CHX tracks correspond to translation 
initiation and elongation signal captured by ribo-seq. 
From the total of 2,578 N-terminal peptides identified (Appendix Table II.1A) we retained 
1,972 peptides that were identified in at least 3 of the time points analysed (Appendix 
Table II.1B). Their SILAC ratio values were then used to calculate protein stabilities by 
monitoring protein degradation and synthesis based on changes in M/L and H/L isotope 
ratios, with the crossing point between the degradation and synthesis profiles enabling a 
direct readout of the 50% protein turnover (Fig 3B) [2]. Using a simple exponential model we 
calculated turnover times for 1,928 (98%) of the 1,972 proteoforms with minimal R2 
coefficients ≥ 0.8. To evaluate the relationship between the number of observations and the 
predictive power of our model, we re-calculated turnover times of selected proteoforms 
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based on a subset of available observations showing that turnover times can be precisely 
reproduced using as few as 3 randomly selected data points (Appendix Fig II.1). Our model 
very well described the variation in experimental data (as supported by a high median R2 
value of 0.98; see Appendix Fig. II.2), overall demonstrating that protein degradation in 
Jurkat cells follows mono-exponential kinetics. Only a minority of degradation and synthesis 
curves (2%) showed monotonic changes in time not following an exponential trend 
(R2 < 0.8). In 13 such cases turnover times were determined using a linear interpolation of 
the crossing point, but otherwise such proteoforms were excluded from further analysis. In 
total, we could assign 50% turnover times to 1,941 N-terminal proteoforms (Appendix 
Table II.1B). 
.
Figure 3 - Experimental setup using pSILAC and N-terminal COFRADIC to assess N-terminal 
proteoform stability. A. Jurkat cells were pre-labeled with light or medium L-Arg isotopes. A 
label swap was performed of cells growing in medium Arg, whereas light cells were cultured 
in the same medium. Cells were harvested at different time points and equal proteome 
amounts were mixed, followed by N-terminal COFRADIC fractionation and LC-MS/MS 
analysis. B. Ratios between three dynamic forms of N-terminal peptides reflect protein 
synthesis and degradation rates, allowing the calculation of 50% turnover times. C. The 
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distribution of turnover times (N=1,894) calculated was not unimodal, with a sizable number 
of quickly turned over proteins and the median protein turnover rate being 21.6 h. The 
doubling time of Jurkat cells (24 h) is indicated in red. 
To account for cell growth, our exponential model of protein degradation incorporated the 
doubling time measured for Jurkat cells (24 h, see Appendix Fig. II.3). This allowed for the 
determination of two additional parameters, namely protein degradation rate constants 
(kdeg) and protein half-life values [h]. Since 50% turnover values can be measured more 
directly and reflect both protein synthesis and degradation, we selected 50% turnover time 
as the desired parameter to perform our subsequent analyses. 
Protein function and turnover: correlation with previous reports 
Overall, protein turnover times in Jurkat cells varied from less than 1, to more than 48 hours 
with a median turnover time of 21.6 h (Fig 3C). Protein degradation constants determined 
for Jurkat cells (control sample) [40], protein turnover times measured in HeLa cells (whole 
cell lysates) [2] and protein half-lives derived from NIH3T3 mouse fibroblasts [7] were 
retrieved and compared to their corresponding values of canonical proteoforms quantified 
in our study. We detected a moderate correlation between our data and previous reports, 
with Spearman rank correlation coefficients reaching 0.49 for HeLa data [2], 0.48 for NIH3T3 
data [7] and 0.44 for Jurkat data [40]. Moreover, a median protein half-life of 50.5 hours 
measured in our study was in good agreement with previously reported values in mouse 
NIH3T3 cells (47.8 h) [7] and human Jurkat cells (55.8 h) [40]. Further, we observed a highly 
similar median turnover time (21.6 h) and turnover distribution to estimates obtained in 
HeLa cells (20 h) [2]. 
Based on gene ontology (GO) biological process term enrichment of our data using the 
Gorilla software [41] and considering one proteoform per gene, we found that proteins with 
common functional annotations displayed comparable cellular stabilities. To reduce the 
complexity and redundancy of enriched categories we applied REViGIO [42] and visualised 
selected GO terms with false discovery rate (FDR) q-values lower than 0.05. Lower stability 
was detected for proteins involved in mitosis, chromosome segregation, cell cycle and 
apoptosis, next to regulation of RNA transcription and protein ubiquitination (Fig 4A). On the 
other hand, RNA splicing, protein translation, folding and transport as well as various 
metabolic processes of carbohydrates, nucleotides, aldehydes, ketones, glutathione, 
nitrogen and phosphorus were conducted by more stable proteins (Fig 4B). Along the same 
line, category enrichment analysis of KEGG pathway terms clearly pointed to increased 
stability of spliceosome and ribosome components next to RNA degradation, aminoacyl-
tRNA biosynthesis, glycolysis and gluconeogenesis, and pentose phosphate pathways (all 
with FDR values below 9.0E-04) [2, 7]. Pfam data did not point to a significant influence of 
protein domain composition on protein turnover. 
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Overall, the results of our annotation enrichment analysis agree very well with previous 
studies in mouse [7] and human [2, 40] and thus, protein turnover rates seem to be 
conserved between different cell lines and organisms, especially at the level of protein 
groups and biological processes. 
Figure 4 - GO term enrichment analysis for unstable (A) and stable (B) proteins. Horizontal 
bar chart representations are given for significantly enriched GO terms in the human 
proteome (FDR q-value ≤ 0.05). 
Stability, abundance and structural disorder of alternative proteoforms 
To facilitate the interpretation of the relationship between alternative translation and 
protein turnover, whenever an iMet-retaining and -processed proteoform was identified, we 
only selected the expected mature N-terminus per proteoform, according to the rules of 
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iMet processing [15]. In total, we assigned protein turnover rates for 323 aTIS and 1,571 
dbTIS N-terminal proteoforms (Fig 5A). 
Figure 5 - Characterisation of identified N-terminal proteoforms. A. We assigned the 
turnover time of 1,941 proteoforms, including 1,894 proteoforms derived from 1,571 dbTIS 
and 323 aTIS next to 47 N-termini generated by alternative iMet processing. dbTIS and aTIS 
derived proteoforms are indicated in shades of blue and shades of red, respectively. Stability 
of 100 N-terminal proteoform pairs derived from the same gene (dark red). B. Distribution of 
iMet positions giving rise to 323 N-terminal proteoforms with assigned turnover times (to 
avoid redundancy a single iMet processed proteoform was considered). C. Distribution of 
turnover values shows differences in the overall stability of dbTIS versus aTIS proteoforms. 
The majority of the identified aTIS resulted in relatively short N-terminal protein truncations 
(protein length reduced by less than 13%). The distribution of aTIS corresponding iMet 
positions centered within the first 200 amino acids with a median position of 52 (Fig 5B), an 
observation in line with the fact that leaky ribosome scanning is likely to be responsible for 
the majority of downstream translation events observed (see above and [9, 38]). 
Interestingly, N-terminal proteoforms derived from aTIS usage frequently displayed distinct 
stabilities (Fig 5C). We were able to quantify turnover rates for 100 dbTIS/aTIS pairs and 
observed that some aTIS displayed altered stabilities as compared to their dbTIS 
counterparts. More specifically, we detected numerous examples of aTIS proteoforms with 
increased as well as decreased stability (Fig 6A-B). This effect appeared not to correlate with 
the distance between aTIS and dbTIS positions (Fig 6C). Since the differences in stabilities 
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between aTIS and dbTIS expressed forms of the same gene were not uniform, no statistical 
difference was detected between their turnover times (Fig 6C, Table 1). However, when we 
compared the entire populations of aTIS to dbTIS, alternative proteoforms were on average 
found to be significantly more stable (p-value=1.52e-08) (Fig 5C, Table 1). 
Variable Dataset Test p-value Conclusion
turnover time 
complete dataset Mann-Whitney test 1.52e-08 aTIS>dbTIS 
dbTIS/aTIS pairs Wilcoxon signed-rank test 0.5021 no difference 
disorder 
complete dataset Mann-Whitney test 0.00157 aTIS>dbTIS 
dbTIS/aTIS pairs Wilcoxon signed-rank test 0.01216 aTIS>dbTIS 
spectral counts 
complete dataset Mann-Whitney test 4.31e-09 aTIS<dbTIS 
dbTIS/aTIS pairs Wilcoxon signed-rank test 3.44e-09 aTIS<dbTIS 
NSAF 
complete dataset Mann-Whitney test 1.15e-07 aTIS<dbTIS 
dbTIS/aTIS pairs Wilcoxon signed-rank test 6.45e-09 aTIS<dbTIS 
Table 1 - Differences in turnover, disorder and abundance values between aTIS and dbTIS. 
For the complete dataset of aTIS and dbTIS with reliable turnover measurements and 
considering a single iMet proteoform (N=1,894; 323 aTIS and 1,571 dbTIS), a comparison of 
turnover, disorder and abundance values was performed using Mann-Whitney one-sided 
test for independent samples. Differences in paired dbTIS-aTIS data were measured using a 
Wilcoxon signed-rank one-sided test for paired samples. All analyses were performed at p ≤ 
0.05 significance level. 
We further determined if aTIS indicative N-termini share features that are distinct from 
dbTIS. Given that translation is a one-directional process and downstream initiation due to 
leaky scanning only occurs with a limited probability, in a normal cellular context one might 
expect that many aTIS variants are less efficiently produced than dbTIS variants, leading to 
lower abundance of the former [9, 43]. To investigate this we used spectral counts as well as 
NSAF scores [44] as quantitative proteoform measures. Using a Mann-Whitney one sided 
test to compare the aTIS (323) and dbTIS (1,571) groups we confirmed that, on average, aTIS 
variants are less abundant with high significance values when using both spectral counts (p-
value= 4.31e-09) as well as NSAF scores (p-value= 1.15e-07). The same was observed when 
directly comparing dbTIS to aTIS variants originating from the same gene using a Wilcoxon 
signed-rank test for paired samples (p-values of 3.44e-09 and 6.45e-09 respectively for 
spectral counts and NSAF, see Table 1). Finally, we observed a slight positive correlation 
between turnover time and protein abundance (Spearman rank correlation of 0.285). 
Further analysis indicated reduced levels of the top 10% of unstable proteins and higher 
levels of the 10% most stable proteins in relation to the mean protein abundance in our 
dataset (Benjamini–Hochberg FDR of 2.29e-11and 7.44e-05, respectively). 
Intrinsic disorder in protein structures is an important factor that determines protein 
degradation rates (reviewed in [45]). The extent of structural disorder can be assessed, 
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amongst others, by studying the amino acid composition of proteins [46]. For every 
proteoform sequence, the percentage of intrinsically disordered regions was predicted using  
Figure 6 - N-terminal proteoforms may display different stabilities. A. Degradation profiles 
of AIMP2, MARE2 and AN32E dbTIS and aTIS proteoforms as representative examples of Nt-
proteoforms that differ in stability. B. MS spectra of the N-termini of two proteoforms 
originating from the aminoacyl tRNA synthase complex-interacting multifunctional protein 2 
(AIMP2): a dbTIS indicative N-terminus with processed iMet and starting at the second 
amino acid Pro, an aTIS indicative peptide starting at position 3 and retaining its iMet. As 
evident from the MS spectra shown, these N-terminal proteoforms displayed largely 
different turnover rates. C. Differences in turnover times were calculated for 100 dbTIS and 
aTIS proteoform pairs and presented in ascending order. The extent of N-terminal truncation 
in each pair was colour-coded to visualize the absence of correlation between the number of 
lacking amino acids and the direction of turnover shift. D. An increase in disorder content 
between aTIS and dbTIS proteoforms can be observed for a multitude of dbTIS/aTIS pairs. 
the RAPID server [47]. The average disorder of aTIS proteoforms was found to be higher than 
that of dbTIS proteoforms (Mann-Whitney one sided test, p=0.00157). These observations 
were confirmed in paired samples of aTIS and dbTIS products of the same gene (Wilcoxon 
signed-rank test, p=0.01216, see Fig 6D). In conclusion, aTIS proteoforms were characterized 
by lower expression levels and higher structural disorder than dbTIS proteoforms. Moreover, 
the aTIS population displayed an overall higher stability compared to dbTIS. Additionally, a 
82 
low negative correlation was observed between protein turnover and the percentage of 
disordered sequence (Spearman rank correlation of -0.209), suggesting that unstable 
proteins tend to have more disordered regions, as reported in previous studies [5, 6]. In line 
with this, the 10% most stable proteins had significantly lower disorder content, contrary to 
the 10% least stable proteins with highly disordered structures (Benjamini–Hochberg FDR of 
3.27e-11). 
Protein turnover and N-terminal amino acid composition 
We next investigated if the identified N-termini hold intrinsic information on the so-called N-
degrons [27], and what the role is of iMet cleavage in this process.  
To correlate the N-end rule with our pSILAC dataset we examined the relation between the 
turnover rate and the identity of the two utmost N-terminal residues. A Bartlett test 
indicated insufficient homogeneity of variance between the studied groups, leading to the 
selection of non-parametrical tests for further analysis. First, we performed a pairwise 
comparison of protein stability across N-termini grouped according to their N-terminal 
amino acid identity. A Kruskal-Wallis rank sum test indicated a significant impact of N-
terminal residues on protein turnover, whereas a subsequent multiple comparison test 
allowed to indicate the most deviating pairs (with p<0.05). Met-Asn and Met-Asp were 
among the least stable N-termini which deviated significantly from stable N-termini such as 
Met-Thr, Met-Val, Met-Ala and Pro starting N-termini (Fig 7A).  
To further dissect our data, we compared the stability of N-termini undergoing iMet 
processing, leading to N-terminal Ser, Ala, Thr, Cys, Val, Gly and Pro. Interestingly, a general 
lower stability was observed for proteoforms with their iMet residue removed compared to 
proteoforms that retained the iMet. A significant impact of iMet processing on turnover 
rates was confirmed using a Kruskal-Wallis rank sum test (p < 2.2e-16). To decouple the 
effect of Nt-acetylation from iMet processing we compared completely or partially Nt-
acetylated (Ser, Ala, Thr, Cys, Val, Gly) to in vivo free (Pro) N-termini and for both groups we 
observed a lower stability of proteoforms with their iMet removed (see Fig 7B). Considering 
individual amino acids, only Thr and Val deviated significantly from their corresponding iMet 
retaining N-termini (see Fig 7B-C). However, a less strict analysis with pairwise Wilcoxon rank 
sum test (without correction for multiple testing) pointed to significant deviation between 
iMet-processed and -retaining Ala-, Ser- and Gly- starting N-termini. To conclude, turnover 
rates of N-termini with different susceptibility for Nt-acetylation [18] were generally affected 
by iMet processing. 
These findings suggest that irrespective of (the degree of) Nt-acetylation, iMet processing, 
rather than Nt-acetylation, seems to be a main contributing factor to N-terminal proteoform 
stability. In particular and in line with previous findings [26], no correlation was found with 
the Nt-acetylation susceptibility of protein N-termini (Fig 7B). Secondly, the presence of a 
hydrophobic residue at the second position has no apparent influence on average turnover 
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rates as proteins starting with N-termini such as Met-Leu, Met-Phe, Met-Tyr and Met-Ile 
have stabilities close to the median stability of all protein N-termini (Fig 7A). A more detailed 
analysis of grand average of hydropathy (GRAVY) of 2 and 10 most N-terminal residues 
revealed no correlation with protein turnover times (Spearman correlation coefficients of 
0.013 and 0.0085 respectively). 
Figure 7 - Relationship between N-terminal amino residue(s) identity and 50% turnover 
rates. A. All protein N-termini were grouped according to the identity of their N-terminal 
84 
residues and sorted in ascending order of stability. B. Methionine processing typically affects 
N-termini displaying amino acids with small gyration radii (S, A, T, C, V, G or P residues at the
second position). Although the majority of these N-termini undergo methionine cleavage,
some (partially) retain their first amino acid. Subsequently, iMet processed N-termini may be
Nt-acetylated by NatA in the following order of efficiency (S, A, T, C, V and G) with the
exception of P which always remains unmodified [18]. The stability of iMet processed N-
termini is very similar for S, A, T, C and G and P starting N-termini, but their iMet retaining
counterparts have overall higher stability, and this especially for MT and MV N-termini. In
contrast to methionine processing, Nt-acetylation susceptibility does not appear to have an
effect on the stability of proteoforms. *The extent of in vivo Nt-acetylation was described by
Van Damme et al. [18]. C. Differences in turnover times where calculated for N-termini
starting with S, A, T, C and G and P and their iMet retaining counterparts (47 proteoform
pairs with valid turnover measurements). Decreased stability of processed N-termini could
be observed, especially for T and V starting N-termini.
Ubiquitination and protein turnover 
Post-translational modifications, such as ubiquitination, may affect protein stability and are 
thus worthwhile to consider in the context of N-terminal proteoforms. Ubiquitination has a 
known, direct impact on protein degradation and was previously studied at the proteome-
wide level using Jurkat cells as a model system [48]. Our group reported on a compilation of 
more than 7,500 in vivo ubiquitinated peptides in more than 3,300 different proteins [48]. 
Using this dataset, we investigated if annotated N-terminal proteoforms holding possible 
(previously identified) ubiquitination sites displayed different stabilities than proteoforms 
not found to be ubiquitinated. We compared the stability of 348 dbTIS containing at least 
one detected ubiquitination site to 388 N-termini with one or more lysine residues but no 
experimental evidence of ubiquitination in Jurkat cells. A one-sided Mann-Whitney test 
revealed a significant higher median stability of ubiquitinated proteoforms compared to 
non-ubiquitinated proteoforms (p= 0.0005; see Appendix Fig. II.4), although in each case a 
very broad range of protein stabilities could be observed. To provide more insight, we 
decided to investigate particular cases of ubiquitinated N-termini. The existence of 
additional ubiquitination sites may contribute to the difference in turnover observed 
between longer and shorter proteoforms, as reported in the case of the mu opioid receptor 
(MOP) [12]. Interestingly, in our dataset, we found 31 dbTIS proteoforms holding unique 
ubiquitination sites not present in a shorter proteoform (aTIS). 11 such proteoforms 
displayed reduced stability (turnover time decreased by at least 2 hours) compared to their 
aTIS counterparts (Appendix Table II.2). For these proteoforms ubiquitination potentially 
contributes to the observed differences in stability. We also found 14 proteoform pairs 
where ubiquitination of the longer variant possible contributed to an increased stability and 
5 cases where irrelevant differences in stability between proteoform pairs were observed 
(<2 h). 
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Protein turnover in macromolecular complexes 
Following up on a recent report on the precise regulation of protein synthesis rates being 
proportional to the stoichiometry of macromolecular protein complexes [49], we here 
investigated if protein synthesis and degradation are coordinated for members of known 
macromolecular protein complexes (Appendix Table II.1B). According to the strategy 
reported by [5], we retrieved the human core protein complexes from the CORUM database 
[50]. Next, we assigned turnover times to members of complexes using only the dbTIS 
proteoforms identified in our study. We calculated the absolute difference in stability 
between every protein and all other members of a given complex. Significant outliers with 
statistically larger differences to other proteins in a complex were identified using the Mann-
Whitney test (α=0.05, one-sided). In this way we estimated the dispersion of turnover rates 
for 333 proteins within 173 macromolecular complexes with 3 or more members identified, 
and came to the conclusion that a majority of turnover rates correlate well within a complex 
(127 or 73% of the complexes). Inconsistencies were observed in 46 complexes of which 74% 
involved a single outlier. In 28 complexes we detected a single unstable component, hinting 
to a rate-limiting factor for complex formation. 
Next, we investigated if protein-protein interactions could be affected by the expression of 
alternative N-terminal proteoforms. Here, a comparative analysis of GO terms related to 
protein function in aTIS- versus dbTIS-derived proteoforms revealed that alternative 
proteoforms were clearly enriched in protein forming homomultimers (FDR q-value of 
0.0096) hinting to the likely impact of alternative proteoform incorporation on the overall 
stability of protein complexes. 
Verification of protein turnover times 
Cycloheximide (CHX) pulse-chase experiments were performed to confirm the stability of 
selected proteoforms. Half-lives of 6 selected endogenous proteins (Fig 8A) were assayed by 
western blotting using lysates of Jurkat cells treated with CHX for 0 to 24 hours. Protein 
levels of short-lived securin, lamin B, β-catenin and GCIP-interacting protein p29 levels were 
monitored by western blotting and compared to those of stable proteins such as actin and 
GAPDH. Protein half-lives deduced from western blot analyses corresponded well to those 
calculated from pSILAC data. Overexpression of selected V5-tagged proteoforms in the 
human colorectal HCT116 carcinoma cell line allowed us to validate differential turnover of 
identified dbTIS and aTIS products from two different genes; MARE2 and AN32E (Fig 8B-C). 
Data from the latter experiments further suggest that common trends can be observed in 
the regulation of proteoform stability across different human cell lines, despite discrepancies 
in the exact values calculated using CHX-chase and pSILAC 
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Figure 8 - Comparison of protein turnover measured by pSILAC and CHX-chase. A. Jurkat 
cells were treated with 100 µg/ml CHX for 0, 0.5, 1.5, 4, 8, 12 or 24 hours. Protein 
degradation was monitored by western blotting and stabilities of several short-lived 
endogenous proteins were confirmed using antibodies (including lamin B, securin, β-catenin, 
GCIP interacting protein p29) and compared to stable proteins (such as GAPDH and actin). 
Proteoform-specific bands were used to calculate protein half-lives which were in a good 
agreement with turnover times obtained from pSILAC B-C. Validation of the differential 
turnover time of the dbTIS and aTIS derived proteoforms of MARE2 and AN32E. Selective C-
terminal V5-tagged proteoforms were overexpressed in HCT116 cells for 24 hours and CHX 
pulse-chase experiments were performed as described for Jurkat cells. Degradation of 
overexpressed proteoforms was monitored by an anti-V5 antibody and compared to the 
turnover of stable proteins such as actin and tubulin. 
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Discussion 
The selection of translation initiation sites attributes to the complexity of proteomes as N-
terminally truncated and extended proteoforms may be differentially regulated, localized 
[51, 52], display altered stabilities [12] and functionalities [53-55] especially in the case of 
some large Nt-truncations. Proteoforms arisen from alternative translation initiation are 
generally well conserved among eukaryotic orthologous protein species [9]. Selection 
between alternative translation start sites is regulated under conditions of cellular stress 
[36] and may change the repertoire of N-terminal proteoforms expressed in a
developmental and tissue-specific manner [53, 55].
pSILAC was already used in several proteome studies to determine the dynamic properties 
of thousands of proteins in a single experiment. Most studies made use of non-synchronised, 
proliferating cell lines [2, 6, 7, 56], while others employed growth arrest [1] or studied 
protein synthesis and degradation rates in dynamically changing systems (for example during 
differentiation [5] or following drug-mediated inhibition of Hsp90 [40]). We decided to 
employ a pSILAC approach similar to the one described by [2] which enabled the 
measurement of protein half-lives (t1/2) as well as protein turnover, reflecting the overall 
protein synthesis and degradation rates [2]. To better reflect our experimental results, we 
simplified the mathematical model proposed by Boisvert and colleagues [2]. In their setup, 
levels of medium Arg were retained at 20% instead of asymptotically approaching zero as 
degradation of proteins proceeds, an observation which they attributed to amino acid 
recycling. In Jurkat cells we observed a complete isotope replacement, similar to another 
recent pSILAC study conducted in the same cell line [40]. 
Here we performed a first global, N-terminal proteoform-specific analysis of protein stability 
and identified numerous N-terminally truncated proteoforms with distinct turnover rates 
compared to their full-length counterparts. Among the compared dbTIS/aTIS pairs, the 
stability of alternative proteoforms was not correlated to the length of truncation. The 
regulation of protein turnover rather seemed proteoform-specific, pointing to many 
different factors involved in the synthesis and degradation of specific proteins. One such 
contributing factor may be post-translational modifications, as we found 11 proteoform 
pairs where ubiquitination of the longer variant possibly contributed to reduced proteoform 
stability. 
To validate the difference in half-lives of selected proteoform pairs we turned to the use of a 
more classic method for measuring protein turnover, being CHX pulse-chase experiments 
followed by western blot analysis. We confirmed turnover rates of several endogenously 
expressed short- and long-lived proteins. Due to the limitation in molecular weight 
resolution and sensitivity we subsequently turned to over-expression studies for the 
validation of differential Nt-proteoform stabilities from two human genes. Nonetheless, 
since upon incubation of the cells with protein synthesis inhibitors, protein degradation may 
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be altered [57, 58] and cell toxicity can only be controlled for a relatively short period, CHX 
treatment may preclude a correct delineation/validation of long protein half-lives.  
We further evaluated the origin of N-terminal proteoforms identified in our study using 
ribosome profiling and extensive mining of public databases (Appendix Table II.1C) and 
found that 74% of the aTIS were generated by alternative translation initiation, whereas 23% 
likely pointed to splicing events. Truncated proteoforms displayed a lower translation 
initiation signal at the start codon, in line with their reduced proteome abundance estimated 
by spectral counting. These finding are consistent with a lower frequency of downstream 
translation initiation assumed from the leaky scanning model of translation initiation and 
corroborated by previous reports (Lee et al, 2012). Next to their lower abundance, the 
limited overlap between aTIS identified by means of proteomics and ribo-seq might be 
additionally attributed to the TIS calling approach used, since typically a higher interference 
is observed at internal TIS typically flanked by signal at both 5’ and 3’ end. Moreover, some 
aTIS may actually be the sole or preferential TIS site selected due to alternative splicing and, 
in some cases, alternative translation initiation. In this context, previous studies 
demonstrated that their corresponding dbTIS sites are typically embedded in less optimal 
Kozak consensus sequences [9]. Indeed, we found 12 aTIS proteoforms exclusively expressed 
in the absence of dbTIS both at the translatome and the proteome level. In some cases a 
truncated proteoform may also display superior stability over the canonical proteoform. 
Viewing their general lower abundance, stable aTIS proteoforms are more likely to be 
detected. The latter could explain why the aTIS population was slightly enriched for long-
lived proteins.  
As reported previously [1, 5], turnover rates were similar for proteins belonging to similar 
functional groups or macromolecular complexes. This is supported by the notion that some 
proteins get stabilised upon complexation with other proteins, lipids, sugars or nucleotides 
[1]. In line, other studies suggested that protein subunits turn over quickly where the 
complex is assembled, but are stabilised in cellular compartments where the complex is 
functional [2]. Some of the identified protein truncations are predicted to be benign for a 
protein’s function or binding but have large consequences for protein stability. For example, 
a single amino acid truncation of AIMP2 increases protein stability (see Fig 6A-B) but was not 
predicted to alter its sequence disorder content, localisation (TargetP [59], WoLF PSORT 
[60]) or any of its known interacting domains. Considering such cases, a differential 
regulation of N-terminal proteoform stability may potentially result in elimination or 
introduction of unstable components into a complex. It is also important to consider that the 
relative expression levels of proteoforms are responsive to cellular conditions [53, 61, 62]. In 
this context, depletion of one proteoform may increase the impact of another proteoform’s 
turnover on protein complex formation. As we observed that aTIS proteoforms were 
enriched in proteins forming homomultimers, generation of alternative proteoforms may be 
important in the context of homomultimerisation. Interestingly, in the case of the 
transcription factor GATA-1, proteoforms generated by alternative translation initiation 
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were already shown to produce dimers [55] with altered activities dependent on the relative 
ratios of the two proteoforms in the complex. 
The extent of intrinsic disorder in protein structures was correlated with turnover times, 
indicating that a change in structural disorder of protein N-termini from truncated 
proteoforms might have an impact on the proteoforms’ cellular stabilities. In line with the 
observation that proteins displaying iMet cleavage are overrepresented in vivo, the general 
belief is that retained iMet reduces the stability of proteins [15, 63]. Unexpectedly, our 
stability data showed a reduced stability of iMet processed proteoforms in numerous cases. 
However, it is important to discriminate between the effect of iMet removal on protein 
abundance and the effect on protein turnover time, as these two terms should not be used 
interchangeably. Relying on previous quantitative data on protein Nt-acetylation [9], another 
common co-translational modification, Nt-acetylation seemed to have no overall impact on 
turnover rates. Of note however, due to the experimental methodology applied, we cannot 
distinguish Nt-acetylated from Nt-free proteoform counterparts. In fact, the role of Nt-
acetylation in protein stability is debated [25, 26] and is likely protein context and NAT 
dependent [30, 31]. It was postulated that Nt-acetylation may stabilize otherwise flexible 
structures of N-termini and reduce their propensity for aggregation [24]. At the same time, 
acetylated protein N-termini are substrates of the N-end rule pathway [29] which may 
constitute a clearance mechanism for N-terminally misfolded or non-complexed proteins 
[21, 32, 33, 64]. Moreover, it is difficult to directly compare our results to the destabilizing 
properties of the corresponding N-terminal amino acids originally described by Varshavsky 
and colleagues, especially considering differences in the studied organisms and the 
techniques used for protein turnover determination (pSILAC vs. CHX-chase). We believe that 
the property of iMet retention to increase the stability of N-terminal proteoforms described 
in our study may exist as an additional mechanism next to the N-end rule pathways to 
ensure the fine tuning of protein stability in eukaryotic cells. 
Recent large-scale studies on protein stability report a limited correlation to other high-
throughput data and especially, differences in the methodologies applied appear to account 
for the observed discrepancies [1, 2, 6, 65, 66]. In this context, pSILAC approaches share 
general advantages, as they target endogenous proteins expressed at physiological levels in 
untreated cells. We therefore sought to cross-examine our present turnover data with 
previous studies performed using pSILAC in human (HeLa and Jurkat cells [2, 40]) and mouse 
(NIH3T3 cells [7]). We observed a positive correlation of our data with these other protein 
stability studies, with Spearman’s correlation coefficients of 0.48, 0.44 and 0.49 for [7, 40] 
and [2], respectively. Moreover, comparison of gene ontology enrichment analyses indicated 
that protein turnover rates seem to be conserved between different cell lines and 
organisms. Despite similar experimental procedures, there was still a lot of unexplained 
variation between the datasets, which may be attributed to differential regulation of protein 
stability in different cell lines or differential growth conditions in the case of the Jurkat cell 
line, while data processing and interpretation are other factors to consider. Importantly, we 
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clearly demonstrate the contribution of proteoform-specific turnover rates and that 
differences in stability between N-terminal protein variants may in principle only be resolved 
by focusing on their unique peptides, whereas shared peptides are a potential source of 
error in turnover measurements. 
Protein turnover measurements were recently extended to protein isoforms and (modified) 
protein pools [2, 67]. The Lamond group provided evidence for differential stabilities and 
localisation of proteoforms. Their shotgun approach, however well suited to study splice 
variants, had limited application for N-terminal proteoforms. Our pSILAC/N-terminal 
COFRADIC approach can be further extended to study changes in stability and proteoform 
expression levels during dynamic processes or in different tissues [5, 40]. Since targeting to 
diverse micro-environments allows fine-tuning of local protein concentrations, adding a 
spatial context to protein turnover may increase our understanding of the functional 
diversity of proteomes in future studies. 
Materials and Methods 
Cell culture 
For N-terminal COFRADIC analyses, human Jurkat T-lymphocytes (clone E6-1 ATCC TIB-152, 
ATCC), were subjected to SILAC labelling [68]. Cells were cultured in a 5% CO2 gas-
equilibrated, humidified incubator in Roswell Park Memorial Institute (RPMI) - 1640 medium 
without arginine and lysine (Silantes, GmbH, Munich, Germany) containing 10% fetal bovine 
serum dialyzed using a 10 kDa cut-off membrane (Gibco, Life Technologies, Paisley, Scotland, 
UK), 2 mM alanyl-L-glutamine dipeptide (GlutaMAX, Gibco), 50 units/ml of penicillin (Gibco), 
50 µg/ml of streptomycin (Gibco) and 146 µg/ml light (12C6) L-lysine (Cambridge Isotope 
Labs, Andover, MA, USA). Media were supplemented with either light (Arg0, 12C614N4) or 
medium (Arg6, 13C614N4) L-arginine (Cambridge Isotope Labs) at a final concentration of 48 
µg/ml at which Arg to Pro conversion was not detected. To achieve a complete incorporation 
of the labelled amino acids, cells were maintained in culture for 7 population doublings 
(Appendix Fig. II.5).  
The pulsed SILAC strategy for protein turnover measurements was previously described by 
Boisvert et al. [2]. Briefly, suspension cultures containing equal numbers of unlabelled (Arg0) 
and labelled (Arg6) cells were taken and the medium was removed by centrifugation for 5 
min at 350 g. Cell pellets were washed with PBS and centrifuged for 5 min at 350 g. The 
unlabelled cells were then suspended in light RPMI medium, whereas the medium labelled 
(Arg6) cells were suspended in medium containing heavy Arg (Arg10, 13C615N4) L-arginine. 
Following medium change, separate starting cultures of 107 cells were cultured at a 
concentration of 2*105 cells/ml for periods of 0.5, 1.5, 4, 8, 12, 24, or 48 h, after which 
cultures of 107 cells were collected by centrifugation. Following two rounds of re-suspending 
in PBS and centrifugation at room temperature, cell pellets were immediately frozen on dry 
ice and stored at -80oC.  
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Proteins were isolated from cell pellets by 3 rounds of freezing and thawing in 1 ml of 50 
mM sodium phosphate buffer, pH 7.5 and cell debris was removed by a 10 min 
centrifugation at 13,200 g at 4oC. The protein concentration in the supernatants was 
measured by the Bradford method and for every time point sample, an equal amount of 
medium/heavy labelled proteome sample was mixed with the corresponding equivalent of 
light control sample.  
Cycloheximide pulse-chase experiments 
100 µg/ml cycloheximide was added to Jurkat cells that were cultured at a density of 
180,000 cells/ml. 3.46 x 106 cells were harvested after 0, 0.5, 1.5, 4, 8, 12 or 24 hours of 
treatment and pelleted for 3 minutes at 800g. Cells were lysed in 100 µl of RIPA buffer (50 
mM Tris-HCl pH 8.0, 150 mM NaCl, 1% NP-40) with protease inhibitors added (Roche). All 
lysates were flash-frozen and stored at -80oC until further processing. Samples were thawed, 
centrifuged for 10 min at 13,200g, followed by measurement of protein content using the 
Bradford method. 40 µg of protein material from each sample was separated by SDS-PAGE 
(4-12% Criterion Bis-Tris gel, Bio-Rad) and protein levels were monitored by western 
blotting. The following antibodies were used: anti-lamin B (NA12, Calbiochem), anti-securin 
(ab3305, Abcam), anti-β-Catenin (C2206, Sigma), anti-SYF2 (ab3610, Abcam), anti-GAPDH 
(ab9484, Abcam), anti-actin (A2066, Sigma) and anti-α-tubulin (T5168, Sigma). The intensity 
of bands was assessed using the LICOR Odyssey software for western blot image processing. 
To validate the proteomics-derived differential protein turnover of dbTIS and aTIS 
proteoforms of MARE2 and AN32E, complete cDNA clones were obtained from the 
ORFeome 7.1 collection (ID 4499) and I.M.A.G.E. (ID 3047915) respectively. Site-directed 
mutagenesis (Stratagene, Agilent Technologies) by mutating ATG (Met) to TTG (Leu) codons 
was performed to analyse the expression of selected proteoforms. (Mutagenized) constructs 
were subcloned into the eukaryotic pEF-DEST51 expression vector (Gateway, Life 
Technologies) and transfected in HCT116 cells using Fugene HD (Promega) at a 
0.8/3/150,000 ratio of DNA [µg], Fugene HD [µl] and number of cells. Cycloheximide pulse-
chase experiments were performed as described above for Jurkat cells, except that 150,000 
HCT116 cells were harvested for every overexpressed construct and time point analysed. 
Cells were lysed in 80 µl RIPA buffer and about 10 µg of total protein material was separated 
by SDS-PAGE. Degradation of overexpressed proteoforms was monitored by western 
blotting using the anti-V5 antibody (R96025, Life Technologies) and compared to the 
turnover of stable proteins such as actin [7]. 
N-terminal COFRADIC
The combined proteome mixtures were analysed by N-terminal COFRADIC [18, 69]. In 
summary, proteins are first blocked at their N-ends (α-amines) and lysines (ε-amines) by 
acetylation. After trypsin digestion, terminal peptides are enriched for by means of SCX at 
low pH and by applying two consecutive RP-HPLC separations. In the latter, any remaining 
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internal peptides and C-terminal peptides are shifted by reaction of their free α-amino-
groups (new free α-amino-groups introduced by the action of trypsin) with 2,4,6-
trinitrobenzenesulphonic acid (TNBS) thereby allowing for their segregation from N-terminal 
peptides. Fractions enriched for N-terminal peptides are subsequently analysed by means of 
LC-MS/MS. All steps of the N-terminal COFRADIC analysis, including SCX enrichment, were 
performed as described [69]. More specifically, solid guanidinium hydrochloride (Gu.HCl) 
was added to the proteome mixtures to a final concentration of 4 M in order to denature all 
proteins. Next, proteins were reduced and alkylated using TCEP and iodoacetamide 
respectively. Upon desalting of the S-alkylated samples in 50 mM sodium phosphate (pH 
8.0), primary free amines were N-acetylated (no distinction between can be made between 
in vivo Nt-free (and thus in vitro Nt-acetylated) and in vivo Nt-acetylated N-termini by adding 
sulfo-N-hydroxysuccinimide (NHS)-acetate (Pierce). Twice the molar excess of glycine over 
the NHS ester was subsequently added to quench any non-reacted NHS-acetate. Possible O-
acetylation of Ser, Thr or Tyr residues was reverted by adding hydroxylamine (Fluka) to the 
modified protein mixtures. A final desalting step was performed in protein digestion buffer 
(10 mM ammonium bicarbonate, pH 7.9) and the proteomes were digested overnight at 
37 °C with sequencing-grade, modified trypsin (Promega, Madison, WI, USA) 
(enzyme/substrate of 1/100, w/w). Subsequent steps of the N-terminal COFRADIC analysis, 
including SCX enrichment, were performed as described [48]. 
Following label-swapping, one N-terminal COFRADIC analysis was performed and per time-
point (7 N-terminal COFRADIC analysis in total). During the primary RP-HPLC separation of 
the actual N-terminal COFRADIC procedure, peptides were collected in 13 fractions of 4 min 
each. Next, 12 secondary fractions were collected per primary fraction and pooled as 
described in [69], overall resulting in 36 samples for LC-MS/MS analysis per N-terminal 
COFRADIC setup. 
LC-MS/MS analysis 
LC-MS/MS analysis was performed using an Ultimate 3000 RSLC nano HPLC (Dionex, 
Amsterdam, the Netherlands) in-line connected to an LTQ Orbitrap Velos mass spectrometer 
(Thermo Fisher Scientific, Bremen, Germany). The sample mixture was loaded on a trapping 
column (made in-house, 100 µm I.D. × 20 mm, 5 µm beads C18 Reprosil-HD, Dr. Maisch). 
After back flushing from the trapping column, the sample was loaded on a reverse-phase 
column (made in-house, 75 m I.D. × 150 mm, 5 µm beads C18 Reprosil-HD, Dr. Maisch). 
Peptides were loaded in solvent A’ (0.1% trifluoroacetic acid, 2% acetonitrile (ACN)) and 
separated with a linear gradient from 2% solvent A’’ (0.1% formic acid) to 50% solvent B’ 
(0.1% formic acid and 80% ACN) at a flow rate of 300 nl/min followed by a wash reaching 
100% solvent B’. The mass spectrometer was operated in data-dependent mode, 
automatically switching between MS and MS/MS acquisition for the ten most abundant 
peaks in a given MS spectrum. Full scan MS spectra were acquired in the Orbitrap at a target 
value of 1E6 with a resolution of 60,000. The ten most intense ions were then isolated for 
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fragmentation in the linear ion trap, with a dynamic exclusion of 20 s. Peptides were 
fragmented after filling the ion trap at a target value of 1E4 ion counts. Mascot Generic Files 
were created from the MS/MS data in each LC run using the Mascot Distiller software 
(version 2.4.2.0, Matrix Science, www.matrixscience.com/Distiller.html). To generate these 
MS/MS peak lists, grouping of spectra was allowed with a maximum intermediate retention 
time of 30 s and a maximum intermediate scan count of 5. Grouping was done with a 0.005 
Da precursor tolerance. A peak list was only generated when the MS/MS spectrum 
contained more than 10 peaks. There was no de-isotoping and the relative signal-to-noise 
limit was set at 2. 
The generated MS/MS peak lists were searched with Mascot using the Mascot Daemon 
interface (version 2.3.01, Matrix Science). Searches were performed in the Swiss-Prot 
database with taxonomy set to human (UniProtKB/Swiss-Prot database version 2011_08, 
containing 20,244 human protein entries). The Mascot search parameters were set as 
follows: acetylation at lysine side-chains, carbamidomethylation of cysteine and methionine 
oxidation to methionine-sulfoxide were set as fixed modifications. Variable modifications 
were acetylation of N-termini and pyroglutamate formation of N-terminal glutamine (both at 
peptide level). Endoproteinase semi-Arg-C/P (semi Arg-C specificity with Arg-Pro cleavage 
allowed) was set as enzyme allowing for no missed cleavages. Mass tolerance was set to 10 
ppm on the precursor ion and to 0.5 Da on fragment ions. Peptide charge was set to 1+, 2+, 
3+ and instrument setting was put to ESI-TRAP. Only peptides that scored above the 
threshold score, set at 99% confidence, were withheld. The FDR was estimated by searching 
a decoy database (a shuffled version of the human Swiss-Prot database version 2011_08) 
and ranged from 0.32% to 2.27% for individual samples, with a global FDR of 1.18% on the 
spectrum level. 
Ribosome profiling 
For ribosome profiling, Jurkat cells were grown in RPMI medium (Gibco) supplemented with 
10% fetal bovine serum, 2 mM alanyl-L-glutamine dipeptide (GlutaMAX, Gibco), 50 units/ml 
penicillin and 50 µg/ml steptamycin at 37 °C and 5% CO2. Cultures were treated with 50 µM 
lactimidomycin (LTM) [70, 71] or 100 µg/ml cycloheximide (CHX) (Sigma, USA) for 30 min at 
37 °C before cell harvest. Subsequently, cells were collected by centrifugation (5 min at 
300g), rinsed with ice-cold PBS and recovered again by centrifugation in the presence of 
CHX. 108 cells were re-suspended in 1 ml ice-cold lysis buffer (10 mM Tris-HCl, pH 7.4, 5 mM 
MgCl2, 100 mM KCl, 1% Triton X-100, 2 mM dithiothreitol (DTT), 100 µg/ml CHX, 1 × 
complete and EDTA-free protease inhibitor cocktail (Roche)) [72]. Following 10 min of 
incubation on ice, samples were passed through QIAshredder spin columns (Qiagen). The 
flow-through was clarified by centrifugation for 10 min at 16,000 × g and 4 °C. 600 µl of the 
recovered supernatant was subjected to RNase I (Life Technologies) digestion using 1000 U 
of enzyme. Digestion of polysomes proceeded for 55 min at room temperature and was 
stopped with SUPERase.In RNase Inhibitor (Life Technologies). Next, monosomes were 
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recovered by ultracentrifugation at 75,000 RPM in a cooled TLA-120.2 rotor over a 1 M 
sucrose cushion in 20 mM HEPES-KOH pH 7.4, 5 mM MgCl2, 100 mM KCl, 2 mM DTT, 100 
µg/ml CHX and 100 U/ml Superase.In. Subsequent steps were performed as described by 
Ingolia et al. [73] with some minor adjustments. RNA was extracted from the samples using a 
heated acid phenol; chloroform; isoamyl alcohol (125:24:1) procedure. 17 µg of RNA was 
subjected to electrophoresis under denaturing conditions in 15% TBE-Urea polyacrylamide 
gel (Life Technologies). Ribosome protected fragments (RPFs) of 28-34 nucleotides were 
extracted from the gel in RNase-free water for 10 min at 70 °C and precipitated with 1/10 
volume of 3 M sodium acetate pH 5.2, 1.5 µl GlycoBlue (Life Technologies) and 1 volume of 
isopropanol overnight at − 80 °C. Following a dephosphorylation reaction (end-repair) with 
10 U of T4 polynucleotide kinase (New England Biolabs), the RPFs were depleted of 
ribosomal RNA contaminants using the Ribo-Zero Magnetic Gold Kit (Illumina) according to 
the manufacturer’s protocol. Subsequently, fragments were ligated to a 1.5 µg of Universal 
cloning linker using 200 U of T4 RNA ligase II (both New England Biolabs). The ligated 
product was size-selected using denaturing gel electrophoresis and purified from gel as 
described above. Subsequently, reverse transcription (RT) was performed with 200 U of 
SuperScript III (Life Technologies) according to [73], followed by a size-selection of the RT 
product (described above). Next, samples were subjected to circular ligation using 100 U of 
CircLigase (Illumina) and amplified by PCR using Phusion polymerase (New England Biolabs) 
for 12 cycles of denaturation (10 s at 98 °C), annealing (10 s of 65 °C) and elongation (5 s at 
72 °C) using primer pairs compatible with the Illumina sequencing platform [73]. The 
resulting ribosome-profiling libraries of LTM- and CHX- treated Jurkat cells were sequenced 
on a NextSeq 500 instrument (Illumina) to yield 75 bp single-end reads. 
Measurement of proteoform turnover 
Arg-ending N-terminal peptides were selected that started at position 1 or 2 (entries stored 
in the Swiss-Prot database) or derived from alternative translation initiation at positions >2) 
and which complied with rules of iMet processing and Nt-acetylation [9]. For every unique 
N-terminus (unique proteoform), SILAC ratios (M/L, H/L and H/M) calculated for the highest
scoring peptide identification were included in the analysis. M/L and H/L ratios were
normalized, according to equation 1:
Equation 1: 𝑖𝑓 𝑴 + 𝑯 = 𝑳 𝑡ℎ𝑒𝑛 𝑴 𝑳⁄ +
𝑯
𝑳⁄ = 1
where L, M and H denote light, medium and heavy isotope‐labelled peptide intensities. 
M/L and H/L ratios were plotted in function of time as degradation and synthesis curves, 
respectively. The crossing over point between the two curves corresponds to 50% protein 
turnover, see Equation 2: 
Equation 2: 𝑖𝑓 𝑴 𝑳⁄ +
𝑯
𝑳⁄ = 1 (𝐸𝑞. 1) 𝑎𝑛𝑑 
𝑴
𝑳⁄ =  
𝑯
𝑳⁄  𝑡ℎ𝑒𝑛 
𝑴
𝑳⁄ =
𝑯
𝑳⁄ =
𝟏
𝟐⁄
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50% protein turnover was calculated as the crossing point between protein degradation and 
synthesis curves for proteoforms quantified in at least 3 time points. We assumed that 
protein degradation follows a first-order process. Therefore, an exponential curve with one 
parameter (B) was fitted to M/L data using the R software (version 0.98.739) and the 
turnover time was calculated as follows: 
Equation 3:  𝑴 𝑳⁄ = 𝑒
(−𝒌𝒅𝒆𝒈−
ln(2)
𝒕𝒄𝒄
)𝒕
, simplified to 𝑴 𝑳⁄ = 𝑒
𝑩𝒕, hence 𝑡𝒕𝒖𝒓𝒏 =
ln (
1
2⁄ )
𝑩
where kdeg is the protein degradation constant; tcc, cell doubling time and tturn, turnover 
time. 
Alternatively, the turnover time was approximated from linear equations between two M/L 
and two H/L points lying on opposite sides of the crossing point. We observed a very high 
correlation between the exponential and the linear method (Pearson coefficient of 0.98). 
Exponential curve fitting was used for protein turnover determination if the quality of fit 
determined by the coefficient of determination (R2) was at least 0.8. In other cases, turnover 
time was calculated from the linear approximation, provided a descending trend of M/L 
changes in time was observed. Turnover measurements fulfilling criteria described above 
were regarded as valid, while other turnover rates remained unassigned and were excluded 
from analysis. Protein degradation constants were derived from the parameter B (Equation 
3) of individual M/L profiles and protein half-lives (𝑡1
2⁄
) were calculated accordingly to
Equation 4:
Equation 4: 𝑡1
2⁄
=
ln(1 2⁄ )
−𝑘𝑑𝑒𝑔
=
ln(1 2⁄ )
(𝐵+
ln(2)
𝑡𝑐𝑐
)
Due to the constrains of Equations 3 and 4, negative values of kdeg were disregarded and 
protein half-lives estimated to be infinite due to continuous cell divisions: 𝑡1
2⁄
≫ 𝑡𝑐𝑐  →
𝑡1
2⁄
≈ ∞.
Quantification of proteoform abundance 
Per unique proteoform, spectral counts were averaged among all time points whenever 
identified (using an arithmetical mean). Normalized spectral abundance factor (NSAF) values 
[44] were calculated based on amino acid lengths of individual proteoforms. All proteoforms
identified in at least one time point were taken as the complete dataset (Appendix
Table II.1A).
Analysis of ribosome profiling data 
Ribosome profiling (ribo-seq) performed in Jurkat cells treated with CHX to study translation 
elongation and LTM to study translation initiation were analysed using the PROTEOFORMER 
pipeline [74]. PROTEOFORMER was used to perform the quality control, mapping onto a 
reference genome, identification of TIS and generation of a protein database.  
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The 3’ adapter sequences were clipped using the fastx_clipper and reads shorter than 26 or 
longer than 34 nucleotides were discarded for the ribo-seq based TIS calling. The reads were 
first mapped onto small nuclear RNA, tRNA and rRNA sequences to eliminate contaminating 
reads. The remaining reads were subsequently mapped onto the human GRCh37 reference 
genome (Ensembl annotation bundle 75) allowing for a maximum of 2 mismatches along the 
entire read. Reads mapping to a maximum of 16 locations on the genome were allowed and 
retained for every loci. All mapping steps were performed using STAR 2.4.0i. RPF alignments 
were reduced to a specific position (the P-site nucleotide) using an offset from the 5’ end of 
the alignment based on the read length (+12, +13 and +14 respectively for alignment of ≤ 30 
bases long, 31–33 bases long, and ≥ 34 bases long). Translation start sites were identified by 
setting different parameter values for the different TIS categories in the tool. A TIS was 
called at the Ensembl annotated start site if i.) it had a minimum read count of 5; ii.) the 
position was a local maximum within a 7 nucleotides window (one codon upstream and one 
codon downstream); iii.) the difference between the LTM (foreground) and CHX 
(background) normalized ratio (RLTM-CHX) within the window reached at least 0.01. A TIS was 
called within the coding region of a transcript (downstream of annotated start sites) if it had 
a minimum read count of 15 and RLTM-CHX of 0.15. For TIS located at the 5’UTR, 3’UTR and 
other non-protein-coding transcripts, the minimum read count was set to 10 with a RLTM-CHX 
of 0.05.  
We used the above settings to define translation initiation events in Jurkat cells. Taking into 
consideration every annotated transcript splice variant, all possible ORFs starting at the 
detected TIS sites were in silico translated. The N-terminal peptides identified in our pSILAC 
experiment (N= 2,578) were mapped onto the ribo-seq derived protein sequences allowing 
to associate peptides with ORFs and their corresponding transcripts. 
Analysis of translation initiation and splicing 
To study the contribution of splicing and (alternative) translation initiation to N-terminal 
proteoform expression, we mapped the N-terminal peptides identified in our proteomics 
experiment onto the human Swiss-Prot Isoform, UniProt TrEMBL, Ensembl human protein 
sequences next the ribo-seq data from Jurkat cells. Further, a comparison was made with 
ribo-seq data obtained from another human cell line (HCT116 colorectal cancer cells, 
unpublished data). 
In case of ribo-seq matching evidence, a peptide corresponding to position 1 was assumed to 
be generated via translation initiation. A peptide mapping at position 2 was considered a TIS 
only if the first methionine was preceded by an alanine, cysteine, glycine, proline, threonine 
or valine and therefore likely co-translationally processed. We used the Jurkat data as 
reference i) to retrieve RLTM-CHX values for called TIS sites; ii) to associate transcripts with a 
normalized RPF read count (the normalized read count was calculated by summing all the 
reads that map across the transcript and dividing by its length) and iii) to determine their 
exon coverage. Since an N-terminal peptide might map to multiple transcripts, additional 
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information regarding the expression was provided for every matching transcript to allow for 
a discrimination of transcripts poorly supported by the ribo-seq data.  
We further investigated whether a downstream peptide is pointing to a possible annotated 
splicing or alternative translation event by checking if this peptide matched the N-terminal 
protein sequence previously reported in the protein databases; Ensembl, Swiss-Prot Isoform 
or UniProt TrEMBL protein sequences. A peptide was considered as a possible N-terminus of 
a splice variant if it mapped at position 1 or 2 to a given sequence in Ensembl or Swiss-Prot 
Isoform databases. Further, we qualified the Ensembl derived evidence of splicing as either 
poor (less likely) or good (likely) splicing events. A downstream peptide was considered to be 
supported by a likely splicing event if any of the Ensembl protein sequences associated to 
the peptide had a transcript support level less than or equal to three (with one being the 
highest rank). If none of the protein sequences associated to the peptide had a transcript 
support level less than three, it was considered as a poorly supported splicing event or not 
applicable if there was no transcript support level assigned to any of the valid transcripts. For 
N-terminal peptides matching an N-terminus of a Swiss-Prot Isoform sequence, we further
retrieved the information if this protein isoform is generated via splicing or alternative
translation initiation. The above mentioned data is presented in Appendix Table II.1C.
Analysis of proteoform turnover rates in macromolecular complexes 
To investigate the dynamic properties of macromolecular complex substituents, protein 
turnover times were mapped to members of human protein complexes defined by the 
CORUM database (core set of 1,343 human complexes [75]). Only Swiss-Prot annotated 
proteoforms (dbTIS) with the most plausible iMet processing status ([18]) and high quality 
turnover measurement were considered [16, 18]. Absolute differences in turnover were 
calculated pairwise between all members of a complex. Subsequently, one-sided Mann-
Whitney test at a 95% confidence interval (R, wilcoxon.test, stats package) was applied to 
detect proteins with significantly higher absolute differences than the remaining members of 
a complex.  
Gene ontology enrichment analysis 
Swiss-Prot accessions of the 1,894 proteoforms with high quality measurement of stability of 
one representative N-terminal proteoform were ranked based on their corresponding 
turnover values. Subsequently, an enrichment analysis of GO terms was performed using 
GOrilla (http://cbl-gorilla.cs.technion.ac.il/, [41]) using the “single ranked list of genes” 
option. Duplicate accessions were removed keeping the highest ranking instance per 
accession. The enrichment p-values were computed using mHG (minimal Hyper Geometric) 
statistics and corrected for multiple testing using the Benjamini and Hochberg method giving 
the FDR q-values. GO terms enriched in stable or unstable proteins with FDR q-values ≤ 0.05 
were subsequently summarized using REViGO [42]. Redundant GO terms were removed and 
the remaining terms visualized in bar charts according to their significance (-log10(q-value)). 
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Analogously, we performed an enrichment analysis of GO terms in aTIS vs. dbTIS 
proteoforms using the GOrilla “target and background” option. 
Prediction of protein intrinsic disorder 
Canonical protein sequences identified in at least 3 time points (1,972 proteoforms) were 
retrieved and adjusted to start at the initiating residue of the N-terminal peptide identified. 
Of these proteoforms, the percentage of intrinsically disorder was predicted using RAPID 
(http://biomine-ws.ece.ualberta.ca/RAPID/index.php, [47]) which implements the IUPred 
algorithms [46, 76].  
Hydropathy of protein N-termini 
The grand average of hydropathy (GRAVY) was calculated for the 2 and 10 amino acid long 
N-terminal sequence of every proteoform (1,894 proteoforms) at http://www.gravy-
calculator.de/. Increasing positive score indicated greater hydrophobicity. The calculation
was based on the sum of hydropathy values of amino acids in Kyte-Doolittle scale [77],
divided by the number of residues. Correlation between GRAVY values and turnover times
was estimated using Pearson and Spearman correlation coefficients.
Statistical analysis of turnover, abundance and disorder of aTIS versus dbTIS 
Differences in turnover, abundance and disorder values between aTIS and dbTIS groups 
were measured for paired dbTIS-aTIS data using a Wilcoxon signed-rank one-sided test for 
paired samples (R, stats package) and independently between the whole aTIS and dbTIS 
groups using a Kruskal-Wallis test for difference in distribution (R, stats package), multiple 
comparison test after Kruskal-Wallis (R, pgirmess package) and Mann-Whitney one-sided 
test for independent samples. All analyses were performed in R at p ≤ 0.05 significance. 
Category enrichment analysis in turnover, disorder and abundance data 
1D enrichment analysis of Pfam, KEGG, GO slim and other categories was performed using 
the Perseus software [78] at p ≤ 0.01 significance with a two-sided test with Benjamini-
Hochberg FDR correction. Turnover, disorder and abundance values corresponding to each 
categorical term were tested for deviations from the complete distribution and a preference 
for larger or smaller values was assessed independently for every variable. Correlation of 
turnover, disorder and abundance values was assessed using Spearman rank correlation. 
Relation between protein turnover and N-terminal amino acid composition 
All proteoforms with measured turnover rates (including proteoforms with alternative iMet 
processing; 1,941 in total) were categorised according to the identity of their utmost N-
terminal residues. Additionally, N-termini susceptible to iMet processing were further 
categorised as either Met retaining or Met cleaved. The general impact of N-terminal 
residues and iMet processing (categorical variables) on protein turnover was assessed by a 
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Kruskal-Wallis rank sum test (R, stats package). A subsequent multiple comparison test for 
Kruskal-Wallis (R, pgirmess package) and pairwise Wilcoxon rank sum test (without 
correction for multiple testing; R, stats package) allowed to indicate the most deviating 
subgroups (with p<0.05). 
Data availability 
MS/MS data was converted using PRIDE Converter [79] and is available through the PRIDE 
database [80] with the dataset identifier PXD002091 and DOI 10.6019/PXD002091. 
Ribo-seq sequencing data has been deposited in NCBI’s Gene Expression Omnibus [81] and is 
accessible through GEO Series accession number GSE74279 
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE74279). 
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Abstract 
Next-generation transcriptome sequencing is increasingly integrated with mass 
spectrometry to enhance MS-based protein and peptide identification. Recently, a 
breakthrough in transcriptome analysis was achieved with the development of ribosome 
profiling (ribo-seq). This technology is based on the deep sequencing of ribosome-protected 
mRNA fragments, thereby enabling the direct observation of in vivo protein synthesis at the 
transcript level. In order to explore the impact of a ribo-seq-derived protein sequence search 
space on MS/MS spectrum identification, we performed a comprehensive proteome study 
on a human cancer cell line, using both shotgun and N-terminal proteomics, next to 
ribosome profiling, which was used to delineate (alternative) translational reading-frames. 
By including protein-level evidence of sample-specific genetic variation and alternative 
translation, this strategy improved the identification score of 69 proteins and identified 22 
new proteins in the shotgun experiment. Furthermore, we discovered 18 new alternative 
translation start sites in the N-terminal proteomics data and observed a correlation between 
the quantitative measures of ribo-seq and shotgun proteomics with a Pearson correlation 
coefficient ranging from 0.483 to 0.664. Overall, this study demonstrated the benefits of 
ribosome profiling for MS-based protein and peptide identification and we believe this 
approach could develop into a common practice for next-generation proteomics. 
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Introduction 
A shotgun proteomics experiment typically involves the fractionation of a complex peptide 
mixture followed by LC-MS/MS analysis and the identification of peptides using one of 
several protein or peptide sequence database search tools [1-3]. N-terminal proteomics 
techniques such as N-terminal COFRADIC (combined fractional diagonal chromatography) 
expand on the results of a typical shotgun experiment by enriching for N-terminal peptides, 
thus revealing (alternative) translation start sites, while simultaneously measuring co-
translational modifications of protein N-termini [4]. Protein reference databases only 
contain experimentally verified and/or predicted sequences and are therefore unlikely to 
contain a comprehensive representation of the actual protein content of a given sample. To 
resolve this shortcoming, recent efforts have been directed towards the combination of 
proteomics and next-generation transcriptome sequencing [5-8]. Proteogenomic approaches 
that delineate translation products based on mRNA sequencing data may improve protein 
identification in multiple ways. The transcriptome of a sample offers a more representative 
expression profile than could be obtained with a public database alone while at the same 
time reducing the search space through the elimination of unexpressed gene products [9]. 
The transcript data also contains useful information about sequence variations such as single 
nucleotide polymorphisms (SNP) or mutations and RNA splice and editing variants [9-11], 
which increases the chances of detecting new proteins or protein forms [12-14]. Despite the 
benefits of adding next-generation transcriptome sequencing to an MS-based proteomics 
experiment, there are still several improvements possible. Because of extensive translation 
regulation, the presence of a transcript does not necessarily imply the presence of the 
corresponding protein [15-17]. On top of that, several factors, including internal ribosome 
entry sites, the presence of multiple ORFs per transcript, non-AUG start codons and leaky 
scanning, ribosome frameshifting and stop codon readthrough hamper the prediction of the 
exact protein sequence(s) from a single transcript sequence [18-20]. Recently, a novel 
technique has been described that attempts to tackle these limitations: ribosome profiling 
[21]. 
Ribosome profiling, or ribo-seq, is based on the deep sequencing of ribosome-associated 
mRNA fragments, thus enabling the study of in vivo protein synthesis at the transcript level. 
In a ribo-seq experiment, eukaryotic translation is often halted using cycloheximide (CHX). 
The mRNA that is not protected by ribosomes after the translation halt is digested with 
nucleases and the monosome-mRNA complexes are isolated. Next, the protected mRNA 
sequences are separated from the ribosomes and converted into a DNA library, ready to be 
sequenced. The sequencing results in a genome-wide snapshot of the mRNA that enters the 
translation machinery. Additionally, (alternative) translation initiation sites can be studied 
with sub-codon to single-nucleotide precision through the use of antibiotics such as 
harringtonine (HARR) or lactimidomycin (LTM), which cause the ribosomes to halt at sites of 
translation initiation [22, 23]. When the exact translation start site is known, the ORF can be 
delineated, thus eliminating the need to translate the transcripts in three or six reading 
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frames. The measurement of mRNA at the translation level, combined with the knowledge 
of the exact translation start sites, makes ribosome profiling an excellent choice for the 
creation of a custom protein sequence search space for MS/MS-based peptide identification 
[24]. It has to be noted that ribo-seq does not generate direct evidence of mature proteins 
or protein stability and that some non-coding transcripts do not result in a protein product, 
despite being associated with ribosomes [25-27]. However, MS-assisted validation may help 
to resolve both issues. Apart from canonical translation products, ribosome profiling also 
aids in the identification of unannotated truncated and N-terminally extended protein 
variants and the validation of these variants can come from matching N-terminal COFRADIC 
data [24, 28]. 
In this study we created a custom protein sequence database based on LTM ORF delineation 
for the HCT116 cell line, a widely used human colon cancer cell model, to serve as the search 
space for MS/MS spectra obtained by means of shotgun proteomics and N-terminal 
COFRADIC (Fig. 1). Translation products derived from the ribosome profiling data of the 
HCT116 cells were combined with the public Swiss-Prot protein sequence database [29] to 
Figure 1 - Proteogenomic strategy for the identification of proteins and peptides using a 
Swiss-Prot/ribo-seq-derived database. Ribo-seq was performed twice on the human colon 
cancer cell line HCT116, once with CHX to halt translation globally and once with LTM to stop 
translation specifically at translation initiation sites. After translation initiation site (TIS) 
prediction, the ribo-seq-derived ORFs were translated to create a custom protein sequence 
database. This database was then combined with the human Swiss-Prot protein sequence 
database. Proteome samples were prepared from the same HCT116 cells and analyzed using 
both shotgun proteomics and N-terminal COFRADIC. The proteins and peptides in these 
samples were then identified using the custom combined protein search space. 
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build an optimal protein search space for our proteomics data. The addition of ribo-seq data 
resulted in the identification of 22 new proteins, i.e. proteins that were not contained in the 
Swiss-Prot database, out of a total of 2,816 protein identifications in our shotgun proteomics 
experiment. On top of that, the inclusion of ribo-seq data improved the score of 69 proteins 
as a result of the discovery of proteins with a SNP, new isoforms and homologs and 
extended protein forms. Out of a total of 1,262 peptides, ribo-seq identified 18 extra N-
termini in the COFRADIC experiment compared to Swiss-Prot alone, including 6 N-termini 
originating from extended protein forms with a near-cognate start site (i.e. the protein does 
not start with the canonical AUG codon). It needs to be noted that in the shotgun 
proteomics experiment 312 proteins were uniquely identified using the Swiss-Prot database, 
emphasizing the importance of proteomics techniques for the validation of next-generation 
transcriptome sequencing datasets. Finally, the correlation between the ribo-seq and 
shotgun proteomics data was calculated. Depending on the settings used, the Pearson 
correlation coefficient between the ribo-seq-derived normalized ribosome-protected 
fragments (RPF) counts and the normalized spectral counts of the shotgun experiment (i.e. 
emPAI [30] and NSAF [31] values) ranged from 0.483 to 0.664. 
Results 
A regular shotgun and an N-terminal COFRADIC proteomics experiment were performed on 
a HCT116 cell line to determine the effect of the addition of ribo-seq-derived translation 
products to the Swiss-Prot protein sequence database on MS/MS spectrum identification. 
The shotgun data were used for the overall assessment of protein expression, whereas the 
N-terminal COFRADIC data were specifically used for the validation of the ribo-seq-predicted
translation initiation sites.
Shotgun proteomics 
Using the combination of Swiss-Prot and the ribo-seq-derived database, we identified a total 
of 2,816 proteins in the HCT116 cells (Fig. 2A). The majority of these proteins (2,482 or 
88.1%) were identified in both Swiss-Prot and the custom database. The addition of the ribo-
seq data to the protein search space led to 22 extra identifications, which would not have 
been picked up with just the Swiss-Prot database. Besides 9 previously unannotated protein 
products, these new identifications included 13 proteins with a SNP and three alternatively 
spliced isoforms. The inclusion of ribo-seq data also improved protein identification and 
score significance for 69 proteins since higher peptide coverage was obtained (Appendix 
Fig. III.1 shows three examples). The proteins with an improved score coincided with SNPs 
(52 proteins), alternatively spliced isoforms (14 proteins) and three N-terminal extensions. 
The ribo-seq experiment also missed 312 proteins, but these were still picked up thanks to 
the inclusion of Swiss-Prot in the search space. All the identified proteins and their 
respective annotations can be found in Appendix Table III.1. An 
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Figure 2 - Bar charts showing the number of protein and peptide identifications obtained 
from the shotgun proteomics and N-terminal COFRADIC experiments. A. Shotgun 
proteomics. The custom combined protein sequence database resulted in the identification 
of 2,816 proteins. Most of these proteins (2,482 or 88.1%) were picked up by both databases 
independently, while 312 and 22 proteins were uniquely identified in the Swiss-Prot and 
ribo-seq databases respectively. The 22 unique ribo-seq identifications contained six new 
proteins, 13 proteins with a SNP and 3 unannotated isoforms. The ribo-seq data also 
improved the protein identification and score of 69 proteins. B. N-terminal COFRADIC. Most 
of the 1,289 peptides that were found in the custom combined protein sequence database 
A 
B 
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mapped to canonical, annotated N-termini (1,071 dbTIS peptides or 83.1%). Of the 
remaining N-termini, 208 started downstream of the canonical start site (beyond protein 
position 2), 9 mapped to a 5’-extension and one to an uORF. For both the up- and 
downstream start sites, we identified several near-cognate start sites. 
approximate analysis of the turnover rate and half-lives of the 312 missed proteins using 
publically available datasets [32, 33] showed no significant difference between the missed 
and the other identified proteins (Wilcoxon rank-sum test, p > 0.05). A gene ontology 
enrichment analysis using the DAVID tool [34] revealed that several biological process 
ontologies involving protein transport and localization were significantly enriched in the 312 
missed proteins, just as the corresponding cellular localization ontologies linked to the 
cytoskeleton, cytosol and non-membrane-bounded organelles (Appendix Table III.2). 
N-terminal COFRADIC
In order to validate the TISs identified by the ribo-seq experiment and thus the 
corresponding N-terminal protein isoforms, positional proteomics in the form of N-terminal 
COFRADIC was applied to the HCT116 cells. After LC-MS/MS analysis and the subsequent 
combined database search, we identified 1,289 N-terminal peptides (Fig. 2B). The greater 
part of these peptides mapped to canonical start sites (1,071 peptides or 83.1%), 208 
peptides started downstream of the canonical start site (past protein position 2 in reference 
to Swiss-Prot), 9 peptides mapped to a 5’-extension and one to an uORF. Two examples of 
proteins with an N-terminal extension or truncation are given in Fig. 3. Ribo-seq uniquely 
identified 18 peptides, which would have been missed when only searching Swiss-Prot. Both 
the N-terminal COFRADIC and ribo-seq experiment provided evidence of translation 
initiation at near-cognate start sites, which was also reported in previous COFRADIC and 
ribo-seq studies [22, 23]. A complete list of all identified N-terminal peptides is provided as 
Appendix Table III.1. 
We compared the list of identified protein extensions starting at non-AUG start sites with 
the previously published list of non-AUG derived N-terminal extensions predicted by Ivanov 
et al. (2011) [35] and found matching evidence for one N-terminally extended protein 
(Swiss-Prot entry name HDGF_HUMAN; extension of 50 amino acids starting at GTG) out of 9 
identified in our proteomics study. 
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Figure 3 - Depiction of two different N-termini that were predicted by ribo-seq and 
identified using N-terminal COFRADIC. The figure shows a 5’-extension (A. Swiss-Prot entry 
name RBP2_HUMAN) and an N-terminal truncation (B. Swiss-Prot entry name 
HNRPL_HUMAN). The UCSC genome browser [57] was used to create the plots of the ribo-
seq and N-terminal COFRADIC data and the different browser tracks are from top to bottom: 
CHX treatment data, LTM treatment data, N-terminal COFRADIC data, UCSC genes, RefSeq 
B
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genes and human mRNA from GenBank. The different start sites (a: alternative start site, b: 
canonical start site) are clearly visible in the zoomed genome browser views, just as the 
three-nucleotide periodicity of the ribo-seq data, especially in the N-terminal truncation 
image. The MS/MS spectra and sequence fragmentations indicate the confidence and quality 
of the peptide identifications. 
Correlation analysis 
We calculated a Pearson correlation coefficient to investigate the relation between the ribo-
seq coverage and MS protein abundance measurements. Only transcripts for which 
quantitative information was available from both the ribo-seq and shotgun proteomics 
experiments were used in all the plots and calculations. The Pearson correlation values for 
the different normalization and identification approaches are listed in Table 1 and Fig. 4a 
shows the correlation plots for the NSAF values, which were better correlated with the ribo-
seq coverage than the emPAI values. The highest correlation (r2 = 0.664) was obtained when 
using only validated dbTIS transcripts with a total RPF count ≥ 200. The correlation 
coefficients were also calculated for the 312 protein identifications that were present in 
Swiss-Prot, but not in our ribo-seq-derived search space (Appendix Fig. III.2). These 312 
identifications were missing from the ribo-seq data because no TISs were identified in the 
LTM-treated cells, but, as there was coverage in the CHX-treated cells, the correlation could 
still be calculated. The Pearson correlation coefficients ranged from 0.464 to 0.713, 
depending on the protein selection and normalization procedure, and were similar for the 
proteins identified in both the Swiss-Prot and ribo-seq database. 
1% FDR i ii iii iv 
emPAI 0.488 0.498 0.483 0.518 
NSAF 0.608 0.642 0.634 0.664 
Table 1 - Pearson correlation coefficients between MS protein abundance and ribo-seq 
coverage. MS protein identifications were performed with an FDR of 1% and protein 
abundances were calculated as emPAI and NSAF values. The correlation coefficients were 
computed for each of the following transcript filtering settings: i) all dbTIS transcripts 
without additional thresholds, ii) only transcripts with a validated MS identification (i.e. 
transcripts with a spectral count value > 2), iii) only dbTIS transcripts with a total RPF count ≥ 
200 and iv) only dbTIS transcripts with both a validated MS/MS-based identification and an 
RPF count ≥ 200. 
We also investigated the link between the correlation and the degree of protein stability. Fig. 
4b shows the correlation plot for validated dbTIS transcripts with an RPF ≥ 200 together with 
the instability indexes of the proteins. These indexes were obtained with the ExPASy 
ProtParam tool [36], where a protein with an instability index < 40 is predicted to be stable 
and a protein with an index ≥ 40 is considered unstable. The majority of unstable proteins 
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were characterized by lower NSAF and RPF values than the stable proteins. As reported 
previously, protein stability is among the most significant factors governing the correlation 
between gene expression and protein abundance [11]. 
Figure 4 - A. Correlation plots of protein abundance estimates based on NSAF values and 
RPF counts. Top left: all dbTIS transcripts; top right: dbTIS transcripts with a validated 
MS/MS-based identification (i.e. transcripts with a spectral count value > 2); bottom left: 
dbTIS transcripts with an RPF count ≥ 200; bottom right: dbTIS transcripts with both a 
validated MS identification and an RPF count ≥ 200. The regression line is shown in green. 
For each plot, the number of data points used (i.e. the number of dbTIS transcripts) as well 
as the corresponding Pearson correlation coefficient (r2) is shown. B. Correlation plot with 
A 
B 
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the inclusion of stability data. Only dbTIS transcripts with both a validated MS/MS-based 
identification and an RPF count ≥ 200 were used (bottom right plot in Figure 4A). Instability 
indexes were determined with the ProtParam tool [36]: proteins with an instability index < 
40 were classified as stable and are shown in blue, whereas proteins with an instability index 
≥ 40 were classified as unstable and are shown in orange. 
Discussion 
The successful identification of proteins and peptides from MS/MS spectra depends on a 
number of factors. A state-of-the-art mass spectrometer that provides high resolution and 
mass accuracy is a vital element of a proteomics experiment. Solid experimental design and 
a robust identification pipeline are two other important factors. As even small changes in 
database search algorithms can lead to different identification results, combining several 
search engines, such as X!Tandem [2] and OMSSA[3], helps to increase the number of PSMs 
[37]. A more recent approach to improve the number of PSMs is based on the custom 
tailoring of the search space through the use of next-generation transcriptome sequencing 
[7, 24]. The new and improved protein identifications based on our ribo-seq-derived search 
space were a first indication of the success of our proteogenomics strategy. Especially the 
identification of N-terminally extended proteins would not have been possible when using 
only Swiss-Prot. The positive correlation between protein abundance (measured as NSAF 
and emPAI values) and the ribo-seq footprint coverage (measured as RPF counts) also 
justifies the usage of the described proteogenomics approach. It has been described before 
how NSAF gives a more accurate estimate of protein abundance than emPAI as it uses more 
information (e.g. fragment ion intensities and protein length) [38, 39]. This could explain why 
the NSAF values correlated better with the ribo-seq data. Interesting to note is that proteins 
with a lower stability index displayed both lower protein abundances as well as lower RPF 
counts than their more stable counterparts (Fig. 4B). Several studies have reported 
correlation values between mRNA-seq coverage and protein abundance, ranging from 0.41-
0.44 [40] to 0.51 [11] in mouse and between 0.42 and 0.43 in rat [14]. Nagaraj et al. (2011) 
published a Spearman’s correlation of 0.6 between FPKM-based transcript abundance and 
iBAQ-based protein abundance values for the human HeLa cell line [5]. The improved 
correlation observed in our study can be explained by the fact that, because it measures 
transcripts after they have entered the translation machinery, ribosome profiling is less 
affected by translation regulation. The ability of ribo-seq to take alternative translation 
events into account leads to a better delineation of ORFs, which could also improve the 
correlation. Another advantage of the ribo-seq-derived database was that it allowed us to 
identify translation initiation from non-AUG start sites at the protein level, for which only 
limited evidence is available so far [28, 41-43]. 
Without the addition of the Swiss-Prot database to our custom search space, a significant 
amount of proteins would have been missed (unique Swiss-Prot identifications in Fig. 2). 
These proteins were missing from the ribo-seq-derived search space because no detectable 
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LTM-signal could be observed. But since the CHX treatment resulted in coverage for these 
proteins, we could still calculate the correlation between protein abundance and RPF counts 
(Appendix Fig. III.2). The abundance values and RPF counts, together with their correlation 
values, ruled out low abundance or coverage as a reason for the missed identifications. A 
suboptimal LTM treatment and/or TIS calling could help explain the lack of TIS recognition 
and the resulting absence of the corresponding proteins from the ribo-seq-derived search 
space. These results demonstrate the importance of reference databases and MS for the 
identification and validation of next-generation sequencing-derived translation products. 
The combination of N-terminal COFRADIC and ribo-seq data identified a number of 
alternative TISs. Translation via these start sites produces protein isoforms with a different 
N-terminus if the new start site maintains the reading frame (e.g. the 5’-UTR extension in
Fig. 3). If the start site is not in the same reading frame, completely different proteins will be
generated. The selection of upstream TISs can also lead to the creation of uORFs, which
influence the downstream protein synthesis from the main ORF [44, 45]. Roughly half of all
mammalian transcripts contain one or more upstream TISs, which are often associated with
short ORFs [23]. In contrast to the previously reported frequent occurrence of uORFs in
human and mouse ribosome profiling data [22, 23], we were able to identify only one N-
terminal peptide of an upstream overlapping ORF in the PIDD gene (Appendix Table III.1).
This limited evidence for uORF protein products could be attributed to several factors, such
as a bias towards upstream (near-) cognate start site identification from ribosome profiling
data [46] or the rapid degradation, small size and possibly low abundance of uORFs.
As sequencing techniques become more generally accessible, ribosome profiling has become 
[24, 27, 28, 41, 47] and will continue to be a valuable addition to MS-based protein and 
peptide identification, possibly taking over the role of mRNA sequencing for ORF delineation. 
The benefits of ribo-seq include the positive correlation between protein abundance and 
ribo-seq footprint coverage and the ability to predict TISs with single-nucleotide precision. 
Despite the advantages of ribo-seq, MS-based validation will remain indispensable, not only 
for the general identification of proteins (through shotgun proteomics), but also for the 
validation of ribo-seq-derived (alternative) TIS predictions (by means of N-terminomics 
techniques such as COFRADIC [4]). Furthermore, unlike ribo-seq or any other transcriptome 
sequencing technique, MS provides true in vivo evidence of proteins or peptides, while 
taking potential co- and post-translational modifications into account. We also found that 
both reference protein sequence databases and ribo-seq-derived search spaces can miss 
protein identifications and that the best results were obtained when these databases were 
combined. Overall, our results show the usefulness of a ribo-seq-based proteogenomics 
approach. The ultimate goal will now be the construction of an automated pipeline for the 
easy conversion of ribo-seq data into a custom protein sequence search space that 
incorporates both sequence variation information and TIS prediction, ready to be searched 
for protein identifications. 
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Materials and Methods 
Cell culture for proteomics 
The HCT116 cell line was kindly provided by the Johns Hopkins Sidney Kimmel 
Comprehensive Cancer Center (Baltimore, USA). Cells were cultivated in DMEM medium 
supplemented with 10% fetal bovine serum (HyClone, Thermo Fisher Scientific Inc.), 
100 units/ml penicillin (Gibco, Life Technologies) and 100 µg/ml streptomycin (Gibco) in a 
humidified incubator at 37°C and 5% CO2. Prior to the proteomics experiments, the HCT116 
cells were subjected to SILAC labeling [48] as part of another experiment that compared the 
wild type HCT116 cells to a double knockout line, which was differently labeled (manuscript 
in preparation). For the N-terminal COFRADIC analysis, cells were transferred to media 
containing 140 µM heavy (13C615N4) L-arginine (Cambridge Isotope Labs, Andover, MA, USA). 
For the shotgun proteome analysis, cells were cultured in medium supplemented with 140 
µM medium heavy (13C6) L-arginine and 800 µM heavy (13C6) L-lysine. To achieve a complete 
incorporation of the labeled amino acids, cells were maintained in culture for at least 6 
population doublings. 
Cell culture and sample preparation for ribosome profiling 
The HCT116 cells for the ribosome profiling experiments were cultivated in McCoy's 5A 
(Modified) Medium (Gibco) supplemented with 10% fetal bovine serum, 2 mM alanyl-L-
glutamine dipeptide (GlutaMAX, Gibco), 50 units/ml penicillin and 50 µg/ml steptamycin at 
37°C and 5% CO2. Cultures at 80-90% confluence were treated with 50 µM LTM [49, 50] or 
100 mg/ml CHX (Sigma, USA) at 37°C for 30 min. Subsequently, cells were washed with PBS, 
harvested by trypsin-EDTA, rinsed again with PBS and recovered by 5 min of centrifugation 
at 300 × g, all in the presence of CHX to maintain the polysomal state. Cell pellets were 
resuspended in ice-cold lysis buffer, formulated according to Guo et al. (2010) [51] (10 mM 
Tris-HCl, pH 7.4, 5 mM MgCl2, 100 mM KCl, 1% Triton X-100, 2 mM dithiothreitol (DTT), 100 
mg/ml CHX, 1 × complete and EDTA-free protease inhibitor cocktail (Roche)), at a 
concentration of 40 × 106 cells/ml. After 10 min of incubation on ice with periodic agitation, 
lysed samples were passed across QIAshredder spin columns (Qiagen) to shear the DNA. 
Subsequently, the flow-throughs were centrifuged for 10 min at 16,000 × g and 4°C. The 
recovered supernatant was aliquoted, snap-frozen in liquid nitrogen and stored at -80°C for 
subsequent ribosome footprint recovery and cDNA library generation. 
Shotgun proteome analysis 
4.2×106 cells were lysed in 20 mM NH4HCO3 pH 7.9 by three rounds of freeze-thawing. Total 
protein concentration in cell extracts was measured using Biorad’s Protein Assay (Biorad 
Laboratories, Munich, Germany) and 2 mg protein material was used for downstream 
processing. Digestion was performed overnight using trypsin (Promega, Madison, WI, USA; 
enzyme/substrate, 1/50) after adding 0.5 M guanidinium hydrochloride and 2% ACN to aid in 
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protein denaturation. Methionines were uniformly oxidized to methionine sulfoxides by 
adding 20 µl of 3% (w/v) H2O2 to 100 µl sample (equivalent to 500 µg proteins) for 30 min at 
30°C. For chromatographic separation 100 µl peptide mixture was then immediately injected 
onto an RP-HPLC column (Zorbax® 300SB-C18 Narrow-bore, 2.1 mm internal diameter × 150 
mm length, 5 m particles, Agilent). Following 10 min of isocratic pumping with solvent A (10 
mM ammonium acetate in water/ACN (98:2 v/v), pH 5.5), a gradient of 1% solvent B increase 
per minute (solvent B: 10 mM ammonium acetate in ACN/water (70:30 v/v), pH 5.5) was 
started. The column was then run at 100% solvent B for 5 min, switched to 100% solvent A 
and re-equilibrated for 20 min. The flow was kept constant at 80 μL/min using Agilent’s 1100 
series capillary pump with the 100 μL/min flow controller. Fractions of 30 sec wide were 
collected from 20 to 80 min after sample injection. To reduce LC-MS/MS analysis time, 
fractions eluting 12 min apart were pooled, vacuum dried and re-dissolved in 20 µl 20 mM 
tris(2-carboxyethyl)phosphine (TCEP) in 2% acetonitrile. 
N-terminal COFRADIC analysis
HCT116 cells were lysed in 50 mM HEPES pH 7.4, 100 mM NaCl and 0.8% CHAPS containing a 
cocktail of protease inhibitors (Roche) for 10 min on ice and centrifuged for 15 min at 16,000 
g at 4°C. The protein sample was then subjected to N-terminal COFRADIC as described by 
Staes et al. (2011) [4]. 
LC-MS/MS analysis 
The shotgun proteomics sample was subjected to LC-MS/MS analysis using an Ultimate 3000 
RSLC nano HPLC (Dionex, Amsterdam, the Netherlands) in-line connected to an LTQ Orbitrap 
Velos (Thermo Fisher Scientific, Bremen, Germany). The sample mixture was loaded on a 
trapping column (made in-house, 100 µm id × 20 mm, 5 µm beads C18 Reprosil-HD, Dr. 
Maisch). After back flushing from the trapping column, the sample was loaded on a reverse-
phase column (made in-house, 75 m id × 150 mm, 5 µm beads C18 Reprosil-HD, Dr. 
Maisch). Peptides were loaded in solvent A’ (0.1% trifluoroacetic acid, 2% ACN) and 
separated with a linear gradient from 2% solvent A’’ (0.1% formic acid) to 50% solvent B’ 
(0.1% formic acid and 80% ACN) at a flow rate of 300 nl/min followed by a wash reaching 
100% solvent B’. The mass spectrometer was operated in data-dependent mode, 
automatically switching between MS and MS/MS acquisition for the ten most abundant 
peaks in a given MS spectrum. Mascot Generic Files were created from the MS/MS data in 
each LC run using the Distiller software (version 2.3.2.0). 
The N-terminal COFRADIC sample was analyzed on the LTQ Orbitrap XL mass spectrometer 
(Thermo Fisher Scientific, Bremen, Germany) which was operated in data-dependent mode, 
automatically switching between MS and MS/MS acquisition for the six most abundant 
peaks in a given MS spectrum. 
All the MS data were converted using the PRIDE Converter [52] and are available through the 
PRIDE database [53] with the dataset identifier PXD000304 and DOI 10.6019/PXD000304. 
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Peptide and protein identification and interpretation 
The protein and peptide searches were performed against our custom database using X! 
Tandem Sledgehammer (2013.09.01.1) and OMSSA 2.1.9 in combination with the SearchGui 
(1.16.4) tool [54]. For the shotgun proteomics experiment, pyroglutamate formation of N-
terminal glutamine, acetylation of N-termini (both at peptide level) and methionine 
oxidation to methionine-sulfoxide were selected as variable modifications. Heavy labelled 
arginine (13C6) and lysine (13C6) were selected as fixed modifications. Mass tolerance was set 
to 10 ppm on precursor ions and to 0.5 Da on fragment ions. The peptide charge was set to 
2+, 3+, 4+. Trypsin was selected as the enzyme setting, one missed cleavage was allowed and 
cleavage was also allowed when arginine or lysine was followed by proline.  
For the N-terminomics experiment, the generated MS/MS peak lists were searched with 
Mascot (version 2.3) [55]. Mass tolerance on precursor ions was set to 10 ppm (with 
Mascot’s C13 option set to 1) and to 0.5 Da on fragment ions. The peptide charge was set to 
1+, 2+, 3+ and the instrument setting to ESI-TRAP. Methionine oxidation to methionine-
sulfoxide, 13C2D3-acetylation on lysines and carbamidomethylation of cysteine were set as 
fixed modifications. Variable modifications were 13C2D3 acetylation of N-termini, acetylation 
of N-termini and pyroglutamate formation of N-terminal glutamine (all at peptide level). 
13C615N4 L-arg was set as fixed modification. Endoproteinase semi-Arg-C/P (Arg-C specificity 
with arginine-proline cleavage allowed) was set as enzyme allowing for no missed cleavages. 
Protein and peptide identification and data interpretation were done using the 
PeptideShaker algorithm (http://code.google.com/p/peptide-shaker, version 0.26.2), setting 
the FDR to 1% at all levels (peptide-to-spectrum matching, peptide and protein). 
Ribosome profiling 
100 µl of the clarified HCT116 cell lysate (equivalent to 4×106 cells) was used as input for 
ribosome footprinting. The A260 absorbance of the lysate was measured with Nanodrop 
(Thermo Scientific) and for each A260, 5 units of ARTseq Nuclease (Epicentre) were added to 
the samples. The nuclease digestion proceeded for 45 min at room temperature and was 
stopped by adding SUPERase.In Rnase Inhibitor (Life Technologies). Next, the ribosome 
protected fragments (RPFs) were isolated using Sephacryl S400 spin columns (GE Healthcare) 
according to the procedure described in ‘ARTseq Ribosome Profiling Kit, Mammalian’ 
(Epicentre). The RNA was extracted from the samples using acid 125 phenol : 24 chloroform : 
1 isoamyl alcohol and precipitated overnight at -20°C by adding 2 μl glycogen, 1/10th volume 
of 5 M ammonium acetate and 1.5 volumes of 100% isopropyl alcohol. After centrifugation 
at 18,840 × g and 4°C for 20 min, the purified RNA pellet was resuspended in 10 μl nuclease 
free water. 
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Library preparation and sequencing 
Libraries were created according to the guidelines described in the ARTseq Ribosome 
profiling Kit, Mammalian protocol (Epicentre). The RPFs were initially rRNA depleted using 
the Ribo-Zero Magnetic Kit (Human/Mouse/Rat, Epicentre), omitting the 50°C incubation 
step. Cleanup of the rRNA depletion reactions was performed through Zymo RNA Clean & 
Concentrator-5 kit (Zymo Research) using 200 μl binding buffer and 450 μl absolute ethanol. 
The samples were separated on a 15% urea-polyacrylamide gel and footprints of 26 to 34 
nucleotides long were excised. RNA was extracted from the gel and precipitated. The pellet 
was resuspended in 20 μl nuclease-free water. Next, RPFs were end polished, 3’ adaptor 
ligated, reverse transcribed and PAGE purified. Five μl of circularized template DNA was used 
in the PCR reaction and amplification proceeded for 11 cycles. The libraries were purified 
with AMPure XP beads (Beckman Coulter) and their quality was assessed on a High 
Sensitivity DNA assay chip (Agilent technologies). The concentration of the libraries was 
measured with qPCR and they were single end sequenced on a Hiseq (Illumina) for 50 cycles. 
The ribo-seq libraries have been deposited in NCBI’s Gene Expression Omnibus [56] and are 
accessible through the GEO series accession number GSE58207 
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE58207). 
Swiss-Prot/ribo-seq integrated database construction 
The merged database was constructed using all human Swiss-Prot proteins (downloaded 
from http://www.uniprot.org, version 2014_03) and the translation products obtained from 
the ribosome profiling experiment (Fig. 1). The ribo-seq-derived translation products were 
created from both the predicted (alternative) TIS genomic locations based on the LTM 
ribosome profiling information (according to Lee et al., 2012 [23]) and the corresponding 
mRNA sequences obtained from Ensembl (version 70) that displayed overall CHX ribosome 
protected fragment (RPF) coverage. After reconstructing the amino acid sequences, the 
Ensembl identifiers were mapped to Swiss-Prot identifiers (to safeguard uniformity) using 
the pBlast algorithm.  
In order to remove redundancy introduced by the combination of the ribo-seq-derived 
translation products and the Swiss-Prot protein sequences, duplicated sequences were 
removed, retaining the custom sequence. Moreover, only the longest form of a series of 
gene translation products (N-terminal extended or canonical) was withheld in the combined 
database. The custom database contained 68,961 sequences as compared to the 20,264 
proteins in UniProtKB-SwissProt version 2014_03. Extra information on the custom DB 
creation can be found in Menschaert et al. (2013) [24]. 
Correlation analysis 
Only the transcripts identified in both Swiss-Prot and the ribo-seq-derived translation 
products were selected for the correlation analysis. Ribo-seq measurements were expressed 
as the number of ribosomal footprints per CDS (RPF count), hereby correcting for a possible 
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3’UTR and 5’UTR bias as suggested by Ingolia et al. (2011) [22]. Two quantitative measures 
for protein abundance based on spectral counts (emPAI [30] and NSAF [31]) were calculated 
using the shotgun data. While the first method uses the number of peptides per protein 
normalized by the theoretical number of peptides, the so-called protein abundance index 
(PAI), the NSAF method takes both the protein length and the total number of identified 
MS/MS spectra in an experiment into account. For each dbTIS transcript for which 
quantitative ribo-seq and shotgun proteomics information was available a Pearson 
correlation coefficient was calculated between its normalized RPF count and its normalized 
spectral count. When more than one ribo-seq-derived transcript corresponded with a 
particular Swiss-Prot protein sequence, the one with the highest normalized RPF count was 
used. The different normalization and identification approaches were combined with the 
following additional transcript filtering settings: i) no extra cutoffs, ii) only dbTIS transcripts 
with a validated MS/MS-based identification (meaning that the spectral count value was 
higher than 2), iii) only dbTIS transcripts with a total RPF count ≥ 200, and iv) only dbTIS 
transcripts with both a validated MS identification and an RPF count ≥ 200. All correlation 
coefficients were computed using log-transformed RPF and emPAI/NSAF measures. 
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eIF1 modulates the recognition of suboptimal translation 
initiation sites and steers gene expression via uORFs. 
Abstract 
Alternative translation initiation mechanisms such as leaky scanning and reinitiation 
potentiate the polycistronic nature of human transcripts. By allowing for reprogrammed 
translation, these mechanisms can mediate biological responses to stimuli. We combined 
proteomics with ribosome profiling and mRNA sequencing to identify the biological targets 
of translation control triggered by the eukaryotic translation initiation factor 1 (eIF1), a 
protein implicated in the stringency of start codon selection. We quantified expression 
changes of over 4,000 proteins and 10,000 actively translated transcripts, leading to the 
identification of 245 transcripts undergoing translational control mediated by upstream 
open reading frames (uORFs) upon eIF1 deprivation. Here, the stringency of start codon 
selection and preference for an optimal nucleotide context were largely diminished leading 
to translational upregulation of uORFs with suboptimal start. Affected genes were implicated 
in energy production and sensing of metabolic stress. Interestingly, knockdown of eIF1 
elicited a synergic response from eIF5 and eIF1B. 
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Introduction 
Qualitative and quantitative characterization of gene expression is indispensable to 
understand dynamic phenotypes of eukaryotic cells. Through technological advances in high-
throughput sequencing and proteomics, it is now possible to follow gene expression from 
transcription to protein turnover [1-3]. The remaining fundamental challenges in modern 
biology include the unraveling of the full diversity of proteoforms (i.e., the different 
molecular forms of proteins) [4, 5] expressed from single genes. An increasing line of 
evidence suggests that mRNA translation may both be a rapid means of gene expression 
control [6-8] as well as a major source of proteoforms [9-12]. However, genes undergoing 
translational control [6, 13] and regulation of proteoform expression [14-16] remain poorly 
investigated. 
Alternative translation initiation mechanisms allow to select between multiple start codons 
and open reading frames (ORFs) within a single mRNA molecule. Here, the scanning 
ribosomes may omit less efficient upstream start codons (e.g. non-AUG start codons and 
start codons embedded in a suboptimal nucleotide context) to initiate translation 
downstream in a process referred to as leaky scanning [6, 17]. Besides, reinitiation [6, 17, 18] 
of translation may occur when post-termination ribosomes are retained on the mRNA 
molecule and recycled after completing translation of a typically closely spaced upstream 
ORF (uORF) to support translation of a downstream ORF. A particular role in alternative 
translation was postulated for short ORFs situated in the mRNA 5’ leaders or upstream and 
partially overlapping the main protein-coding sequence (CDS). Due to the directionality of 
ribosomal scanning, these short uORFs may regulate protein translation [19, 20] or even 
impact on the selection of alternative translation sites giving rise to alternative protein N-
termini and thus N-terminal proteoforms [14-16]. The importance of uORFs was supported 
by sequencing of ribosome associated mRNA regions (ribosome profiling, or ribo-seq) [21, 
22] which provided evidence for the ubiquitous translation from non-AUG start sites situated
outside annotated protein-coding regions. Such uORFs were characterized in a variety of
organisms and conditions [7, 8, 23-25], and their impact on the translation efficiency of
proteins was found to be conserved amongst orthologous genes [23, 24]. Considering the
direction of scanning, ribosome profiling experiments revealed that ribosomes distribute
asymmetrically across ORFs, as they readily accumulate at translation initiation and
termination sites [21], an effect which may be enlarged due to pretreatment with translation
elongation inhibitors [21, 26], overall warranting caution when interpreting uORF expression
levels. Importantly however, further studies reveled that ribosome footprints of 5’leaders
generally resemble those of coding sequences, suggesting genuine translation in these
regions [22].
Translation initiation is a determining control step in translation [27]. In consequence, 
translational control is mainly facilitated by eukaryotic translation initiation factors (eIFs) 
which may readily respond to (extra)cellular conditions by changing the global rates of 
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protein synthesis at the ribosome. To reduce the high energy cost of protein production, 
translational control can be triggered by nutrient deprivation and accumulation of unfolded 
proteins [13]. Here, eukaryotic translation initiation factor 1 (eIF1) was shown to directly 
regulate the translation initiation rate at suboptimal translation initiation start sites [28, 29]. 
Besides, eIF1 protein levels and its phosphorylation were linked to reprogrammed 
translation of uORFs [30, 31] and responses to stress stimuli [31]. Although this protein plays 
a central role in translation initiation [32], a genome-wide assessment of its role in 
translational regulation is lacking. By combining tailored proteomic strategies with ribosome 
profiling and mRNA sequencing we here identified the biological targets of the translation 
control exerted by eIF1. 
Results 
Integrative OMICS to map the translational landscape 
To obtain a comprehensive view of the cellular response upon reduced eIF1 levels, we 
performed detailed analyses of transcriptional, translational and protein level regulation at a 
genome-wide scale in the near-diploid colon cancer cell line HCT116. mRNA-seq, ribo-seq, 
and label-free steady-state proteomics experiments were performed upon siRNA mediated 
knockdown of eIF1 (si-eIF1) and compared to control (si-Ctrl) conditions (Fig. 1). In ribo-seq 
experiments we made use of lactimidomycin (LTM) [33] and cycloheximide (CHX) as 
translation inhibitors, enabling the study of translation initiation and elongation respectively. 
Subsequently, the PROTEOFORMER [34] pipeline was applied to map ribo-seq reads to the 
human genome, identify translation initiation sites (TIS) and assess translation efficiencies of 
specific ORFs across the genomic sequence. 
To gain additional insights into the biological role of eIF1 and its paralog gene eIF1B, we 
complemented the studies performed upon eIF1 knockdown with label-free shotgun 
proteomics data from eIF1 knockout (eIF1KO) and eIF1B knockout (eIF1BKO) HAP1 cell lines. 
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Figure 1 - Experimental setup. A. OMICS analysis of si-RNA mediated knockdown of eIF1 in 
HCT116 cells and shotgun proteomics data of eIF1 and eIF1B knockout HAP1 cell lines. B. 
qPCR experiments indicated a 62% eIF1 knockdown efficiency at the transcript level, 
whereas shotgun proteomics experiments (A.) indicated a 50% knockdown efficiency at the 
protein level. 
Overall, using ribo-seq in HCT116 cells we identified potential TIS at 201,934 unique genomic 
positions (Fig. 2A) of which only 37% represented AUG codons (Fig. 2B), an observation in 
line with previous reports [21]. Given the plethora of potential translation start sites and 
annotated splice variants, an integrative OMICS analysis was facilitated by rationalized 
filtering of transcripts without any evidence of transcript-specific translation or poorly 
expressed transcripts [35]. A single representative transcript per translated gene was 
selected using experimental data and meta-data (see Materials and Methods section 
Ribosome profiling data analysis). Next, minimal read count thresholds were applied at the 
transcript (mRNA-seq), CDS (ribo-seq) and uORF (ribo-seq) level. Furthermore, to 
complement transcript-level data, expression proteomics in HCT116 cells was performed by 
searching against a protein sequence database containing all Ensembl annotated CDS 
sequences (“aTIS database”). Consequently, the “aTIS database” was also used in the 
subsequent protein expression profiling in HAP1 cells, allowing to investigate the 
relationship between protein expression changes upon knockdown and knockout conditions. 
Finally, to facilitate the identification of novel peptides expressed in HCT116 cells that 
correspond to non-synonymous mutations and alternative translation events detected by 
the PROTEOFORMER pipeline [34], we searched the HCT116 proteomics data using a protein 
sequence database containing ribo-seq predicted ORFs to which all missing Ensembl 
annotated CDS sequences (“custom database”) were added [34]. 
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Figure 2 - Overview of the identified TIS and TIS-delineated ORFs. A. Initiation sites were 
called at 201,934 unique genomic positions corresponding to aTIS, CDS, 5’UTR, 3’UTR regions 
or non-translated transcripts (ntr). B. Percentage of TIS codon usage in the entire genome 
compared to upstream (uTIS) codon usage in 10433 selected transcripts. Frequencies of at 
least 10% were indicated. C. Transcripts with (at least one) upstream (uORF) and/or 
upstream-overlapping ORFs (u-oORF) in 5’ leader sequences. D. Comparison of observed u(-
o)ORF and CDS length distribution. Nucleotide conservation around the AUG start codon was
analyzed for several ORF categories using phastCons (E) and phyloP (F) scores. Each category
comprises at least 500 AUG-initiated ORFs.
Using an integrative OMICS approach in HCT116 cells, we quantified the expression changes 
of 4,197 proteins and 10,433 transcripts with actively translated CDS. Additionally, in 7,083 
(68%) of these transcripts, we detected translational activity in the 5’ leader sequence, 
pointing to a total of 15,894 uORFs and 8,554 upstream-overlapping ORFs (u-oORFs) (Fig. 
2C). As expected, ORFs located in the 5’ leader were generally 10 to 20- fold shorter, with a 
median length of 84 nucleotides (nt) for the u(-o)ORFs compared to 1,440 nt for CDS (Fig. 
2D). Next, we compared evolutionary conservation patterns of annotated, upstream and 
intronic AUG-initiated ORFs [36], which revealed that u(-o)ORFs have overall intermediate 
nucleotide conservation scores, nonetheless with clearly elevated scores around the start 
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codon [36] (phastCons and phyloP analysis, Fig. 2E-F) and -3 nucleotide position (phyloP 
analysis, Fig. 2F), corresponding to the Kozak consensus sequence hallmarks [37]. Despite 
the increased nucleotide conservation around upstream start sites (uTIS), u(-o)ORF sequence 
conservation was much lower compared to CDS, underscoring their potential regulatory 
rather than peptide- or protein-coding roles [36]. 
We then compared the steady-state levels of translation, mRNA and protein (Fig 3A). In line 
with previous reports in human and mouse [1, 38, 39], we detected moderate to good 
correlation of protein and mRNA levels (Pearson coefficient r = 0.57-0.58). Protein synthesis 
rate was believed to largely explain the remaining variability [1, 3, 38], especially in the case 
of non-perturbed systems, and indeed, we have observed a slightly improved correlation of 
ribo-seq readout of translation to protein levels (r = 0.62), in line with previous reports [1, 
10]. Our results further highlight the importance of downstream processes such as protein 
turnover in establishing a proteome level equilibrium. Moreover, inherent limitations of the 
applied technologies, namely the fact that ribo-seq captures a “snap-shot” of translation 
while proteomics captures steady-state protein abundance, increase the difficulty in 
accounting for the potential delay in the manifestation of the translational response at the 
protein level [40], as may be the case in our study, since translatome and proteome samples 
were harvested at the same time-point after knockdown. Translation of uORFs however, was 
only weakly correlated (r=0.36) to protein changes (Fig. 3A), in line with the postulated 
regulatory role of translationally active 5’ leaders. 
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Figure 3 - Correlation and reproducibility at different OMICS levels. A. Values represent 
average Pearson correlation coefficients for quantitative OMICS experiments performed in 
the si-Ctrl setup of HCT116 cells. LFQ - label free quantification of protein expression. B. 
Identification of differentially expressed genes (p=0.01) based on adjusted significance 
threshold in relation to data distribution obtained by Z-score transformation (Z-score cut-
offs values of -2.58 and 2.58 corresponding (p=0.01) are indicated in red). C. Significantly 
regulated proteins in the HCT116 shotgun proteomics experiment were clustered alongside 
their corresponding mRNA, CDS and TE CDS Z-score fold changes. Additionally, HAP1 LFQ 
data - not used for clustering - was visualised. Columns with protein data represent log2 fold 
change between average LFQ intensities in knockdown/knockout compared to control 
conditions. The scale ranges from red (upregulation in knockdown/knockout) to green 
(downregulation in knockdown/knockout) Clusters depict different modes of protein 
regulation: cluster 1 – transcriptional downregulation; cluster 2 – transcriptional 
downregulation not reflected by CDS translation; clusters 3 and 4 -  downregulated and 
upregulated proteins deviating from the expected transcriptional and translational 
regulation (31 proteins), respectively; cluster 5 – transcriptional upregulation; cluster 6 – 
transcriptional upregulation not reflected by CDS translation; cluster 7 – translational 
downregulation; cluster 8 – mixed (transcriptional and translational) downregulation; cluster 
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9 – translational upregulation; cluster 10 - mixed (transcriptional and translational) 
upregulation. 
An OMICS perspective on eIF1 translational control 
To study expression changes in response to eIF1 deprivation at the level of transcription, and 
CDS and uORF translation, we calculated ratios (fold changes) of normalized read counts 
between the eiF1 knockdown (si-eIF1) and control (si-Ctrl) conditions. Translation efficiency 
(TE) of the CDS or uORF was estimated by dividing normalized ribo-seq reads with 
normalized mRNA read count data of the corresponding transcript. Fold changes in TE were 
further calculated between both conditions. Finally, to determine the regulatory effect of 
uORFs on their downstream CDS, a ratio between uORF TE fold change and CDS TE fold 
change was calculated. In order to identify ORFs and transcripts significantly affected by 
differential eIF1 expression, we applied a Z-scoring strategy with adjustment for expression, 
as described by Andreev et al. [7]. To identify significantly regulated ORFs and transcripts, 
data points were grouped in bins according to read counts, and Z-score normalization was 
performed per bin. This approach allowed to assure sufficient stringency of the analysis in 
case of lowly expressed genes displaying a broader distribution of expression changes, while 
remaining sensitive to smaller fold changes in the case of highly expressed genes. Using a 
threshold p-value of 0.01 we detected significant deviations in response to eIF1 knockdown 
for 159 mRNAs, 125 CDSs and 291 u(-o)ORFs (Fig. 3B, Appendix Table IV.1). Additionally, 121 
CDSs and 313 u(-o)ORFs (i.e. 81 u-oORFs and 232 uORFs) were affected at the TE level. 
Finally, differential regulation of translation efficiency was confirmed for 330 u(-o)ORF/CDS 
pairs (i.e. u(-o)ORF and CDS ORF are located on the same transcript), comprising 68 u-
oORFs/ and 262 uORFs/CDS pairs, originating from 245 unique affected transcripts (Fig. 4A). 
These genes represented a broad spectrum of expression levels (Fig. 4A) and different 
modes of regulation (Fig. 5, 6 and Appendix Table IV.1), including u(-o)ORF initiated at non-
AUG uTIS with a possible inhibitory effect on CDS expression and AUG-initiated u(-o)ORF 
potentially enhancing CDS expression, amongst others. Protein expression data revealed 238 
significantly regulated proteins identified by an ANOVA test with a p-value of 0.05 (Appendix 
Table IV.1). A systematic comparison of affected genes highlighted that the majority of 
protein changes resulted from either transcriptional (41%), translational (28%) or 
concomitant transcriptional and translational regulation (18%) of gene expression, next to 31 
proteins (13%) displaying significant deviations in expression likely caused by perturbed 
turnover and/or posttranslational modifications amongst others (Fig.3C). 
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Figure 4 - Translational response to eIF1 deficiency is in part mediated by uORFs and 
depends on identity of the uTIS codon. A. 330 differentially regulated uORF/CDS pairs (from 
245 transcripts) were identified at a 0.01 confidence level. Gene names were indicated for 
selected examples, also visualized in Fig. 5, Fig. 6 or Appendix Fig. IV.1. B. Lower eIF1 levels 
allow for translational upregulation of non-AUG uORFs and downregulation of AUG uORFs. 
Only significantly regulated uORF/CDS pairs were presented. C. The relationship between 
uORF start codons and the expected directionality of translational regulation is maintained 
for both upstream and upstream-overlapping ORFs. D. The effect of u(o-)ORF start site on 
downstream CDS translation. 
uORF features associated with eiF1 mediated translational control 
Our analysis confirmed that uORFs are implicated in translational control directed by eIF1, 
thereby contributing to regulating protein expression. Therefore, we decided to elucidate if 
certain intrinsic features of uORFs may determine their potential to enhance or repress the 
expression of downstream CDS. Studies reported by the Atkins group demonstrate that eIF1 
levels may orchestrate the stringency of start codon selection [28, 30]. More specifically, 
overexpression of eIF1 resulted in preference for AUG initiation. In light of these findings, we 
hypothesised that decreased eIF1 levels should lead to more flexibility in ribosomes initiating 
138 
Figure 5 - Genes under uORF regulation. We detected a differential translational regulation 
of CDS and at least one uORF for 245 unique transcripts (genes) (Z-score fold change TE 
uORF/TE CDS). Clustering of their corresponding expression values revealed 5 modes of 
regulation with predominant effect of translation, transcription or a combined effect of both 
processes. Selected genes containing regulatory uORF(s), previously shown in Fig. 4A, were 
highlighted in red on the orange background of the entire cluster profile. 
translation at non-AUG codons. Whereas the vast majority (99.6%) of annotated CDS 
detected in our study have AUG initiation sites, u(-o)ORFs display a broad spectrum of TIS 
codons (Fig.2B). In consequence, eIF1 knockdown, by increasing initiation (rates) at near-
cognate start sites, is expected to impact the rate of leaky scanning and reinitiation, leading 
to altered incidences of both uTIS and aTIS initiation. Indeed, we observed a highly 
significant dependence between uTIS codon identity and the regulation of uORF/CDS pairs 
(Kruskal Wallis test p=4.1e-14). This relationship was further confirmed on a subset of 
transcripts with a single uORF (p=0.0014). uORFs with non-AUG start codons had frequently 
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upregulated uORF/CDS TE ratio (Z-score TE uORF/CDS ≥ 2.58), whereas AUG-initiated uORFs 
were typically downregulated compared to their CDS (Z-score TE uORF/CDS ≤ -2.58; Fig.4B; 
Chi2 test p=0.00035). Increased expression of non-AUG uORFs and decreased expression of  
Figure 6 - Ribosome density profiles of transcripts with actively translated u(-o)ORFs. Full 
length ribosome CHX reads of si-Ctrl and si-eIF1 samples were visualized across mRNA 
sequences as positive (blue) and negative (red) values, respectively. Only the 5’ proximal 
part of the 3’UTR sequence was included. Both uniquely and non-uniquely mapped reads 
were included. CDS and u(-o)ORFs were marked using grey or green/red/blue/yellow bars, 
respectively. Direction of expression changes (si-eIF1 vs. si-Ctrl) and start codon of the most 
5’ proximal u(-o)ORF were indicated (see figure). Potential regulatory u(-o)ORFs were 
visualized for PHLDA2, ALDH1A3 FZD3 and AIMP2. These u(-o)ORFs contributed to significant 
Z-score TE uORF/TE CDS changes.
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AUG uORFs was also apparent when considering uORFS and u-oORFs separately (Fig.4C). 
When considering the impact of the uTIS codon on TE of the downstream CDS (Fig.4D), AUG 
uTIS codons more often associated with downregulation of uORF expression and enhanced 
expression of the corresponding CDS, while non-AUG-initiated uORFs displayed increased 
expression, thereby acting as CDS repressors. These results demonstrate that by relying on 
the principle of leaky scanning, eIF1 steers the stringency of start codon selection, thereby 
exerting translational control on protein-coding genes at a genome-wide scale. The direction 
(and likely also the degree) of eIF1-induced regulation is dependent on the cellular 
availability of the translation factor and on the nature of upstream and downstream start 
codons.  
Higher CDS translation efficiency also coincided with increased distance between the uORF 
stop codon and the aTIS compared to a lower distance to uORF observed when TE CDS was 
repressed (Wilcoxon test p=0.00091, Fig. 7A). These results confirm that the relationship 
between repressiveness of uORFs and their distance to CDS [23] are relevant parameters 
upon eIF1 deprivation and suggest that more distant uORFs may act as enhancers of CDS 
translation. Sufficient spacing between the uORF and CDS is necessary to allow the 
occurrence of translation reinitiation in eukaryotes [41]. Kozak et al. [41] illustrated how 79 
nt spacing stimulated efficient reinitiation in mammalian cells by enabling the 40S ribosome 
subunit to reload with translation initiation factors and initiator methionine tRNA, while 
resuming the scanning of mRNA. On the contrary, and similar to previous reports [24], we 
did not observe any relationship between the u-oORF TIS/aTIS distance or the overlap with 
CDS and the significance of the fold change in TE of the CDS (Fig. 7B, Appendix Fig. IV.2A).  
Next we investigated if the number of u(-o)ORFs is relevant for CDS expression levels. Higher 
ribo-seq coverage of transcripts and, by extension, higher translational signals, coincided 
with an increasing number of detected u(-o)ORFs (Kruskal Wallis test shows significant 
relationship between log2 CDS ribo-seq read counts and u(-o)ORF count, p = 6.34e-07; 
Wilcoxon test shows decreased CDS read counts in transcripts with no u(-o)ORFs, p = 7.73e-
09). Despite this potential bias due to sequencing coverage, translation efficiency was 
dependent on the number of u(-o)ORFs (Kruskal Wallis p < 2.2e-16), and TE rates at steady-
state were generally higher for CDS without u(-o)ORFs (Wilcoxon p < 2.2e-16). Interestingly, 
CDSs with one or more u(-o)ORFs were found to be significantly more repressed upon eIF1 
knockdown (lower Z-score of TE CDS fold change; Wilcoxon p = 0.0007; Fig. 7C). 
Next, we sought to determine whether the primary nucleotide context surrounding uTIS 
codons was implicated in steering eIF1 regulation of u(-o)ORFs. Therefore, we first retrieved 
the sequence context of all aTIS called by our PROTEOFORMER pipeline. As described by 
Grzegorski et al. [42], we assigned the entire nucleotide context with a single numeric score 
based on the preferred nucleotide frequency at particular positions. The best scoring context 
in the aTIS set (GCCACCXXXGC, score=345.8) corresponded to the Kozak consensus sequence 
(GCC(A/G)CCXXXG, [37]). Of note however, this was not the most frequent motif observed in 
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our aTIS dataset, instead GGGAAGXXXGC (score= 303.7) was most frequently observed (0.19 
%). Overall, and in line with the original report [42], higher aTIS scores were associated with 
an overall higher incidence (Fig. 7D) as well as higher levels of expression and increased 
translation efficiency of the corresponding CDS (Fig. 7E; Wilcoxon p ≤ 8.917e-10). Using the 
scoring system established for aTIS, we assigned scores to uTIS context sequences. Although 
uTIS identified in our dataset were clearly enriched in non-AUG codons, the nucleotide 
context score of these near-cognate start sites was generally much higher compared to AUG 
uTIS (Fig. 7F, Wilcoxon p < 2.2e-16) [43, 44]. This stronger nucleotide context around non-
AUG uTIS was further confirmed for significantly regulated u(-o)ORF/CDS pairs (Wilcoxon p = 
0.028). Interestingly, the preference for an optimal consensus sequence was perturbed upon 
eIF1 knockdown, resulting in decreased uTIS context scores in the group of regulated 
compared to non-regulated u(-o)ORF/CDS pairs (Fig. 7G; Wilcoxon p = 0.115 and p = 0.0034 
for Z-score TE uORF/CDS threshold 0.01 and 0.05, respectively). The same was observed in 
transcripts with one u(-o)ORF (Wilcoxon p = 0.014 for Z-score TE uORF/CDS threshold 0.01). 
In contrast, aTIS nucleotide context scores were indistinguishable when comparing regulated 
versus non-regulated u(-o)ORF/CDS pairs (Fig. 7H). When considering transcripts with a 
single u(-o)ORF, a decreased quality of the uTIS context sequence in relation to aTIS was 
especially apparent for regulated AUG uTIS compared to the non-regulated AUG uTIS group 
(Fig. 7I, Wilcoxon p = 0.0751 and p = 3.61e-05 for Z-score TE uORF/CDS threshold 0.01 and 
0.05, respectively). To further asses the relationship between uTIS context and the direction 
of u(-o)ORF regulation we turned to a more simplified metric. The quality of context 
sequence was assumed to be “strong” (indicated by-3 purine and+4 guanine relative to uTIS) 
or otherwise ‘‘weak’’ [19]. Using this metric we observed that upregulated AUG uTIS had 
significantly weaker context compared to downregulated AUG uTIS (Fisher’s exact test p = 
0.081 and p = 0.026 for Z-score TE uORF/CDS threshold 0.01 and 0.05, respectively). In 
contrast, such relationship was not detected for non-AUG uTIS, results corroborated by 
sequence logo analysis (http://weblogo.berkeley.edu, [45]) presented in Appendix Fig. IV.3). 
These results allow us to conclude that eIF1 knockdown perturbed translation initiation rates 
at u(-o)ORFs when their start codon was embedded in a suboptimal nucleotide context 
sequence. Although translation initiation rates at uTIS with a poor context was affected upon 
eIF1 knockdown, uTIS start codon identity (AUG vs. non-AUG) seemed to be a stronger 
determinant of eIF1-driven start site selection.  
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Figure 7 - uORF and uTIS features relevant for translational regulation. A. Spacing between 
uORF stop codon and aTIS has impact on CDS translation irrespective of the uTIS codon (AUG 
vs. non-AUG). B. Distance between u-oORF start site and aTIS has no clear impact on CDS 
translation. C. Translation efficiency of CDS is decreased in the presence of uORF(s) (left 
panel) despite the fact that highly expressed CDS tend to have more uORFs (right panel). D. 
Correlation between aTIS context score and its frequency of occurrence in the human 
genome. E. Higher aTIS score can be expected for well expressed (left panel) and efficiently 
translated (right panel) CDS at the steady-state level (si-Ctrl conditions). mRNA abundance is 
also associated with aTIS score, although to a lesser extent. F. Cumulative frequency plot 
demonstrating that non-AUG uTIS are embedded in more optimal nucleotide context 
compared to AUG uTIS. G. Relaxed stringency of start codon selection by eIF1 allowed for 
significant regulation of uORFs with suboptimal uTIS context. H. Nucleotide context of the 
downstream aTIS had no apparent impact on the regulation. I. The impact of differences in 
uTIS and aTIS context scores on regulation in transcripts with 1 detected u(-o)ORF. 
* Wilcoxon test p-value < 0.05.
Impact of eIF1 knockdown on cell metabolism and energy status 
To investigate the consequences of eIF1 deficiency at the cellular level, we analysed changes 
in protein expression upon si-eIF1 treatment in HCT116 cells. Additionally, we validated our 
findings with label-free shotgun proteomics data from two independent eIF1 knockout 
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(eIF1KO) HAP1 cell lines, which have shown overall good agreement with si-eIF1 results (Fig. 
3C, clusters 5 and 8). Combined annotation enrichment analysis of ribo-seq and proteomics 
data revealed a decreased translation efficiency and, concomitantly, lowered expression of 
genes involved in glycolysis/gluconeogenesis (TE CDS FDR = 0.00027, LFQ si-eIF1 FDR = 
0.00044, LFQ eIF1KO FDR = 0.00066) and in the TCA cycle (TE CDS FDR = 0.00021, LFQ 
eIF1KO FDR = 0.0021). In light of these findings, we decided to measure cellular ATP levels 
upon eIF1 knockdown (Fig. 8A). We confirmed that reduced expression of glycolytic genes 
was accompanied by decreased cellular ATP levels, hinting to a more general impairment of 
energy metabolism induced by eIF1 deficiency. Further analysis of gene subsets affected by 
translationally active 5’ leaders (significant Z-score TE uORF/CDS) against a background of all 
quantified genes was performed using GOrilla (Gene Ontology enrichment analysis and 
visualization tool) [46]. This analysis revealed translational downregulation of mitochondrial 
outer membrane translocase complex components (p = 0.000027). To test mitochondrial 
activity upon si-eIF1 treatment, we stained HCT116 cells with JC-10, a dye useful for 
determining mitochondrial membrane potential by flow cytometry. CCCP pre-treatment was 
performed as a positive control of absolute membrane depolarization. Overall, our results 
indicated, that si-eIF1 treated cells may suffer from decreased mitochondrial activity (Fig. 
8B). 
Similar GO-based analysis of the up-regulated genes pointed to the increased expression of 
ribosomal proteins and thus increased ribosomal biogenesis, enhanced aminoacyl-tRNA 
synthesis and amino acid transport throughout all OMICS levels. More specifically, ribosome 
biogenesis (CDS FDR = 0.0065, TE CDS FDR = 0.0019), ribosomal protein (CDS FDR = 0.011, 
mRNA FDR = 0.00006, LFQ si-eIF1 FDR = 5.08e-11), aminoacyl tRNA biosynthetic process 
(mRNA FDR = 0.0083, CDS FDR = 0.0035, LFQ si-eIF1 FDR = 0.0025, LFQ eIF1KO FDR = 0.009) 
and amino acid transport (mRNA FDR = 0.017, CDS FDR = 0.00077, LFQ eIF1KO FDR = 0.0073) 
were significantly upregulated terms. Ingenuity Pathway Analysis (IPA) of ribo-seq data (Z-
score fold change CDS) further identified a causative relationship between the transcription 
factor ATF4 and the upregulation of processes related to amino acid metabolism (Fig. 9A). In 
line, our data point to the increased expression of ATF4, which was linked to the 
translational downregulation of AUG uORFs in the 5’ leader of ATF4 upon eIF1 knockdown 
(Z-score TE uORF/CDS ≤ -2.58).  
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Figure 8 - Energy status upon eIF1 deprivation. A. Chemiluminescent readout of cellular ATP 
levels (lower panel). Glucose deprivation was additionally performed as a positive control for 
ATP level reduction Knockdown efficiency was monitored by Western blot (upper panel) 
using anti-eIF1/1B primary antibody sc-49187 (Santa Cruz). Beta-actin was probed as a 
loading control using A2066 primary antibody (Sigma). *- unspecific band. B. Measurement 
of mitochondrial membrane potential by FACS. **- t test significance p<0.01. 
Equilibrium of eIFs 
Interestingly, knockdown of eIF1 elicited a synergic response from other eIFs. Our 
proteomics data suggest a significant regulation of four other eukaryotic initiation factors (or 
subunits thereof) upon eIF1 knockdown, including EIF1B, EIF2S1 (encoding eIF2α), EIF5 and 
EIF4B (Fig. 9B). More specifically, we observed a significant downregulation of eIF5 and 
eIF2α, while eIF4B and eIF1B were upregulated. In support of these findings, a similar 
expression profile was detected in the HAP1 eIF1KO cell lines, with the sole exception of 
eIF2α that was found significantly upregulated. Interestingly, eIF5 and eIF1 were previously 
reported to have opposing effects regarding the stringency of start codon selection [30]. eIF5 
expression is regulated by uORFs with poor context AUG TIS and therefore expected to 
decrease when translational initiation equilibrium is shifted towards more flexible start 
codon selection [30]. In consequence, and in line with our results, one would predict that 
eIF5 expression is decreased upon eIF1 knockdown. Low eIF5 levels should counteract eIF1 
knockdown to reconstitute the fidelity of translation initiation, however restoration
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Figure 9 - OMICS analysis highlights the effect of eIF1 deficiency on the ATF4 interaction 
network and suggests a widespread remodelling of the translational machinery. A. 
Upregulation of ATF4 expression coincided with increased expression of its downstream 
targets involved in amino acid synthesis (ASNS Asparagine Synthetase (Glutamine-
Hydrolyzing), PHGDH Phosphoglycerate Dehydrogenase involved in the early steps of L-
serine synthesis and PSAT1 Phosphoserine Aminotransferase 1 that participates in glycine, 
serine and threonine metabolism) next to genes involved in amino acid transport (SLC3A2, 
SLC6A9 and SLC7A5 Solute Carrier Family members that transport L-type amino acids). 
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Additionally, the expression pattern of ATF4 upstream regulators, such as EIF2S1, EIF2AK1 
and GCN1L1, were visualized. IPA analysis indicated a common node (FASN Fatty Acid 
Synthase) between ATF4 and ERBB2 interaction network, which pointed to a possible 
impairment of adherent junction formation (due to downregulated KRT7 Keratin 7, SMAD 
Family Member 3 and ERBB2 Receptor Tyrosine Kinase 2). In contrast to the ATF4 network, 
observation concerning adherent junctions could not be confirmed at the protein level. B. 
eIF proteins significantly regulated upon eIF1 knockdown were also found to be significantly 
regulated in eIF1KO cells. Differential expression values were subjected to hierarchical 
clustering using normalized protein expression fold changes next to TE CDS, CDS and mRNA 
Z-score fold changes as input.
of the equilibrium is likely not possible when eIF1 expression is persistently inhibited. eIF1B, 
on the other hand, is an eIF1 paralog gene whose role in translation initiation remains to be 
determined. eIF1 and eIF1B share 97% sequence similarity. Viewing the fact that both eIF1 
and eIF1B were proven to be non-essential genes in HAP1 cells (both produced viable 
knockout cell lines), certain functional redundancy may be expected between these proteins. 
In consequence, eIF1B upregulation may (in part) counteract eIF1 deficiency. 
Discussion 
By combining tailored proteomic strategies with next generation sequencing [9, 10, 47] we 
aimed at identifying the biological targets of translation control exerted by eIF1. Integrative 
OMICS studies face the problem of limited correlation observed between protein and mRNA 
levels. We improved on this aspect by relying on the ribosome-profiling readout for 
translation. We however detected 31 genes with significant changes at the protein level, 
independent of mRNA expression and translation efficiency. Further, in numerous cases, 
proteins levels only moderately corresponded to their synthesis rates (Fig. 3C, clusters 2 and 
6). There may be many reasons as to why such discrepancies are observed. First of all, 
protein synthesis is delayed compared to transcriptional regulation, which reduces the 
overall correlation between mRNA and protein fluctuations [40], especially when sampling 
RNA and protein at the same time point after knockdown. Additionally, ribo-seq provides a 
snapshot of translational engagement of ribosomes, which may correspond to a transient 
state, while the magnitude of expression changes might be insufficient to impact on steady-
state protein levels. Finally, compensatory effects (such as the possible eIF1B activity) might 
be at play.  
Using complementary high-throughput technologies, we here confirmed that eIF1 levels 
determine the stringency of start codon selection at the genome wide scale and thereby 
orchestrate the rates of leaky ribosomal scanning and uORF translation. More specifically, 
low eIF1 levels promote translation initiation at near-cognate codons and start sites 
embedded in a suboptimal nucleotide context (Fig. 10). The initiation context was previously 
also found to determine aTIS versus downstream TIS (dTIS) selection [9]. Although our data 
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suggests, that the direction (and likely also the degree) of eIF1-induced regulation is 
dependent on the cellular availability of the translation factor and on the nature of upstream 
and downstream start codons, eIF1 modification status [31], not monitored in this study, is 
another potential factor involved.  
Figure 10 – Translation initiation upon eIF1 deficiency. Our data suggest that upon eIF1 
knockdown the stringency of start codon selection and preference for an optimal nucleotide 
context were largely diminished. Overall, this leads to translational upregulation of uORFs 
with suboptimal start and decreased translation initiation rates at upstream AUG codons 
embedded in more optimal nucleotide context. 
Although uORFs are omnipresent throughout protein-coding transcripts, uORF mediated 
regulation significantly affects only a subset of genes and tends to have an overall moderate 
effect on absolute expression levels (average fold change in CDS expression of about +/- 
25%), a range similar to miRNA effects [24]. Therefore, we may consider that the 
predominant role of uORFs involves the fine-tuning of proteome homeostasis, buffering the 
effects of stress conditions for most genes while providing the capacity for stress response to 
particular effectors [7]. Although the expression and functionality of uORF-derived peptides 
is debated with only a limited number of active peptides identified and characterized so far 
[48], proteogenomics strategies hold promise in expanding our knowledge in this field. We 
searched our shotgun proteomics data against a “custom database” enriched for ribo-seq 
delineated reading frames, leading to the identification of peptides derived from one uORF 
in the CYP4F11 gene and six u-oORFs (in MFGE8, POLR2M, SAMD1, PSMG4, SLC39A13 and 
RSU1 genes) (see Appendix Fig. IV.1 and Appendix Table IV.2 for these and other examples of 
novel proteoforms and non-synonymous variants identified in our study). Additionally, our 
148 
ribo-seq data has predicted the expression of 14 short ORF-encoded polypeptides previously 
identified by Slavoff et al. [49] and 60 alternative ORFs with peptide evidence reported by 
Vanderperre et al. [50]. Of note however, 10 peptides in the Slavoff et al. dataset and 118 
peptides from the Vanderperre et al. study that were attributed to alternative proteoforms, 
belonged to either Ensembl or SwissProt annotated proteins. These discrepancies were likely 
due to updated database versions used in our study or differences between 
Ensembl/SwissProt and NCBI (RefSeq) annotation used as reference by the other studies. 
Reliable quantification of uORF expression by ribo-seq may be challenging due to their short 
length and the bias in ribosome signal at 5’ leader introduced by the antibiotic treatment 
[26]. Nevertheless, potential biases are similar across all samples analysed, thus unlikely 
affect differential expression analysis, corroborated by the fact that some of the regulatory 
uORFs identified in our study were previously reported in studies that specifically avoided 
antibiotic pretreatment [7, 8] (see Appendix Fig. IV.1). Our data analysis pipeline also 
minimized the impact of ribosome accumulation at start and stop sites by adjusting the 
region used for CHX readout of translation (see Materials and Methods). Analysis of 
overlapping ORFs may be additionally difficult. For example, 68 of differentially regulated u-
oORF/CDS pairs identified in our study were characterised by shorter than average overlaps 
(Appendix Fig. IV.2B), a likely consequence of including the region shared with the CDS for 
calculating u-oORF expression. Although our approach may underestimate the number of 
regulated u-oORFs, namely u-oORFs extensively overlapping with CDS, currently precise 
expression measurement of highly overlapping ORFs remains unfeasible using ribo-seq. 
Our findings suggest the role of eIF1 and its cellular levels as a key mediator for translational 
regulation, but also underline the high interconnectivity of the translational machinery [1, 8, 
40]. The non-essential nature of eIF1 gene in HAP1 cells was not originally anticipated [51] 
and the nearly 3-fold upregulation of eIF1B in eIF1KO cells supports the possible functional 
overlap between the paralog genes. On the other hand, no clear translational impairment, 
especially no apparent change in eIF1 expression, and an overall mildly perturbed to 
unperturbed proteome expression profile of eIF1BKO cells prohibit from drawing any 
conclusion regarding eIF1B activity without additional in vitro studies.  
Overall, the effects of eIF1 deprivation comprise a widespread remodelling of the eIF 
network. Energy production and amino acid demand also seemed to be significantly 
perturbed. In particular, lower cellular ATP levels and decreased mitochondrial respiration 
were detected, however the severity of this phenotype needs further examination. 
Interestingly, changes in gene expression were frequently achieved by engaging uORFs. 
Particularly strong upregulation of gene expression mediated by uORFs was detected for 
ATF4, which coincided with enhanced expression of its downstream targets (Fig. 9A). 
Although our study indicates that ATF4 regulation was elicited by eIF1, previous reports 
indicate another likely reason for enhanced ATF4 translation. It involves the downregulation 
(inactivating phosphorylation) of eIF2α by upstream kinases in response to stress stimuli [6, 
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13]. To set our findings in a broader context, we investigated the expression of EIF2S1 
(encoding eIF2α subunit) and EIF2AK4, encoding a kinase that phosphorylates eIF2α in 
response to amino-acid deprivation [13]. Although eIF1 knockdown coincided with 
decreased EIF2S1 transcription, translation and protein expression, we have observed no 
significant expression change in case of EIF2AK4, while GCN1L1 encoding a positive activator 
of the EIF2AK4 protein kinase activity, was clearly downregulated (Fig. 9A). Additionally, and 
despite the overall good agreement between the knockdown and knockout experiments, 
both eIF1KO cell lines showed increased eIF2α expression (Fig. 9B), suggesting that eIF1 
deficiency is potentially sufficient to elicit the observed response and eIF2𝛼 is not a 
necessary mediator of the process.  
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Materials and Methods 
Cell culture 
The human colon cancer cell line HCT116 was kindly provided by the Johns Hopkins Sidney 
Kimmel Comprehensive Cancer Center (Baltimore, USA). The HAP1 wild type and 
CRISPR/Cas9 engineered knockout cell lines were obtained from Horizon Genomics GmbH, 
Vienna. In particular, a single eIF1B knockout clone and two eIF1 knockout clones were 
acquired (i.e. and eIF1-14bp deletion knock out (eIF1KO cl. 1) and eIF1-265bp insertion 
knock out (eIF1KO cl. 2)). HCT116 cells were cultivated in McCoy’s medium (Gibco, Thermo 
Fisher Scientific Inc.) whereas HAP1 cells were grown in Iscove’s Modified Dulbecco’s 
Medium (IMDM, Gibco, Thermo Fisher Scientific Inc.). All media were supplemented with 
10% fetal bovine serum (FBS, HyClone, Thermo Fisher Scientific Inc.), 2 mM alanyl-L-
glutamine dipeptide (GlutaMAX, Gibco, Thermo Fisher Scientific Inc.), 50 units/ml penicillin 
(Gibco, Thermo Fisher Scientific Inc.) and 50 µg/ml streptomycin (Gibco, Thermo Fisher 
Scientific Inc.). HCT116 and HAP1 cells were maintained in a humidified incubator at 37°C 
and 5% CO2 or 8% CO2, respectively. 
Knockdown experiments in HCT116 cells 
For knockdown experiments, HCT116 cells were transferred to serum-free McCoy’s medium 
and seeded at a density of 2.4*10E6 cells per 10 cm2 plate. Cells were transfected with 
either 10 nM control si-RNA (si-Ctrl, ON-TARGETplus Non-targeting Control siRNAs: D-
001810-01-05, Dharmacon, GE Healthcare Life Sciences) or 10nM si-RNAs targeting eIF1 (si-
eIF1, SMARTpool: M-015804-01-0005, Dharmacon, GE Healthcare Life Sciences) using 63ul 
of HiPerFect (QIAGEN) per 10 cm2 plate. 5 hours post-transfection, cells were supplemented 
with FBS at a final concentration (f.c.) of 10%. 1 plate per condition was harvested after 72 
hours for label-free proteomics and qPCR experiments using Trypsin/EDTA solution (Gibco, 
Thermo Fisher Scientific Inc.). The remaining 4 plates per condition were used for the 
ribosome profiling and mRNA-sequencing experiments performed.  
Label-free shotgun proteomics 
For label-free shotgun proteomics experiments in HAP1 cells, 3 biological replicates of WT 
cells, eIF1B knockout and both eIF1 knockout clones were prepared. For the label-free 
shotgun proteomics experiment in HCT116 cells, 2 biological replicates of WT cells and si-
eIF1 were prepared in parallel with the ribo-seq experiment. 10 million cells per replicate 
were harvested and lysed by 3 rounds of freeze-thaw lysis in 300µL Gu.HCl lysis buffer (4M 
Gu.HCl, 50 mM NH4HCO3 pH 7.9). The lysates were sonicated using a Branson probe sonifier 
(output 20, 0.5 second pulses, 3 x 30 seconds, after each 30 seconds cooled on ice) and 
centrifuged for 30 minutes at 3,500g (4 °C). Supernatants were transferred to a fresh 
protein-low-bind tube (Eppendorf) and the protein concentration was determined according 
to the Bradford method. An aliquot equivalent of 200 µg was transferred to a clean 2 mL-
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tube and diluted to 1 mg/mL with 4M Gu.HCl + 50 mM NH4HCO3. The protein mixture was 
further diluted with an equal volume of HPLC grade water followed by a precipitation with 
4x volumes of -20 °C acetone for 2 hours at -20°C. Precipitated proteins were collected by 
centrifugation at 4,000g for 15 minutes (4 °C). Pellets were washed twice with 1 mL of ice-
cold 80% acetone by vortexing and centrifugation at 16,000g for 5 minutes. Pellets were air 
dried upside down for approximately 10 minutes at RT until no residual acetone odor 
remained. Protein pellets were then resuspended in 200µL TFE (2,2,2-trifluoroethanol) 
digestion buffer (11% TFE, 100mM NH4HCO3) and the pellets dissolved by sonication using a 
Branson probe sonifier (output 10-15, 0.5 second pulses, cool samples on ice if necessary) 
until a homogenous suspension was formed. Samples were digested overnight at 37°C using 
mass spectrometry grade trypsin/Lys-C mix (enzyme/substrate of 1:50 w/w, 4µg) while 
mixing at 550 rpm. The samples were acidified on the next day with trifluoroacetic acid (TFA) 
added to a final concentration of 0.5% and centrifuged 10 minutes at 16,000g. The 
supernatants were transferred to a fresh protein-low-bind tube and H2O2 was added to each 
sample at a f.c. of 0.5% and incubated for 30 minutes at 37 °C. Solid phase extraction of 
peptides was performed using C18 reversed phase sorbent containing 100µL pipette tips 
(Piece C18 tips – Thermo Scientific) according to the manufacturer’s instructions. The pipette 
tip was conditioned by aspirating the maximum pipette tip volume of water-ACN (50:50, v/v) 
and the solvent discarded. After equilibration of the tip by washing 3 times with the 
maximum pipette tip volume in 0.1% TFA in water (separate tubes and solvent prepared for 
each sample), 100 µL of the acidified samples (approximately 100 µg of proteins) were 
dispensed and aspirated for 10 cycles to achieve maximum binding efficiency. The tip was 
washed 3 times with the maximum pipette volume of 0.1% TFA in water-ACN (92:2, v/v) and 
the bound peptides eluted in LC-MS/MS vials with the maximum pipette volume of 0.1% TFA 
in water-ACN (30:70, v/v) by aspirating and dispensing the buffer twice. The samples were 
then vacuum-dried in a SpeedVac concentrator and re-dissolved in 20µL 2 mM TCEP (tris(2-
carboxyethyl)phosphine) in water/ACN (98:2, v/v) for LC-MS/MS analysis. 
LC-MS/MS analysis of label-free proteomes 
Samples were analyzed by LC-MS/MS using an UltiMate 3000 RSLC nano HPLC (Dionex) in-
line connected to a Q-Exactive HF mass spectrometer (Thermo Fisher Scientific Inc.). Samples 
were  separated on a 40 cm column packed in the needle (produced in-house, 75 μm I.D. × 
400 mm, 1.9 μm beads C18 Reprosil-HD, Dr. Maisch) using a non-linear 150 min gradient of 
2-56% solvent B’ (0.1% formic acid (FA) in water/ACN, 20/80 (v/v)) at a flow rate of 250
nL/min. This was followed by a 10 min wash reaching 99% solvent B’ and re-equilibration
with solvent A (0.1% FA in water). Column temperature was kept constant at 50°C
(CoControl 3.3.05, Sonation). The mass spectrometer was operated in data-dependent,
positive ionization mode, automatically switching between MS and MS/MS acquisition for
the 16 most abundant peaks in a given MS spectrum. The source voltage was set to 3.5 kV
and the capillary temperature was 250°C. One MS1 scan (m/z 375-1500, AGC target  3E6
ions, maximum ion injection time of 45 ms) acquired at a resolution of 60,000 (at 200 m/z)
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was followed by up to 16 tandem MS scans (resolution 15,000 at 200 m/z) of the most 
intense ions fulfilling predefined selection criteria (AGC target 1E5 ions, maximum ion 
injection time of 60 ms, isolation window of 1.5 m/z, fixed first mass of 145 m/z, spectrum 
data type: centroid, under fill ratio 2%, intensity threshold 1.3E4, exclusion of unassigned, 
singly charged precursors, peptide match preferred, exclude isotopes on, dynamic exclusion 
time of 12 s). The HCD collision energy was set to 32% Normalized Collision Energy and the 
polydimethylcyclosiloxane background ion at 445.12002 Da was used for internal calibration 
(lock mass). 
Spectra identification was performed with MaxQuant (version 1.5.3.30) using the 
Andromeda search engine [52] with FDR set at 1% on peptide and protein level. Spectra 
were searched against the “aTIS database” (in-silico translated ORFs of protein-coding 
transcripts annotated in Ensembl 82 Sep 2015) or “custom database” (in-silico translated 
ORFs  both annotated in Ensembl 82 Sep 2015 and predicted based on HCT116 ribo-seq data 
presented in this article). The mass tolerance for precursor and fragment ions was set to 4.5 
and 20 ppm, respectively, during the main search. Methionine oxidation to methionine-
sulfoxide was set as a fixed modification. Acetylation of protein N-termini was set as a 
variable modification. Trypsin/P was set as enzyme allowing for 2 missed cleavages. The 
match between runs function was enabled and proteins were quantified by the MaxLFQ 
algorithm integrated in the MaxQuant software [53]. Minimum of 2 ratio counts and only 
unique peptides were considered for protein quantification.  
Data analysis of label-free shotgun proteomics 
Further data analysis was performed with the Perseus software [54] (version 1.5.3.0) after 
uploading the protein groups file from MaxQuant. Proteins only identified by site and 
reverse database hits were removed as well as potential contaminants. To be able to 
perform GO (Gene Ontology), KEGG, Pfam, Corum and Keyword term enrichment, available 
annotations were uploaded from the Homo sapiens database (release date 2015-06-20). The 
replicate samples were grouped and the LFQ-intensities were log(2) transformed. Proteins 
with less than three (for HAP1 experiments) or two (for HCT116 experiment) valid values in 
at least one group were removed and missing values were imputed from a normal 
distribution around the detection limit (with 0.3 spread and 1.8 down-shift). A multiple-
sample ANOVA test was applied with S0 parameter (corresponding to the minimal fold-
change considered to be significant) set to 0.1 and p-value threshold of 0.01 (for HAP1 
experiment) or 0.05 (for HCT116 experiment) enabling for an analysis of proteins with 
significantly different expression intensities between groups. Differentially expressed 
proteins were selected for subsequent Z-score normalization and k-means clustering. 
Median log2 LFQ values per condition were calculated for individual genes and 2D 
enrichment analysis [55] of annotation terms was performed using the Perseus software 
package with corrected p-value threshold of 0.02. The results of the “custom database” 
search of the HCT116 label-free shotgun proteomics data was visualized on the human 
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GRCh38 reference genome (Ensembl annotation bundle 82) as a BED track (Appendix File 
IV.1).
Ribosome profiling 
Knockdown experiments were performed to obtain 4 x 10 cm2 plates of si-Ctrl and 4 x 10 
cm2 plates of si-eIF1 treated HCT116 cells. For ribosome profiling, 2 plates per condition 
were incubated with either 50 µM lactimidomycin (LTM) [56, 57] or 100 µg/ml 
cycloheximide (CHX) (Sigma, USA) in a total volume of 5 ml per plate for 30 min at 37°C. 
Subsequently, cells were harvested by trypsinitation (Trypsin/EDTA solution, Thermo Fisher 
Scientific Inc.), collected by centrifugation (5 min at 300g), washed with ice-cold PBS with 
100 µg/ml CHX added and recovered again by centrifugation. Cells were re-suspended in 1 
ml ice-cold lysis buffer (10 mM Tris-HCl, pH 7.4, 5 mM MgCl2, 100 mM KCl, 1% Triton X-100, 
2 mM dithiothreitol (DTT), 100 µg/ml CHX, 1 × complete and EDTA-free protease inhibitor 
cocktail (Roche)) [58], lysed by incubation on ice for 10 min and subsequently passed 
through QIAshredder spin columns (Qiagen). The flow-through was clarified by 
centrifugation for 10 min at 16,000 × g and 4°C. The supernatant was recovered and protein 
concentration was measured. 600 µl of each lysate was subjected to RNase I (Thermo Fisher 
Scientific Inc.) digestion using 3000 U of enzyme for every 7 mg protein. The remaining lysate 
was snap-frozen and kept at -80°C for mRNA-sequencing. Digestion of polysomes proceeded 
for 45 min at room temperature. Subsequent steps were performed as described previously 
[59] with certain adjustments. Ribosome protected fragments (RPFs) of 26-34 nt were
extracted from 22 µg of RNA. Ribosomal RNA derived contaminants were depleted from
reverse transcribed samples using a custom set of 20 biotynylated deoxy-oligonucleotides.
100 pmol of mixed probes with 60ul MyOne Streptavidin C1 DynaBeads (Thermo Fisher
Scientific Inc.) were used each time. The relative amount of probes was experimentally
adjusted to the prevalence of the corresponding contaminants. Samples were amplified by
PCR using compatible primers (Appendix Table IV.3). The resulting ribosome-profiling
libraries were duplexed (samples treated with the same inhibitor, LTM or CHX, were joined)
and sequenced on a NextSeq 500 instrument (Illumina) to yield 75 bp single-end reads.
Ribosome profiling data analysis 
CHX and LTM data were analysed in parallel using the PROTEOFORMER pipeline [34]. The 3’ 
adapter sequences (Appendix Table IV.3) were removed using the fastx_clipper and reads 
between 26 and 34 nt in length were retained. Reads were initially mapped onto small 
nuclear RNA, tRNA and rRNA sequences to remove contaminant sequences. The remaining 
reads were then mapped onto the human GRCh38 reference genome (Ensembl annotation 
bundle 82) using STAR 2.4.0i allowing only unique mapping with a maximum of 2 
mismatches. RPF alignments were assigned to a specific P-site nucleotide, as previously 
described [5, 34]. Separate BedGraph files (normalized for the total number of genome-
mapped reads) were generated for the sense and antisense strand with CHX and LTM read 
alignments reduced to single-nucleotide genomic position (P-site). Additional Bedgraph files 
154 
were created with full-length CHX reads. The TIS calling algorithm was applied with default 
PROTEOFORMER settings, followed by ORF delineation, as described previously [5, 34]. 
Protein sequence database of in-silico translated Ensembl annotated CDS sequences (“aTIS 
database”) was generated from PROTEOFORMER output disregarding any detected single 
nucleotide polymorphisms (SNPs). CHX reads were counted in the annotated CDS and u(-
o)ORF regions of protein-coding transcripts. To account for the accumulation of RPFs at start
and stop codons ([21, 26, 60]), when counting reads we excluded the first and the last 15 nt
in ORFs longer than 300 nt. For shorter ORFs though, we restricted the region relatively (5%
of nucleotides were excluded at both sides). To account for differences in sequencing depth
amongst CHX samples, read counts were normalized according to the total number of
genome-mapped reads. The most probable protein-coding transcript per gene was selected
based on the similarity between gene and transcript positional read coverage using a zero-
inflated negative binomial model for count data (“pscl” R package). When experimental data
was inconclusive and the algorithm failed (2% of genes), the preferred transcript was chosen
according to the following order of importance: i) the longest CDS, ii) the most upstream
aTIS, iii) the longest transcript. Subsequently, differential expression analysis was performed
on the unique set of transcripts provided that the quantified ORFs met the minimum
required number of CHX reads in both (si-eIF1 and si-Ctrl) conditions (at least 32 reads in
CDS and 8 reads in u(-o)ORF, respectively). To generate the custom protein library (“custom
database”) that contains both ribo-seq predicted and Ensembl annotated ORFs, ribo-seq
data was mapped to the genome as described above, except that multiple mapping reads
(up to 16 genomic loci) were allowed and SNP detection was enabled.
mRNA sequencing and data analysis 
RNA was isolated from ribo-seq cell lysate with TRIzol reagent (Invitrogen, Thermo Fisher 
Scientific Inc.) according to manufacturer’s instructions. RNA quality was assessed by Agilent 
Bioanalyzer RNA 600 Nano Kit and RIN values above 9 were accepted. Random 
fragmentation, cDNA synthesis and library generation were performed according to TruSeq 
Stranded Total RNA Sample Preparation protocol (Illumina). Libraries were subjected to 
sequencing on a NextSeq 500 instrument (Illumina) to yield 75 bp single-end reads. The 3’ 
adapter sequences (Appendix Table IV.3) were trimmed using the fastx_clipper. Reads were 
pre-mapped onto small nuclear RNA, tRNA and rRNA. The remaining unmapped reads were 
then mapped onto the human GRCh38 reference genome (Ensembl annotation bundle 82) 
using STAR 2.4.0i allowing only unique mapping with a maximum of 2 mismatches. Reads 
were counted across annotated protein-coding transcripts and normalized for differences in 
sequencing depth between samples as described for ribo-seq data. Separate normalized 
BedGraph files were generated for the sense and antisense strand. From the set of selected 
transcripts (see ribosome-profiling data analysis section), mRNAs with less than 32 reads in 
all samples were excluded from further analysis. 
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Differential expression analysis at the transcript level 
Differential expression analysis was performed according to Andreev et al. [7]. Only selected 
transcripts exceeding the minimal read count thresholds at both mRNA and CDS level were 
included in the analysis. In brief, normalized read counts across mRNA, CDS and uORF 
regions were used to calculate expression fold change between si-eIF1 and si-Ctrl samples. 
Subsequently, these ratios (fold changes) were log2 transformed and grouped in bins of 300 
transcripts/ORFs according to the minimal read count value across samples. Each bin was 
individually Z-transformed and evaluated for differential expression. mRNAs, CDSs and 
uORFs found to be significantly regulated at a 1% significance level (absolute Z-score value ≥ 
2.58) were selected. Subsequently, translation efficiencies were calculated separately for si-
eIF1 and si-Ctrl samples by dividing the CDS or uORF read counts by their corresponding 
mRNA read counts. Next, a ratio of TE values was obtained, representing the fold change in 
TE CDS or TE uORF between si-eIF1 and si-Ctrl conditions. Finally, differential TE regulation 
between uORF and CDS of the same transcript was assessed by first calculating the ratio TE 
uORF/TE CDS in each condition and then obtaining the ratio between conditions. TE CDS, TE 
uORF and TE uORF/TE CDS fold changes were subjected to log2 and Z-score transformation 
as described above. To be able to perform GO (Gene Ontology), KEGG, Pfam, Corum and 
Keyword term enrichment, annotations were retrieved for all 10433 transcripts analyzed. 1D 
enrichment analysis [55] of annotation terms was performed using the Perseus software 
package with corrected p-value threshold of 0.02. 
Calculation of context score 
Sequences between -10 and +10 bp around aTIS called by the PROTEOFORMER pipeline 
were used to establish a scoring system enabling us to grade the entire nucleotide context 
with a single numeric score based on the preferred nucleotide frequency at particular 
positions, as described by Grzegorski et al. [42]. As such, we observed that the frequency of 
nucleotide occurrence from positions +6 to +5 deviates significantly from the neutral 
nucleotide frequency (1:1:1:1 A:T:G:C) [61] (Chi2 test, p=<0.001). Once the region of interest 
was specified, nucleotides were assigned a percentage frequency per position and the total 
score was calculated as a sum of these frequencies. 
Conservation analysis 
Metagenic plots were generated based on phastCons and phyloP scores over a 25-nt 
windows around the start site of the aTIS, uORF and uoORF groups. Averaged scores were 
also calculated from a control set of intergenic ORFs derived from the same pool of 
transcripts. Conservation information of the multiple alignments of 99 vertebrate genomes 
to the human genome was downloaded from 
http://hgdownload.cse.ucsc.edu/goldenPath/hg38 subfolders phastCons100way and 
phyloP100way. We ensured that only 25-nt regions were included that completely reside in 
exonic regions of mRNA. 
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Isolation of total RNA and RT-qPCR 
RNA isolation and quality assessment was performed as described above. cDNA synthesis 
was performed using 0.5 µg RNA, 0.5 µl PrimeScript RT Enzyme Mix I, 2.5 µM Oligo dT Primer 
and 5 µM random hexamers by 15 min incubation at 37oC followed by 5 sec at 85oC. qPCR 
primers (Appendix Table IV.3) were designed using QuantPrime software [62]. PCR efficiency 
over a series of cDNA dilutions and product specificity was assessed by qbase+ software 
(Biogazelle) and melting curve analysis (LightCycler 480 Software, Roche), respectively. 
mRNA expression levels of EIF1 and EIF1B were quantified in triplicate in relation to 3 
reference genes (HPRT1, GAPDH and ACTB).  
ATP measurement 
HCT116 cells were seeded in DMEM medium supplemented with 10% FBS, 2 mM GlutaMAX, 
50 units/ml penicillin and 50 µg/ml streptomycin (all Thermo Fisher Scientific Inc.) and 
cultivated in a humidified incubator at 37oC and 5% CO2. 5,000 HCT116 cells per well in a 96-
well plate were transfected with 10nM si-RNA (si-eIF1 or si-Ctrl) and 0.75 µl HiPerFect 
(QIAGEN) using the fast forward procedure according to manufacturer’s instructions. 
Following 72 hours of knockdown, medium was replaced with either complete DMEM 
medium with 10% FBS or glucose-free DMEM with 10% FBS dialyzed using a 10 kDa cut-off 
membrane. Treatment continued for 6 hours and cellular ATP levels were measured using 
CellTiter-Glo® Luminescent Cell Viability Assay (Promega), according to manufacturer’s 
instructions. 
Mitochondrial membrane potential measurement 
si-RNA mediated knockdown was performed as described in the “Knockdown experiments in 
HCT116 cells” section of the Materials and Methods. After 72 hours post-transfection, cells 
were harvested by trypsinitation (trypsin-EDTA solution, Gibco, Thermo Fisher Scientific), 
counted and dissolved in fresh medium at a concentration of 1 million cells/ml. 1 ml of cells 
was treated with either 0.5 µl of DMSO or 0.5 µl of 100mM CCCP in DMSO (mitochondrial 
membrane depolarization agent, Sigma). Cells were incubated for 15 min at 37oC and 
centrifuged for 3 min at 300xg. The JC-10 reagent from the Mitochondria Membrane 
Potential Kit (Sigma) was dissolved in the appropriate buffer at a final concentration of 0,5 % 
(v/v). Cells were suspended in 1 ml of JC-10 solution and incubated for 30 min in darkness at 
37 oC, collected by centrifugation and suspended in 1 ml pre-warmed PBS. Cells were 
subjected to flow cytometry analysis. 20,000 events (cells) were measured in 488 and 633 
nm channels with compensation for emission cross-over. Events were gated to separate cells 
with active mitochondria (red and green JC-10 emission) from cells with depolarized 
mitochondria (only green JC-10 emission).  
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Data availability 
The mass spectrometry proteomics data have been deposited to the ProteomeXchange 
Consortium via the PRIDE [63] partner repository with the dataset identifier PXD004980 
(reviewer account username: reviewer62516@ebi.ac.uk and password: sVaRaznu). 
Ribo-seq sequencing data has been deposited in NCBI’s Gene Expression Omnibus [64] and is 
accessible through GEO Series accession number GSE87328 
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE87328; reviewer access link: 
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=izaviucsrdebdwr&acc=GSE87328). 
Besides, a BED file of peptides identified in the “custom database” search of the HCT116 
label-free shotgun proteomics data and mapped onto the human GRCh38 reference genome 
(Ensembl annotation bundle 82) was provided in Appendix File IV.1. 
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Although the complete human reference genome sequence is known for over a decade, 
functional annotation of genomic DNA regions remains challenging, especially in the case of 
protein-coding genes which may generate multiple protein versions (proteoforms) from a 
single locus [1]. Until recently, one of the most widely acknowledged sources of protein 
diversification in mammalian genomes was alternative splicing [2, 3]. However, positional 
proteomics has marked a new chapter in the proteogenomics era by providing novel insights 
into translation initiation. The unexpected discovery that numerous alternative protein N-
termini are formed co-translationally [4-6] was supported by evidence that such novel 
proteoforms undergo N-terminal modifications linked to the initiation phase of protein 
synthesis occurring at the ribosome. These observations highlighted the incompleteness of 
current protein start site annotation and sparked our interest in exploring the real N-
terminal proteome complexity. Therefore, we initiated N-terminomics studies in 3 mouse 
and 7 human cell models (including cell lines and primary cells) to systematically assess the 
occurrence of alternative N-terminal proteoforms in these organisms. Based on positional 
proteomics data, we estimated that approximately 20% of unique protein N-termini result 
from the expression of truncated or extended proteoforms, likely as a consequence of 
alternative translation initiation or in some cases also due to alternative splicing [7]. Overall, 
we reported on 1,254 human and 484 mouse alternative N-termini (i.e,. N-termini previously 
not annotated in databases), with the grand majority pointing to N-terminal truncations 
(98% and 96% in human and mouse datasets, respectively). Of note is that these datasets 
confirmed several previously reported truncated proteins resulting from downstream 
translation initiation events [8-12]. Metadata for the genuine translational origin of the 
alternative delineated TIS landscape was provided by including various sources of proteome-
matching data on transcript annotation, ribosome profiling, start codon context, PhastCons 
sequence conservation analysis and subcellular localization prediction (see below).  
Our discoveries of N-terminal proteoforms (Fig. 1) coincided with major developments in the 
genome-wide mapping of translation (initiation) event by means of ribosome profiling or 
ribo-seq. By deep sequencing of ribosome-protected mRNA fragments, ribo-seq allowed to 
study translation initiation with sub-codon resolution [13, 14]. This presented a unique 
opportunity to explore the relationship between translation events captured at the mRNA 
and protein levels. Overall, ribo-seq data obtained in a variety of mammalian cells revealed 
that only half of the TIS captured genome-wide made use of AUG as the translation initiation 
codon, although more recent strategies for ORF delineation pointed to 92% of AUG start 
codons in human [15]. Regardless of the TIS calling algorithms, distinct codon usage was 
shown for TIS residing in 5’ mRNA leader sequences (upstream TIS or uTIS) as opposed to the 
annotated CDS. uTIS utilized mostly non-AUG codons, while downstream TIS or dTIS 
predominantly made use of AUG codons [14]. Most dTIS occurred in-frame, presumably 
leading to protein N-terminal truncations [14]. In fact, increased frequency of downstream 
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in-frame AUG codons in the 5’ proximal part of annotated coding sequences was initially 
reported by Kochetov et al. [16] purely based on the in silico analysis of human mRNA 
sequences. Our N-terminomics findings were in line with these observations, as the vast 
majority of truncated proteoforms we identified utilized AUG start sites, while from 37 N-
termini pointing to near-cognate translation initiation sites, nearly all gave rise to N-terminal 
protein extensions [7]. 
Conformity between ribo-seq and N-terminomics extended further as both techniques 
pointed to a major contribution of leaky scanning in selecting alternative TIS. Annotated TIS 
falling in strong Kozak consensus sequences were frequent in genes with no detectable dTIS, 
while weak nucleotide context of annotated TIS frequently coincided with the occurrence of 
downstream initiation [7, 14], overall suggesting that leakiness of the first AUG codon 
determines the translation initiation rate at the downstream AUGs.  
As previously shown to be the case for selected proteoforms [17-19], N-terminal extension 
and truncations may lead to the gain or the loss of subcellular targeting signals, putting 
forward translation initiation as an attractive mechanism of regulating protein localization. 
By predicting the localization of full-length and truncated N-terminal proteoforms using 
TargetP [20], truncated proteoforms were found less likely to contain N-terminal 
presequences such as a mitochondrial targeting or a secretory pathway signal sequence. 
Nevertheless, we discourage from drawing general conclusions, as trafficking of proteoforms 
to different cellular compartments ought to be individually investigated. For example, the 
p43 component of the mammalian multi-synthetase complex loses its mitochondrial 
targeting sequence when translation initiates at a downstream AUG [21]. Alternatively 
however, opposed to the full length protein version, a truncated proteoform of Flap 
endonuclease 1 exposes a cryptic mitochondrial targeting signal [22]. Our predictions as well 
as other lines of evidence [23] indicate that alternative translation initiation can give rise to 
iso-functional, though localization-specific N-terminal protein variants. 
Besides steering protein localization, TIS selection can regulate protein stability and protein 
expression levels. Such intriguing properties were reported for several truncated 
proteoforms identified in our study [24-26]. Downstream initiation may produce 
degradation-resistant proteoforms, as is the case for truncated IκBα lacking phosphorylation 
sites essential for targeted proteasomal degradation. In consequence, this overly-stable 
proteoform may act as a dominant-negative regulator of NF-κB activity. Interestingly, a low 
level of truncated proteoform synthesis may also have undesired effects. A nonsense 
mutation in IKKγ/NEMO found in patients suffering from anhydrotic ectodermal dysplasia 
prevents full-length protein synthesis, but still permits the expression of a truncated and 
functional variant. Unfortunately, this protein variant is produced in insufficient amounts for 
the development of protective immune responses in these patients. According to our data, 
alternative N-terminal proteoforms tend to display decreased spectral counts compared to 
their full-length counterparts, generally suggesting either lower translation efficiency or 
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Figure 1 – A graphical representation summarizing the major findings described in this thesis 
studying alternative translation initiation mechanisms and their genome-wide effects on N-
terminal (Nt-) proteoform expression, stability, localisation and regulation of translation 
initiation. 
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possibly increased degradation ultimately leading to lower concentration of protein products 
expressed from such alternative initiation codons. Yet again, this trend is not universal, as a 
more balanced expression can be observed from closely spaced TIS that give rise to N-
terminal proteoforms differing less than 6 amino acids. With no easily discernible difference 
in molecular weight, such protein products can easily be overlooked by conventional 
detection methods such as Western blotting, underlining the unique capabilities of N-
terminal proteomics approaches.  
Nevertheless, there are certain inherent limitations to N-terminomics or more specifically N-
terminal COFRADIC and mass spectrometry in general, overall restricting the range of 
(theoretically) detectable N-termini. First, the coverage of N-termini with cleavage sites of a 
single protease is known to be incomplete, while combining results obtained with different 
proteome-digestive enzymes assures a more comprehensive detection of N-termini [27]. 
Second, physical and chemical properties of N-terminal peptides may restrict their efficient 
recovery during extraction, separation or ionization. N-terminal peptides are frequently the 
only unique peptides that allow differentiation between proteoforms of the same gene, 
which makes them per definition “one-hit wonders”. Additionally, quantification of N-
terminal proteoform expression using only spectral counts as abundance estimates is subject 
to considerable errors, inherent to MS2 data acquisition [28, 29], and may be less reliable 
especially for low abundant proteins. Although our dataset is enriched in proteoforms likely 
expressed at low(er) levels and thus characterized by low spectral count numbers, we never 
directly compared abundances of individual proteins, but rather of protein groups. In this 
case, the uncertainty of measurement is diminished by the number of observations. 
Additionally, proteoform quantification is generally reproducible across samples and cell 
lines. Despite these drawbacks, N-terminal proteomics remains an excellent identification 
tool for proteoforms, while associated spectral counts, treated with careful consideration, 
provide quantitative estimates that allow to draw conclusions regarding proteoform 
abundance. 
Beside (N-terminal) proteomics approaches, proteoform synthesis rates can be measured 
using ribosome profiling. Relying on lactimidomycin to detect translation initiation events in 
human cells, we observed that dTIS had significantly lower ribosomal signal at the start 
codon compared to annotated TIS of the same gene [30], in line with abundance estimates 
gathered at the N-terminal peptide level. Reduced ribosome footprint counts at downstream 
start sites are perfectly explained by the leaky scanning model. According to the model, the 
efficiency of upstream initiation regulates the number of leaky ribosomes that reach the 
downstream TIS. In consequence, the number of ribosomes detected on a particular TIS is 
not a direct measure of TIS strength, but rather greatly depends on the presence of 
preceding start sites [31]. Therefore, we may expect to observe large accumulation of 
ribosomes at weak TIS (such as the non-AUG codons) upstream of strong TIS, but it’s less 
probable to detect such weak start sites downstream. The quantitative value of translation 
initiation profiling with lactimidomycin and harringtonine was explored by Michel et al. [31], 
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who proposed an elegant model which explained why non-AUG TIS are commonly found in 
mRNA 5’leaders but, despite high ribosome occupancy, are generally inefficiently recognized 
as start sites, likely resulting in low synthesis rates of thereby encoded proteoforms, 
supported by limited mass spectrometry evidence for N-terminally extended proteoforms 
and uORF-encoded peptides [7]. To further improve on the quantitative aspect of translation 
initiation profiling, Gao et al. proposed a new experimental strategy, called QTI-seq [32]. By 
administering lactimidomycin shortly after cell lysis, they preserved the original ribosomal 
occupancy at the start codon and prevented new rounds of translation initiation during 
prolonged pre-incubation with the drug (especially in the 5’ part of mRNA). This method 
provided hitherto unavailable, experimental translation initiation rate estimates upon 
dynamically changing (extra)cellular conditions. Such new strategies for ribosome profiling 
experimental design and data analysis are expected to provide improved approximations of 
proteoform synthesis rates, especially with regard to truncated proteoforms frequently 
captured by mass spectrometry-driven approaches, yet difficult to quantify by ribosome 
profiling due to the overlap with other ORFs. 
With a substantial inventory of N-terminally truncated proteoforms at hand [7], we set out 
to characterize the stability of these novel proteome components (Fig. 1). Cellular protein 
stability has the potential to reflect a protein’s individual properties and biological functions 
[33, 34]. In eukaryotic cells, a wide variety of proteins with roles in cell cycle progression, 
signal transduction and metabolic regulation is quickly degraded by the proteasome [35], 
whereas in contrast, some constituents of abundant protein complexes (i.e., the ribosome, 
spliceosome) can be extremely stable [33, 34]. Large-scale studies of proteome dynamics 
were made possible by applying stable isotope labeling in combination with mass 
spectrometry. In previous studies, researchers either made use of non-synchronised, 
proliferating cells [34, 36, 37], while others employed growth-arrest conditions [33]. Cells 
were then harvested at different time points after the growth medium swap, ranging from 
only two [33] to up to eight time points [34]. Since the frequency of measurements increases 
the coverage of the dynamic range of the protein levels studied, we decided to employ the 
approach of Boisvert et al. [34], which is considered to provide more experimental data in 
proportion to computational approximations. Our experimental setup enabled the 
measurement of proteoform half-lives as well as protein turnover, which reflects the overall 
protein synthesis and degradation rates [34]. 
At the time that our project was initiated, only limited evidence indicated that alternative 
translation initiation could indeed produce protein variants that differ in stability from their 
database-annotated counterparts [24, 38]. Alternative translation initiation of the opioid 
receptor previously showed that an N-terminal extension rich in lysine residues and prone to 
ubiqitination, contributes to the high degradation rate of this proteoform [38]. As suggested, 
the main reason for generating this N-terminally extended variant was to decrease 
translation efficiency of the canonical protein. Such rapidly degraded N-terminal 
proteoforms may be prematurely dismissed as potential translation “by-products”. Instead, 
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we challenged the common perception by considering that N-terminal isoforms may possibly 
have equal or superior stability as compared to database-annotated isoform. 
To address these hypotheses, we performed the first large-scale study on protein stability 
that discriminates between protein products of a single gene that differ in their N-terminal 
parts. We combined our proteome analysis with ribosome profiling to confirm that N-
terminal proteoforms are translated from alternative translation start sites within the same 
gene. We concluded that N-terminal proteoforms raised by alternative translation initiation 
are typically less abundant than canonical proteoforms, but may display altered stabilities. 
Interestingly, truncated proteoforms often displayed a lower translation initiation signal at 
the start codon and reduced proteome abundance. These finding were consistent with a 
lower frequency of downstream translation initiation assumed from the leaky scanning 
model of translation initiation also corroborated by previous reports [14]. Occasionally, 
truncated proteoforms were exclusively expressed in the absence of their full-length 
counterparts both at the translatome and the proteome level.   
N-termini were previously reported to hold intrinsic information on the so-called N-degrons
[39]. N-end rule mediated degradation was shown to affect unmodified iMet-starting N-
termini followed by a hydrophobic amino acid [39] and neo-N-termini generated upon
proteolytic cleavage [39, 40]. Additionally, a specific branch of this pathway was implicated
in targeted degradation of proteins with Nt-acetylated residues [41]. Overall, we did not find
a direct link between our data and the N-end rule pathway which proposes a relation
between the nature of protein N-terminal residues and protein degradation rates. More
specifically, we discovered that the removal of the initiator methionine by methionine
aminopeptidases generally reduced the stability of processed proteoforms, while N-terminal
acetylation susceptibility did not seem to influence protein turnover rates. Discrepancies
between mass spectrometric studies of protein turnover and the N-end rule were previously
reported by Doherty et al. [36]. However, while well described in yeast, the N-end rule is
incompletely studied in human cells, and additional efforts are needed to characterize some
of the executioner enzymes and their targets in higher eukaryotes in general. Since the N-
end rule pathway holds an exceptionally broad range of potential substrates, additional
mechanisms have been postulated to repress undesirable protein degradation. For example,
N-degrons may be shielded by proper folding of the mature protein or by its integration into
macromolecular complexes [42]. As there are many ways for proteins to evade degradation
mediated by N-degrons, this pathway may constitute a clearance mechanism for N-
terminally misfolded or non-complexed proteins [43, 44]. Given that protein N-termini are
often more flexible and disordered [45], the conditional silencing of N-degrons may involve
other types of regulation besides a physical protection of the (acetylated) N-terminal
residues.
In contrast to other proteome studies that did not distinguish between N-terminal 
proteoforms, we combined SILAC pulse-labeling [34] with N-terminal proteomics [46] to 
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study the stability and turnover rates of proteoforms with heterogeneous N-termini. 
Another advantage of our approach was the fact that we relied on the complementary use 
of positional proteomics and in-house generated ribosome profiling data to aid in the 
characterization of the human N-terminome. So far we often relied on existing ribo-seq 
datasets [6, 7]. However, to fully explore the possibilities coming from coordinated OMICS 
analyses, we optimized ribosome profiling experiments in our laboratory. Moreover, we 
used our knowledge on co-translational modifications occurring on protein N-termini to 
unambiguously assign an identified N-termini as a proxy of translation initiation.  
We and others have shown that bioinformatics-assisted integration of ribosome profiling 
data to the protein sequence search space facilitates the discovery of novel proteoforms, 
enabling a more comprehensive (re-)annotation of the translation initiation landscape [6, 7, 
47, 48]. Here, we applied ribosome profiling next to positional and whole proteome analysis 
in a colorectal cancer cell line (i.e., HCT116 cells) to identify features of human proteins that 
cannot simply be identified using standard analysis pipelines or annotations (Fig. 1). We have 
built upon the successful marriage of the two techniques introduced in our lab [6]. Here, we 
have extended our proteogenomic strategy by taking into account sample-specific SNP 
variants, next to alternative translation products, overall leading to improved identification 
scores of 69 proteins next to 22 novel proteoforms identified in the shotgun proteomics 
experiment [49]. Abundance estimates derived from ribo-seq and shotgun proteomics data 
correlated well, especially for sufficiently covered ORFs. Interestingly, poorly expressed 
proteins and ORFs were often predicted to be unstable (according to the instability index of 
ExPASy ProtParam tool [50]). Furthermore, 18 new N-terminal proteoforms (including 5’ 
extensions, N-terminal truncations and a uORF) were identified uniquely in the ribo-seq 
enriched custom database by N-terminal COFRADIC. Nonetheless, the majority of N-terminal 
peptides linked to alternative translation initiation pointed to downstream AUG usage (204 
proteoforms), N-termini which in principle can be identified in conventional protein 
databases when making use of semi-specific enzyme settings, or by using non-redundant 
peptide search space supplemented with predicted truncated proteoform-specific peptides 
[51]  
Proteomics evidence of upstream (near-cognate) start site usage appeared 
underrepresented, compared to the expected frequency as estimated by ribosome profiling, 
meaning that besides N-terminal extensions the products of uORFs and out-of-frame 
translation products remained largely undetected. Many of these hypothetical cases are 
expected to result in the production of small peptides and proteins that have routinely been 
excluded from database sequence annotations. In contrast to the frequent occurrence of 
short ORFs in ribosome profiling data [13, 14], we were able to identify only one N-terminal 
peptide of an upstream overlapping ORF in the PIDD gene. This limited evidence for uORF 
protein products could be attributed to several factors, such as a bias towards upstream 
(near-) cognate start site identification from ribosome profiling data [52] (see also Results 
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Chapter 4) or the rapid degradation, small size and possibly low abundance of uORF 
translation products. 
Although the sensitivity of ribosome profiling to detect TIS sites and delineate reading 
frames remains unprecedented, the bioinformatics approaches used for TIS assignment may 
be ineffective in some cases. In fact, custom databases do not saturate the expressed 
proteome and we supplement them with Swiss-Prot entries to comprehensively capture the 
proteome complexity. This can be partially explained by the incompleteness of Ensembl 
genome annotation used as basis for ribosome footprint mapping or incorrect ORF 
delineation and in-silico translation, especially in the case of mitochondrial genetic code 
which utilizes non-standard translation start and stop codons. Moreover, ribo-seq provides 
an instant snapshot of translation, while certain stable proteins may not undergo synthesis 
at the time of sampling. This, as well as the recent finding that ribosome occupancy may not 
always imply effective translation initiation [31] or active elongation [53], necessitates the 
demand for proteomics evidence to identify products of translation. 
We have compared the list of protein extensions and truncations identified using a 
customized ribo-seq derived protein database with previous studies that mapped translation 
initiation in cultured human cells (lactimidomycin treated HEK293 cells [14]; harringtonine 
and lactimidomycin treated human foreskin fibroblast cell cultures (HFFs) [47] and 
puromycin treated THP-1 cells [54]). We used the GWIPS-viz browser [55] to look for 
evidence of translation initiation at these alternative start sites confirmed by our proteomics 
and ribosome profiling experiments. Despite certain shortcomings (different translation 
inhibitors and TIS calling algorithms used), we observed a complete overlap of TIS selection 
between the 4 human cell lines under study for 11 out of 29 proteoforms. However in many 
instances, cell type specific TIS selection could be observed. In line with this finding, cell type 
or cellular context dependence of TIS selection and thus translation regulation was 
previously observed for FGF2 [56], K2P2.1 [57] and BNIP-2 [58]. 
Experience gained in the course of this project facilitated the development of 
PROTEOFORMER [59], an automated bioinformatics pipeline for conversion of ribo-seq data 
into a custom protein sequence search space that incorporates both sequence variation 
information and TIS prediction. 
Translation initiation site recognition depends on the fidelity of codon-anticodon base 
pairing. Initiation is considered to be the most important rate limiting step of protein 
synthesis at the ribosome. Unsurprisingly perhaps, translational control is exerted mainly 
during the initiation process and often engages uORFs situated in translationally active 
mRNA 5’ leaders [60]. eIF1 and 1A are key regulators that modulate ribosome 
conformational changes needed for successful translation initiation. eIF1 and 1A both 
impose an open conformation of the 43S scanning complex [61]. Upon establishing a stable 
interaction between the initiation site and the Met-tRNAi, the ribosome undergoes spatial 
remodeling, which is antagonized by eIF1. This factor probably prevents incorrect initiation 
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by discriminating against non-AUG codons and a suboptimal nucleotide initiation context, 
and can dissociate aberrantly assembled complexes [62]. eIF1 mutant studies in yeast 
revealed that premature eIF1 release near the P-site decreased the stringency of start codon 
selection [63]. Dissociation of eIF1 probably leads to partial closure of the ribosomal 
conformation followed by eIF5-mediated hydrolysis of GTP bound to eIF2. Genetic 
suppressor studies in yeast linked both eIF2 and eIF5 to the accuracy of initiation site 
selection, as several mutations in these genes significantly promoted initiation at near-
cognate, non-AUG codons [64]. Other studies reported a role of the eIF3-eIF1 interaction 
interface in AUG recognition in S. cerevisiae [65]. Further, similar endeavors were 
undertaken to prove a role of eIF4G in non-AUG discrimination, mediated by its interactions 
with eIF1 and 5 [66]. 
This convincing line of evidence situates eIF1 at the forefront of translation initiation factors 
involved in steering start codon selection. We therefore decided to extend our knowledge in 
mapping translational events at steady state levels to investigate dynamic systems. For this 
purpose, we used ribosome profiling, mRNA sequencing and label-free shotgun proteomics 
to assess the impact of eIF1 on start codon selection and uORF usage in the already well-
characterized cell line HCT116 (Fig. 1).  
While non-AUG translation initiation has been experimentally verified at the single transcript 
level, its genome-wide prevalence, the impact on steady-state protein levels and the in vivo 
regulation governing the recognition of such near-cognate translation initiation codons 
remained unclear. Our results indicate that eIF1 depletion significantly reduces the incidence 
for translation initiation at AUG start sites and affects the stringency of nucleotide context 
recognition. In consequence, the expression of 245 genes was significantly affected by 
altered start codon selection. Translation efficiency of uORFs seemed to be especially 
perturbed, affecting the synthesis rate of their downstream canonical proteins by 
mechanisms such as leaky scanning or reinitiation. Our findings are well in line with previous 
reports where eIF1 over-expression reduced initiation at TIS residing in a suboptimal KOZAK 
context as well as initiation at near-cognate codons [67].  
Protein synthesis, as one of the most energy-consuming processes in living cells, is 
frequently perturbed in response to various stress conditions [68-70]. Perhaps 
unsurprisingly, translational control programme elicited by eIF1 resulted in decreased 
translation efficiency and lower expression of genes involved in glycolysis/gluconeogenesis 
and TCA cycle, accompanied by decreased cellular ATP levels and decreased mitochondrial 
activity. These observations hinted to a more general impairment of energy metabolism 
induced by eIF1 deficiency. Translation machinery itself was also placed under regulatory 
pressure, as indicated by the upregulation of genes implicated in ribosomal biogenesis, 
enhanced aminoacyl tRNA synthesis and amino acid transport observed at protein and 
transcript levels. Additionally, we observed concomitant change in expression of other eIFs, 
which seemed to be affected mostly at the transcription level, suggesting that secondary 
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effects of eIF1 knockdown attempt to restore the stringency of start codon selection, for 
example by downregulating eIF5 [71]. Upregulation of eIF1B, a paralog gene sharing high 
sequence similarity to eIF1, suggests that further compensatory effects might take place, 
potentially accounting for some of the differences observed between the knockdown and 
the knockout models studied. 
Next to several uORFs and 5’ extensions identified with the use of customized sequence 
library, we captured many peptides containing non-synonymous mutations. In most cases 
these peptides were associated with canonical proteins, however some of these peptide 
identifications were likely miss assigned to pseudogene expression. Pseudogenes generally 
share high sequence similarity to certain protein-coding genes, though they are exempted 
from purifying/negative selection. During the mapping of ribosomal footprints containing 
SNPs, search engines tend to preferably map reads to pseudogenes (with a 100% identity) 
instead of protein-coding genes, where the same footprint may map with a mismatch. This 
truly complicates protein inference and underlines that peptide identifications pointing to 
novel proteoforms, perhaps especially in the case of pseudogene expression, need thorough 
inspection. Sample-specific detection of genetic variation is still not a standard task of ribo-
seq analysis pipelines, as such pseudogene expression [48] might easily be overestimated. 
With broad accessibility and decreasing costs of high-throughput sequencing, ribosome 
profiling, (full-length) mRNA sequencing and SNP genotyping may become widely used to 
complement MS-based protein and peptide identification. 
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Our laboratory has made a substantial contribution to the annotation of N-terminal 
proteoforms in yeast, fruit fly, mouse and human [1-4]. By the extensive mapping of the 
translation initiation landscape, the increased complexity of proteomes versus genomes and 
transcriptomes could in part be explained by the process of translation initiation, adding 
another layer of complexity. We anticipate that our results may be extrapolated to other 
model organisms as proteoforms arisen from alternative translation initiation are generally 
well conserved among eukaryotic orthologous genes [3, 5, 6].  
With our research we hope to augment the current understanding of the proteome 
complexity and improve the human genome annotation by considering alternative 
translation start sites. We and others have demonstrated that ribosome profiling readout of 
translation enables the exploration of protein-coding potential outside of annotated open 
reading frames in the genome. However, with the constant progress in ribosome profiling 
data analysis, we were made aware that the sole association of mRNA with the ribosome is 
not necessarily indicative of translation [7]. Moreover, translation of certain non-canonical 
ORFs might play a regulatory role with no direct (functional) implications of the resulting 
peptides. Therefore, our future efforts will be dedicated to increase the stringency of 
translated ORF prediction from ribosome profiling data. Recently, new approaches were 
proposed to distinguish merely ribosome-associated from actively translated mRNA regions. 
Confidence of short ORF identification can be increased by exploring their sequence 
signatures (conservation, homology, mutation rates) and close inspection of ribosome 
profiles (ribosome footprint lengths and triplet periodicity) [8-11]. In this aspect, proteomics 
is increasingly recognized as a validation tool for reading frames delineated from the 
translatome [4, 11]. Despite the omnipresence of ribosome footprints in so-called 
“untranslated” (UTR) mRNA regions, long non-coding RNAs and pseudogenes, few of such 
events are supported by matching peptides. Optimized peptide and short protein 
enrichment will be required to boost the identification of short ORF translation products or, 
alternatively, disproof their coding potential. 
The association of functional features to largely unexplored genomic regions may be 
especially important to tackle the problem of missing heritability [12, 13]. A large proportion 
of disease or trait associated variants (SNPs) maps to “non-coding” regions of the human 
genome [13]. Lacking the appropriate annotation, the relevance of such variants for the 
phenotype is difficult to assess. However, an increasing line of evidence demonstrates that 
mutations in mRNA 5’ leaders are prevalent and may result in perturbed translational 
control over gene expression, deciphering disease etiology and heritability [14, 15]. It seems 
that polymorphisms found in uORFs may be both disease causing mutations as well as 
epistatic modulators that affect the predisposition to disease or severity of the phenotype.  
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N-terminal proteoforms are generally overlooked, but may explain common observations in
biomedical research such as the recognition of numerous proteoforms by antibodies. In
consequence, rather than looking at one specific gene or transcript product, many
antibodies and, by extension, ELISA tests and immunofluorescence studies, may profile
several proteoforms or alternatively miss out on specific protein variants. Our innovative
project can serve as a base for the development of new protein expression approaches and
selective antibody generation. So far, the Human Protein Atlas consortium has dedicated
significant efforts to systematically generate splice-isoform specific antibodies. We have
shown that, next to alternative splicing, alternative translation initiation further augments
proteoform diversity, the study of which would benefit from the development of selective
antisera. Our work might also have important implications for the rapidly developing field of
genome editing. A gene knockout may be achieved by introducing a point mutation in its
DNA sequence. However, this genetic manipulation may induce undesired outcome, such as
the formation of a truncated proteoform with an altered stability. In addition, knocking out
one gene might result in the disappearance of multiple gene products with possibly different
localizations and functions, as is the case for certain N-terminal proteoforms, warranting
caution. As such, our data may aid in the rational design of genome editing efforts
minimizing the risk of such complications, next to providing novel routes for investigating
previously unannotated genomic elements. In collaboration with Horizon Discovery, we have
elaborated on this topic in a webinar https://www.horizondiscovery.com/resources/
webinars/alternative-proteoforms-a-new-layer-of-proteome-complexity.
N-terminally truncated and extended proteoforms remain poorly characterized. Results
covered by this PhD thesis should be of general relevance to the whole scientific community
and can contribute to the common awareness of N-terminal proteoform expression by
implementation to publicly available databases. Our research is also the first attempt to
globally characterize N-terminal proteoform stability. Indeed, we demonstrated that N-
terminal proteoform expression may have important functional implications for the
proteome, by generating functionally related proteins with different cellular turnover rates
[16]. However, many other biological aspects of N-terminal proteoform expression are still
insufficiently studied. The scarce available literature indicates, that such proteoforms may be
differentially regulated, localized [17, 18] and display altered functionalities [19-21].
Moreover, selection between alternative translation start sites is regulated under conditions
of cellular stress [22] and may change the repertoire of N-terminal proteoforms expressed in
a developmental and tissue-specific manner [19, 21]. With the avenue of automated high-
throughput screening methods in for example transgenic zebrafish [23], genome-wide
assessment of (N-terminal) proteoform expression throughout organs and developmental
stages is now within reach. Such studies will surely shed light on proteoform functionalities
and allow for prioritization of most interesting examples for further, proteoform-oriented
assays.
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Studies of the regulatory mechanisms underlying translation may reveal novel patterns in TIS 
recognition, leading to improved start site prediction algorithms [24, 25] that are much 
needed for interpreting genomic data. This is especially important for the proper prediction 
of N-terminal protein extensions and (regulatory) uORFs that are frequently initiated at non-
AUG start sites [3-5, 26-28]. Translational control driven by eIF1 introduced significant 
alterations in start codon (context) usage, leading to the discovery of numerous uORFs that 
potentially regulate the expression of their downstream canonical protein-coding sequences. 
Further, our results highlighted the interconnectivity of the translation machinery and 
pointed to potential, but yet unexplored roles for eIF1B (an eIF1 paralog gene). Our future 
efforts will be dedicated to increase the understanding of translation regulation and 
proteoform expression. Translation may be perturbed in response to a variety of stress 
signals to which the cellular response is orchestrated by eIFs [29-32]. There are however 
substantial gaps in our knowledge regarding the functional potential of numerous eIFs and 
their paralog genes, for example eIF1B. Another interesting case is eIF4E2, a paralog of the 
conventional cap-binding eIF4E which was reported to potentially steer translation under 
hypoxic conditions observed deep within tumors [33]. Further elucidation of eIF4E2 target 
genes holds promise to indicate novel targets of therapeutic intervention that may reduce 
angiogenesis and cancer cell survival. 
Finally, we aim at characterizing the (differential) localization of proteoforms across 
subcellular compartments. These N-terminally different proteins may show a loss of 
targeting signal, as well as acquire novel functions. Indeed, several proteins were already 
reported to exist in differential subcellular localizations due to alternative translation 
initiation [17, 34, 35]. Besides displaying iso-functional, though compartment-specific 
enzymatic activity [34], several of such protein forms showed novel and unique properties, 
such as transcription factor activity [35]. Our future research will aim at putting alternative 
TIS selection and its resulting proteoforms into a spatial cellular context, which is necessary 
to understand their biological role. 
Efforts undertaken in the framework of this doctoral thesis lay grounds for improved 
characterization of functional translation products. As such, we foresee that deep 
integration of complementary OMICS approaches will ultimately result in a comprehensive 
catalogue of translation initiation events across various genomes. 
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Proteins are responsible for most biological activities of living cells and thus are considered 
the functional entities of genetic information. Protein biosynthesis is carried out by 
ribosomes which decode mRNA to amino acid sequences in a process called translation. 
Despite its fundamental importance - acknowledged by the Nobel Prize in Chemistry 
awarded in 2009 to Venkatraman Ramakrishnan, Thomas A. Steitz and Ada E. Yonath for 
structural and functional studies of ribosomes - the mechanism of translation is still not 
entirely understood. The initiation of protein synthesis is presumed to occur at the 5’ 
proximal AUG codon encountered by the scanning ribosome, albeit significant deviations 
from this canonical model were described. Alternative translation initiation mechanisms 
such as leaky scanning and re-initiation allow for the selection between different start sites 
and/or reading frames within a single mRNA transcript, ultimately leading to the expression 
of multiple protein products or proteoforms. By allowing for reprogrammed translation, 
these mechanisms contribute to the overall proteome diversity and allow gene regulation. 
So far, individual N-terminal proteoforms harbouring different N-terminal extensions or 
truncations were described to display altered localisation, stability or functionalities, 
demonstrating the biological importance of alternative translation initiation. However, the 
exact scope and regulatory role of this process remains to be investigated on a genome-wide 
scale. 
In this respect, technological advances in next generation sequencing and state-of-the-art 
mass spectrometry became indispensable to match the complexity of transcriptomes, 
translatomes and proteomes. Recently, ribosome profiling, based on deep sequencing of 
ribosome protected mRNA fragments, revealed a highly underestimated occurrence of 
alternative translation initiation sites (TIS) and widespread selection of non-AUG start 
codons throughout various genomes. Additionally, N-terminal COFRADIC, a technology 
developed in our laboratory, provided unprecedented precision in the assignment of protein 
N-termini, showing that in higher eukaryotes around 20% of all identified N-terminal
peptides point to alternative translation initiation sites including non-AUG start codons, to
incorrect annotation of translation start site or to alternative splicing.
With these technologies at hand, we decided to elucidate the true landscape of N-terminal 
proteoforms in mouse and human. Here, in a pioneering study we reported on more than 
1,700 unique alternative protein N-termini identified at the proteome level in human and 
murine cellular proteomes. Customized databases, created using the translation initiation 
maps obtained from ribosome profiling data, additionally demonstrated the use of near-
cognate codons as translation start sites decoded to initiator methionine, and the existence 
of N-terminal extended protein variants at the proteome level. Various newly identified TIS 
were confirmed by mutagenesis, and meta-analyses demonstrated that downstream TIS 
(dTIS) reside in strong Kozak-like motifs and are conserved among eukaryotes, hinting to a 
possible biological impact. Finally, we predicted that the usage of dTIS may result in N-
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terminal truncated proteoforms with altered subcellular localization patterns, providing an 
additional regulatory mechanism for functional diversification of the proteome. 
Next, we performed a proteome-wide study on protein stability using positional proteomics 
and ribosome profiling to distinguish between N-terminal proteoforms of individual genes. 
By combining pulsed SILAC with N-terminal COFRADIC we monitored the stability of 1,941 
human N-terminal proteoforms, including 147 N-terminal proteoform pairs that originate 
from alternative translation initiation, alternative splicing or incomplete processing of the 
initiator methionine. N-terminally truncated proteoforms were typically less abundant than 
canonical proteoforms and often displayed altered stabilities, likely attributed to individual 
protein characteristics, including intrinsic disorder, but independent of N-terminal amino 
acid identity or truncation length. We discovered that the removal of initiator methionine by 
methionine aminopeptidases reduced the stability of processed proteoforms, while 
susceptibility for N-terminal acetylation did not seem to influence protein turnover rates. 
Taken together, our findings revealed differences in protein stability between N-terminal 
proteoforms and pointed to a role for alternative translation initiation and co-translational 
initiator methionine removal in the overall regulation of proteome homeostasis. 
To further explore the advantages of deep OMICS data integration for peptide identification, 
we performed an integrative proteomics and ribosome profiling study using a human cancer 
cell line as a model system. Here, ribosome profiling was used to delineate (alternative) 
translational reading-frames and map single nucleotide polymorphisms in a sample-specific 
manner. By including evidence of genetic variation and alternative translation in a 
customized database, this strategy improved the identification score of 69 proteins and 
allowed for the identification of 22 new proteins in the shotgun proteomics experiment. 
Additionally, we observed an improved correlation between the quantitative measures of 
ribo-seq and shotgun proteomics as compared to many previously reported relationships 
between mRNA and protein abundance. Furthermore, we discovered 208 truncated 
proteoforms, 9 N-terminal protein extensions and obtained N-terminal peptide evidence of 
the expression of one upstream overlapping ORF.  
Despite the scarce peptide evidence for upstream ORF (uORF) expression, ribosome profiling 
data suggested that uORFs frequently populate 5’ leader sequences of protein coding genes 
and are more widespread than initially anticipated. By repressing or activating canonical 
protein translation, these uORFs may likely serve their biological role regardless of the 
corresponding peptides produced. Eukaryotic translation initiation factors seem to be key 
regulators of uORF activity that link cellular metabolism and external stimuli to elicit specific 
translational control programmes. In our work, we combined proteomics with ribosome 
profiling and mRNA sequencing to identify the biological targets of translation control 
triggered by the eukaryotic translation initiation factor 1 (eIF1), a protein implicated in the 
stringency of start codon selection. We quantified expression changes of over 4,000 proteins 
and 10,000 actively translated transcripts, leading to the identification of 245 genes 
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undergoing translational control mediated by upstream open reading frames (uORFs) upon 
eIF1 deprivation. The stringency of start codon selection and preference for optimal 
nucleotide context were largely diminished leading to translational regulation of uORFs with 
suboptimal start sites (non-AUG, poor context). Affected genes were implicated in energy 
production and sensing of metabolic stress. Interestingly, knockdown of eIF1 elicited a 
synergic response from eIF5 and eIF1B, highlighting the interconnectivity of the translational 
machinery. 
Our results demonstrate that ribosome profiling and (positional) proteomics provide highly 
complementary data that give valuable novel insights to alternative translation initiation at a 
genome-wide scale. We believe that comprehensive discovery of alternative proteoforms, 
studies on their abundance, stability and regulation are essential to improve our 
understanding of gene expression and proteome diversity, and may in the long-term 
perspective facilitate the assignment of biological functions to protein N-terminal variants. 
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Eiwitten zijn verantwoordelijk voor het grootste deel van de biochemische processen in 
cellen. Bijgevolg worden eiwitten beschouwd als de functionele, en dus uitvoerende 
eenheden van genetische informatie. Biosynthese van eiwitten bestaat uit het decoderen 
van een mRNA molecule tot een keten van aminozuren door ribosomen. Ondanks het 
fundamenteel belang van eiwitsynthese, ook translatie genoemd, is het onderliggende 
mechanisme nog niet volledig opgehelderd. In het algemeen wordt aangenomen dat initiatie 
van de eiwitsynthese start vanaf het 5’ proximale AUG startcodon. Anderzijds werden reeds 
verschillende afwijkingen van dit standaardmodel van translatie-initiatie gerapporteerd. 
Meer bepaald maken alternatieve initiatiemechanismen, zoals ‘leaky scanning’ van en ‘re-
initiatie’ door ribosomen, de selectie van andere startplaatsen en/of leeskaders mogelijk in 
één mRNA molecule. Naast genregulatie kan de keuze uit diverse startplaatsen leiden tot de 
expressie van diverse eiwitproducten of zogenaamde proteovormen. Zulke proteovormen 
die dus ontstaan door alternatieve translatie-initiatie leiden tot een stijging van de 
proteoomdiversiteit. Studies over N-terminaal verkorte of verlengde proteovormen toonden 
het biologisch belang van N-terminale proteovormen aan. Zo werden reeds alternatieve 
proteovormen gerapporteerd met een gewijzigde stabiliteit, lokalisatie of functionaliteit. 
Echter, de globale impact en regulatorische rol van het proces van alternatieve vormen 
translatie-initiatie moet nog op een genoomwijde schaal onderzocht worden. 
Daarnaast is de technologische vooruitgang rond next-generation sequentieanalyses en 
massaspectrometrie onontbeerlijk gebleken om de complexiteit van transcriptomen, 
translatomen en proteomen in kaart te brengen. Meer specifiek toont ribosoomprofilering 
of Ribo-seq - een recent ontwikkelde technologie die gebaseerd is op de sequentieanalyse 
van mRNA fragmenten die door ribosomen beschermd worden - het wijdverspreid gebruik 
aan van alternatieve translatie-initiatieplaatsen (TIS), inclusief de selectie van niet-AUG 
startcodons, en dit in verschillende genomen. Daarenboven konden we in ons labo via 
positionele proteoomanalyse (zijnde N-terminale COFRADIC, een technologie oorspronkelijk 
ontwikkeld in ons laboratorium) de diversiteit van het N-terminoom heel nauwkeurig in 
kaart brengen. Uit een gedetailleerde analyse van eiwit N-termini bleek dat in hogere 
eukaryoten ongeveer 20% van alle geïdentificeerde N-terminale peptiden afkomstig zijn van 
alternatieve translatie-initiatie, alternatieve splicing van prematuur mRNA of de incorrecte 
annotatie van translatiestartplaatsen in referentie eiwitdatabanken. 
Aangezien deze technologieën in het labo beschikbaar waren, werd besloten om het 
landschap van N-terminale proteovormen in kaart te brengen. In een eerste studie 
rapporteerden we over de identificatie van meer dan 1.700 unieke, alternatieve eiwit N-
termini (zijnde alternatieve N-terminale peptiden) afkomstig van diverse cellulaire muis of 
mens proteomen. Aangepaste eiwitdatabanken, gebaseerd op het translatie-initiatieprofiel 
afgeleid uit Ribo-seq data toonden tevens het gebruik aan van niet-AUG startcodons aan die 
gedecodeerd werden tot initiatormethionines, naast de aanwezigheid van N-terminaal 
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verlengde eiwitvarianten. Meerdere nieuwe TIS werden bevestigd door mutagenese studies. 
Meta-analysen in diverse eukaryotische organismen toonden tevens aan dat stroomafwaarts 
gelegen TIS frequent gevonden worden in sterke en geconserveerde Kozak 
consensusmotieven. Al deze bevindingen ondersteunden het belang van alternatieve 
translatie-initiatie in cellen. Op basis van in silico data-analysen kon tevens ook voorspeld 
worden dat verkorte eiwitvormen, ontstaan door het gebruik van stroomafwaarts gelegen 
TIS, een gewijzigd lokalisatiepatroon kunnen vertonen. Bijgevolg kan de selectie van 
alternatieve TIS selectie resulteren in een verdere functionele diversificatie van een 
proteoom. 
Vervolgens werd de cellulaire eiwitstabiliteit onderzocht met behulp van positionele 
proteoomanalyses en ribosoom profilering. Door het combineren van ‘pulsed SILAC’ (pSILAC) 
met N-terminale proteomanalyses konden we de stabiliteit van ongeveer 2.000 N-terminale 
proteovormen in kaart brengen. Meer bepaald werden 147 N-terminale proteovormparen 
afkomstig van alternatieve translatie-initiatie, alternatieve splicing of partiële verwijdering 
van het initiatormethionine geïdentificeerd. N-terminaal verkorte proteovormen waren 
doorgaans minder abundant in vergelijking tot hun databank geannoteerde variant en 
vertoonden vaak een gewijzigde stabiliteit. Deze wijziging in stabiliteit kon toegeschreven 
worden aan individuele eiwitkenmerken zoals eiwitopvouwing, maar bleken onafhankelijk 
van bijvoorbeeld de identiteit van het N-terminale aminozuur of de wijziging in eiwitlengte 
veroorzaakt door het gebruik van een alternatieve TIS. We ontdekten dat het verwijderen 
van het initiatormethionine door methionine aminopeptidasen de stabiliteit van deze 
proteovormen verminderde, terwijl de gevoeligheid voor N-terminale acetylatie - een 
andere cotranslationele modificatie - de stabiliteit van eiwitten nagenoeg niet leek te 
beïnvloeden. Samengevat wijzen onze bevindingen op verschillen in eiwitstabiliteit tussen N-
terminale proteovormen en een rol voor alternatieve translatie-initiatie en co-translationele 
verwijdering van het initiatormethionine in de globale regeling van de 
proteoomhomeostase. 
Om de voordelen van de integratie van diverse OMICS-data voor de identificatie van MS/MS-
spectra te onderzoeken, voerden we een integratieve proteoom en ribosoomprofilering 
studie uit op een humane cellijn als modelsysteem. Ribosoomprofilering werd gebruikt om 
(alternatieve) open leesramen en genetische variatie (nucleotide polymorfismen) in kaart te 
brengen. Door de incorporatie van dergelijke informatie in een aangepaste eiwitdatabank, 
werd een verbetering in identificatiescore van 69 eiwitten vastgesteld en konden 22 nieuwe 
proteovormen geïdentificeerd werden op basis van proteoomdata. We vonden voorts een 
verbeterde correlatie tussen kwantitatieve ribo-seq (translatoom) data en proteoomdata, dit 
in vergelijking met de reeds eerder gerapporteerde, veelal slechte correlatie tussen mRNA 
en eiwit expressie. Via N-terminale proteoomanalyses, werden ook 208 N-terminaal verkorte 
en 9 N-terminaal verlengde eiwit proteovormen geïdentificeerd, naast het eiwitproduct van 
één stroomopwaarts overlappend open leesraam (upstream ORF of uORF). 
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In tegenstelling tot de schaarse evidentie van peptidendata afkomstig van de expressie van 
uORFs, suggereert ribosoomprofilering een wijdverspreide translationele activiteit van 
uORFs in de 5' leader sequenties van eiwitcoderende genen. Meer bepaald wordt 
aangenomen dat uORFs hun rol voornamelijk uitoefenen door het onderdrukken of 
activeren van standaard eiwittranslatie, en dit ongeacht de overeenkomstige peptiden die 
mogelijks gevormd worden. Eukaryotische translatie-initiatiefactoren (eIFs) lijken belangrijke 
regulatoren van uORF activiteit door het koppelen van het cellulaire metabolisme en 
welbepaalde (externe)stimuli aan wijzigingen in translatie. In ons meest recente werk 
werden verschillende OMICS-strategieën (proteomics, ribosoomprofilering en mRNA 
sequentie-analyse) aangewend om de biologische doelwitten van de eukaryote translatie-
initiatiefactor 1 (eIF1) in kaart te brengen. eIF1 is betrokken bij de striktheid van startcodon 
selectie. Het monitoren van wijzigingen in expressie van meer dan 4.000 eiwitten en 10.000 
actief vertaalde transcripten resulteerde in de identificatie van 245 genen onderhevig aan 
eiF1 translationele controle gemedieerd door uORFs. De striktheid van startcodon selectie 
en de voorkeur voor een optimale nucleotidecontext was grotendeels verminderd, wat 
resulteerde in een gewijzigde expressie van uORFs met suboptimale TIS (niet AUG, slechte 
context) en bijgevolg de translationele regulering van de corresponderende stroomafwaarts 
gelegen open leesramen. Voornamelijk genen betrokken bij energieproductie en de detectie 
van metabole stress bleken onderhevig te zijn aan deze vorm van eIF1 gereguleerde 
translationele controle. Interessant is het ook op te merken is dat neerregulatie van eIF1 een 
synergetisch effect van eIF5 en eIF1B teweegbrengt, een bevinding die de interconnectiviteit 
van verschillende translatiefactoren benadrukt. 
Onze resultaten tonen dus aan dat ribosoomprofilering en (positionele) proteoomanalyses 
zeer complementaire data leveren die waardevolle nieuwe inzichten geven omtrent 
alternatieve translatie-initiatie op een genoomwijde schaal. Wij zijn ervan overtuigd dat de 
identificatie en karakterisering van N-terminale proteovormen onder meer door functionele 
studies (proteovorm stabiliteit, lokalisatie, abundantie en regulatie) essentieel is om 
genregulatie beter te begrijpen en proteoomdiversiteit beter in kaart te brengen. Op termijn 
kan dit het toewijzen van biologische functies aan N-terminale eiwitvarianten 
vereenvoudigen 
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Appendix Part I 
Appendix Figure I.1 
Appendix Figure I.1 - WebLogos created for the flanking sequences (12 bases upstream, 9 
bases downstream) of the dbTIS sites of 5,000 randomly chosen CCDS proteins for both 
Homo sapiens and Mus musculus. Both the probability and bits values are plotted. The CCDS 
set is built by consensus between the European Bioinformatics Institute (EBI), the National 
Center for Biotechnology Information (NCBI), the Wellcome Trust Sanger Institute (WTSI), 
and the University of California at Santa Cruz (UCSC). 
Appendix Figure I.2 
Appendix Figure I.2 - Conservation plots for the flanking (12 bp upstream, 9 bp 
downstream) exonic regions of human and mouse dbTIS sites of 5,000 randomly chosen 
CCDS proteins. The conservation measure averages the phastCons score at every position of 
all flanking sequences after alignment based on the translation start site. For all flanking 
positions, the mean is provided together with its 95% confidence interval. The CCDS set is 
built by consensus between the European Bioinformatics Institute (EBI), the National Center 
for Biotechnology Information (NCBI), the Wellcome Trust Sanger Institute (WTSI), and the 
University of California at Santa Cruz (UCSC). 
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Appendix Table I.1 
Appendix Table I.1 can be accessed via the URL: 
https://goo.gl/hoz76i 
Appendix Table I.1 - List of identified N-termini matching Swiss-Prot annotated and non-
annotated translation initiation sites in mice and human. A. List of 2,879 N-termini 
(corresponding to 2723 unique protein entries) indicative of dbTIS in human. B. List of 1,231 
N-termini (corresponding to 1030 unique protein entries) indicative of dTIS in human. C. List
of 1,771 N-termini (corresponding to 1708 unique protein entries) indicative of dbTIS in
mice. D. List of 465 N-termini (corresponding to 418 unique protein entries) indicative of
dTIS in mice. Lists of 19 and 23 identified non-canonical mouse (E) and human (F) N-terminal
peptides matching N-terminal extensions, uORF, and overlapping uORF as determined by
ribosome profiling [1, 2]. In each case the start and end positions, the first two amino acid
residues (P1’ and P2’) and the amino acid residue preceding the identified N-terminus (if
any) (P1), identified peptide sequence, Ensembl gene and transcript ID, chromosomal and
DNA strand location, chromosomal location and exon number of TIS start, UniProt database
primary accession number, whenever the iMet-retaining and iMet processed -termini were
identified (-/+ iMet) and a dTIS or dbTIS in the same protein accession could be identified,
Uniprot name, protein description, matching protein isoforms (if any), the overall degree of
Nt-acetylation (if determined), N-terminal modification status/states confirmed by MS/MS,
spectral count, maximum Mascot ion score, delta threshold (= maximum score - minimum
threshold), minimum threshold score and number of experiments and cell lines in which the
N-terminus was identified are indicated. In the dTIS lists, additional information concerning
the corresponding mouse peptide and identification thereof in the mouse proteome
background (retrieved by globally aligning the surrounding sequences of aTIS sites in all
known homologs or orthologs (found in the HomoloGene database) [3]), whether the dTIS
matches a dbTIS of (a) Swiss-Prot or TrEMBL entr(y)(ies), the flanking nucleotide context, the
length of the canonical and truncated CDS and gene name info are additionally given. In the
lists of non-canonical mouse (E) and human (F) N-terminal peptides matching N-terminal
extensions, uORF, and overlapping uORF as determined by ribosome profiling, additional
information on the start codon (type), resulting type of protein product, the start position
relative to the dbTIS and transcript region of the TIS start are given. N-termini are ranked
alphabetically according to their protein description (or gene name) and start position.
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Gene 
name 
TIS aa 
pos. 
Sequence of forward mutation primer 
(mutation: ATG>CTG) 
Sequence of reverse mutation primer 
(mutation: ATG>CTG) 
A
IM
P
2
 1 TGCTTTGGTTCTGCCCTGCCGATGTACCAGG  CCTGGTACATCGGCAGGGCAGAACCAAAGCA 
3 GGTTCTGCCATGCCGCTGTACCAGGTAAAGC  GCTTTACCTGGTACAGCGGCATGGCAGAACC 
1+3 TGCTTTGGTTCTGCCCTGCCGCTGTACCAGGTAAAGC  GCTTTACCTGGTACAGCGGCAGGGCAGAACCAAAGCA 
C
R
LF
3
 
1 CGCGCGGCCAGCTGAGGGGGGCG  CGCCCCCCTCAGCTGGCCGCGCG 
5 ATGAGGGGGGCGCTGGAGCTGGAGC  GCTCCAGCTCCAGCGCCCCCCTCAT 
N
EM
O
 1 CCCTTGCCCTGTTGGCTGAATAGGCACCTCT AGAGGTGCCTATTCAGCCAACAGGGCAAGGG 
13 GCCAACTGTGTGAGCTGGTGCAGCCCAGT ACTGGGCTGCACCAGCTCACACAGTTGGC 
38 GGGAAGCCAGCCCTGCTGCACCTGC  GCAGGTGCAGCAGGGCTGGCTTCCC 
JU
N
B
 
1 CCTGGGCCGCCCGGCTGTGCACTAAAATGG  CCATTTTAGTGCACAGCCGGGCGGCCCAGG 
5 CCGGATGTGCACTAAACTGGAACAGCCCTTCTAC GTAGAAGGGCTGTTCCAGTTTAGTGCACATCCGG 
1+5 CCTGGGCCGCCCGGCTGTGCACTAAACTGG CCAGTTTAGTGCACAGCCGGGCGGCCCAGG 
N
A
P
1
L1
 
1 GATATTTGGAGTTCTTACAACCTGGCAGACATTGACAACAAAG  CTTTGTTGTCAATGTCTGCCAGGTTGTAAGAACTCCAAATATC 
42 TCTGAGGATTTTGCATCAGCTGAACAGTTAGCTGACG  CGTCAGCTAACTGTTCAGCTGATGCAAAATCCTCAGA  
43 GTCAGCTAACTGTTCAGATGCTGCAAAATCCTCAGATTCTT  AAGAATCTGAGGATTTTGCAGCATCTGAACAGTTAGCTGAC 
42+43 CACGTCAGCTAACTGTTCAGCTGCTGCAAAATCCTCAGATTCTT  AAGAATCTGAGGATTTTGCAGCAGCTGAACAGTTAGCTGACGTG 
P
N
P
O
 
1 GGCGGCCCCCCCTGACGTGCTGG  CCAGCACGTCAGGGGGGGCCGCC 
32 CGCAGTGCTGCCCTGGACCTGGGAC  GTCCCAGGTCCAGGGCAGCACTGCG 
SF
3
A
3
 
1 CCGCGACTAAGGGAAGCTGGAGACAATACTGGA  TCCAGTATTGTCTCCAGCTTCCCTTAGTCGCGG 
22 CGGCTCATGGACGTCCTGGCTAAAGAGATGC  GCATCTCTTTAGCCAGGACGTCCATGAGCCG 
26 ACGTCATGGCTAAAGAGCTGCTCACCAAGAAGTCC  GGACTTCTTGGTGAGCAGCTCTTTAGCCATGACGT 
22+26 CGGCTCATGGACGTCCTGGCTAAAGAGCTGC  GCAGCTCTTTAGCCAGGACGTCCATGAGCCG 
U
C
H
L1
 1 GCGCTCCGCGAAGCTGCAGCTCAAGCC  GGCTTGAGCTGCAGCTTCGCGGAGCGC 
6 TGCAGCTCAAGCCGCTGGAGATCAACCCC  GGGGTTGATCTCCAGCGGCTTGAGCTGCA 
12 GGAGATCAACCCCGAGCTGCTGAACAAAGTGCT  AGCACTTTGTTCAGCAGCTCGGGGTTGATCTC C 
SY
D
C
 1 TCCGTGTCCCGCTGCCCAGCGCC GGCGCTGGGCAGCGGGACACGGA 
18 CGCGGGAGATCCTGGACGCGGCG CGCCGCGTCCAGGATCTCCCGCG 
ZN
2
9
6
 
1 GCCCGCGACTCCTGTCCCGCCGC GCGGCGGGACAGGAGTCGCGGGC 
25 AACCCAGACGACGAGCTGGAAATGCAGGACC GGTCCTGCATTTCCAGCTCGTCGTCTGGGTT 
27 CCCAGACGACGAGATGGAACTGCAGGACCT AGGTCCTGCAGTTCCATCTCGTCGTCTGGG 
25+27 CCCAGACGACGAGCTGGAACTGCAGGACCTCGT ACGAGGTCCTGCAGTTCCAGCTCGTCGTCTGGG 
Appendix Table I.2 – Primers used in site-directed mutagenesis experiments. 
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Appendix File I.1 
The H2G2 Genome Browser can be accessed via the URL http://h2g2.ugent.be/biobix.html 
using the following login credentials: Name: aTIS - Password: SITa1052.  
In the upper left corner under “Select Project” one can choose “TIS Human” or “TIS Mouse”. 
The genome browse software lets you zoom from the chromosome to the nucleotide level in 
a semantic way, as such data is loaded and displayed according to the zooming level and 
region displayed. The projects hold several visualization tracks: (A) an Ensembl gene track (B) 
an Ensembl transcript track (visible after mouse-click on the gene track), and tracks holding 
(C) the annotated TIS within the UniProtKB database split into SwissProt and trEMBL (D) the
annotated TIS within the Ensembl database (E) the reported aTIS and dbTIS locations (F) a
conservation track based on the PhastCons conservation scores based on alignment of 45
and 29 vertebrate genomes respectively for human and mouse. (G) 3 extra tracks with
ribosome profiling information (Ingolia et al., Cell, 2011 data for mESC and Lee et al., PNAS,
2012 for HEK293), one depicting the cycloheximide treated sample, one depicting the
harringtonine or lactimidomycin treated sample and one with the translation product
prediction based on the 2 aforementioned tracks. Furthermore all genes where an aTIS or
dbTIS has been identified by means of the N-terminal COFRADIC experiments are listed in
“GeneDigest” reports within the H2G2 genome browser environment. The aTIS
“GeneDigest” report lists all genes wherefore an alternative start site is reported, whereas
the dbTIS “GeneDigest” report lists all genes wherefore a Swiss-Prot database annotated TIS
has been identified. A third “Genedigest” report lists extra translation start sites identified
from the N-terminomics experiments searching a protein product database constructed
based on ribosome profiling sequence information. This ribosome profiling information is
also mapped on the reference genome and presented in the H2G2 genome browser
interface as separate visualization tracks.
Extra information in the form of static and sample tracks can be dragged into the 
visualization field from the left. Further information on the usage of the H2G2 genome 
browser can be found in the manual which can be downloaded here: 
http://h2g2.ugent.be/downloads/ManualV1_0.pdf. 
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Appendix Figure II.1 
Appendix Figure II.1 - Turnover time calculations using a subset of available data points. A. 
Representative proteoforms (10) identified in 7 time points displaying a large variety of 
turnover rates. B. For each peptide, all possible combinations of 3 random points were fitted 
with an exponential model and used for calculating 50% turnover time. Next, models with R2 
coefficient below 0.8 were rejected. The remaining valid models were grouped per peptide 
and represented as box plots. 
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Appendix Figure II.2 
Appendix Figure II.2 - For each proteoform quantified in at least 3 time points (1,972), 
variation of data unexplained by the exponential model was calculated as (1-R2) and 
represented in %. The distribution of the unexplained variations is tightly centred around 2% 
(corresponding to a median R2=0.98) while only a minority of exponential models fitted 
insufficiently (R2<0.8) and were rejected. 
Appendix Figure II.3 
Appendix Figure II.3 - Experimental assignment of Jurkat cell doubling time. Density of cell 
culture was monitored in triplicate over the course of 48 hours and fitted with an 
exponential model using the Doubling Time Online Calculator (http://www.doubling-
time.com/compute.php). Cell doubling time was calculated from the assigned growth rate 
(0.0288) as follows: ln(2)/0.0288 and represented in hours. 
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Appendix Figure II.4 
Appendix Figure II.4 - Distribution of turnover values for lysine containing ubiquitinated 
(N = 348) and non-ubiquitinated dbTIS indicative N-termini (N = 388). 
Appendix Figure II.5 
Appendix Figure II.5 - SILAC labelling of Jurkat cells. Jurkat cells cultured in regular RPMI 
medium were transferred to RPMI SILAC medium containing Arg6 L-arginine and cultured for 
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7 days. Subsequently, cells were transferred to a RPMI SILAC medium containing Arg0 L-
arginine for next 7 days, to achieve complete unlabelling. The isotope replacement was 
monitored by quantifying the identified MS-spectra using Mascot Distiller. 
Appendix Table II.1 
Appendix Table II.2 can be accessed via the URL: 
https://goo.gl/hoz76i 
Appendix Table II.1 - Stability of N-terminal proteoforms in Jurkat cells. A. Calculations of 
50% turnover times and abundance of 2,578 proteoforms identified across the time points 
studied. B. A detailed analysis of 1,972 proteoforms identified in at least 3 time points. 
Information on proteoform-specific measurements of turnover, abundance, disorder, 
hydropathy and dbTIS association with macromolecular complexes are given. C. Tracking the 
origin of 2,578 N-terminal proteoforms identified in our study using ribosome profiling and 
extensive mining of public databases, including Swiss-Prot Isoform, UniProt TrEMBL, 
Ensembl and TopFIND 3.0. Column headers used in A-C. are additionally explained in legends 
supplied in the table. 
Appendix Table II.2 
(see next page) 
Appendix Table II.2 - Contribution of ubiquitination to proteoforms stability. Ubiquitination 
sites previously reported in Jurkat cells [4] were mapped onto dbTIS indicative N-termini 
identified in this study. As such, we found 11 proteoform pairs of which only the database-
annotated variant holds (a) previously identified, and thus possible ubiquitination site(s) 
with lower stability as compared to its N-terminally truncated counterpart. 
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Appendix Part III 
Appendix Figure III.1 
Appendix Figure III.1 - Examples of improved identifications in the shotgun proteomics 
experiment. The addition of ribo-seq data to the proteomics experiment improved the 
identification and score significance for 69 proteins and three representative examples are 
depicted here. The left column shows the Clustal Omega [5] alignment of the ribo-seq-
derived amino acid sequences to the Swiss-Prot sequences with the relevant peptide 
identifications highlighted in cyan. The column on the right shows the corresponding 
fragmentation spectra and peptide sequence fragmentations. 
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Appendix Figure III.2 
Appendix Figure III.2 - Correlation plots of protein abundance based on NSAF values and 
RPF counts for the proteins uniquely identified in Swiss-Prot. Some transcripts were not 
contained in our custom database because the LTM treatment and/or TIS calling failed to 
identify these TISs. Correlations could still be calculated as the CHX treatment did result in 
detectable coverage for these transcripts. The number of data points used in every plot was 
lower than the total number of unique Swiss-Prot identifications (312), because whenever a 
Swiss-Prot protein corresponded to multiple transcripts only the transcript with the highest 
normalized RPF value was used. Top left: all transcripts; top right: transcripts with ribo-seq 
coverage in all exons; bottom left: all transcripts with an RPF count ≥ 200; bottom right: 
transcripts with both coverage in all exons and an RPF count ≥ 200. The regression line is 
shown in green. For each plot, the number of data points used (i.e. the number of dbTIS 
transcripts) as well as the corresponding Pearson correlation coefficient (r2) is shown. 
217 
APPENDIX 
Appendix Table III.1 
Appendix Table III.1 can be accessed via the URL: 
https://goo.gl/hoz76i 
Appendix Table III.1 - General overview of peptide and protein identifications. A. List of all 
2,816 human protein products identified in HCT116 cell lysates. B. List of all 1,289 human 
protein N-terminal peptides identified in HCT116 cell lysates. 
Appendix Table III.2 
Appendix Table III.2 can be accessed via the URL: 
https://goo.gl/hoz76i 
Appendix Table III.2 – A gene ontology enrichment analysis of 312 proteins missed by the 
ribo-seq experiment, but identified thanks to the inclusion of Swiss-Prot in the search 
space. 
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Appendix Figure IV.1 
Appendix Figure IV.1 - Ribosome density profiles of transcripts with actively translated u(-
o)ORFs. Full length ribosome CHX reads of si-Ctrl and si-eIF1 samples were visualized across
mRNA sequences as positive (blue) and negative (red) values, respectively. Only the 5’
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proximal part of the 3’UTR sequence was included. Both uniquely and non-uniquely mapped 
reads were included. CDS and u(-o)ORFs were marked using grey or green/red/blue/yellow 
bars, respectively. Direction of expression changes and start codon of the most 5’ proximal 
u(-o)ORF were indicated (see figure). Potential regulatory u(-o)ORFs were visualized for 
UBE2S, RPL12, MIEF1, PCNXL4, GAPDH and TOMM7. These u(-o)ORFs contributed to 
significant Z-score TE uORF/ TE CDS changes, except in the case of UBE2S, which fell below 
our significance threshold, but displayed significant translational regulation of CDS 
expression. Genes presented in the two upper rows were reported to undergo uORF-
directed translational regulation upon arsenite treatment or glucose and oxygen deprivation 
conditions in previous ribo-seq studies (UBE2S[6], RPL12, MEIF1 and PCNXL4[7]). 
Additionally, we presented the ribosome profile of POLR2M. Although POLR2M was 
unaffected by eiF1-mediated translational regulation, we confirmed the expression of its u-
oORFs with two independent peptide identifications (3 in-frame u-oORFs were detected by 
ribo-seq holding the identified peptides, see Supplementary Table 2). 
Appendix Figure IV.2 
Appendix Figure IV.2 – Analysis of the length of overlap between u-oORF and CDS. A. 
Translation efficiency of significantly regulated CDSs was generally not affected by the 
overlap with of u-oORFs. However, the 68 cases of differentially regulated u-oORF / CDS 
pairs were characterised by shorter than average overlap (B). 
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Appendix Figure IV.3 – WebLogo analysis [8] representing frequencies of nucleotides 
surrounding start sites. uTIS context sequences were represented for regulatory u(-o)ORFs 
with AUG (A.) and non-AUG (B.) uTIS (Z-score TE uORF/ TE CDS ≥ 2.58 as upregulated and Z-
score TE uORF/ TE CDS ≤ -2.58 as downregulated). C. Context analysis of all aTIS identified in 
our study. WebLogo analysis revealed very weak nucleotide consensus sequence 
surrounding upregulated AUG uTIS ((C/T)TGATGT, lacking the -3 purine and +4 guanine) in 
comparison to optimal Kozak context in the aTIS group ((A/G)CCATGG). 
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Appendix Table IV.1 
Appendix Table IV.1 can be accessed via the URL: 
https://goo.gl/hoz76i 
Appendix Table IV.1 – Ribosome profiling and proteomics readout of translation upon eIF1 
knockdown in HCT116 cells. Quantification of gene expression changes at several OMICS 
levels: mRNA, translation, translation efficiency and protein was supplemented with a 
detailed analysis of upstream (-overlapping) ORFs. 
Appendix Table IV.2 
Appendix Table IV.2 can be accessed via the URL: 
https://goo.gl/hoz76i 
Appendix Table IV.2 – Customized protein library is a source of novel peptide 
identifications. Examples of novel proteoforms and non-synonymous variants identified in 
our study using ribosome profiling (for delineation of in vivo translated ORFs and generation 
of a custom protein sequence database) in combination with label-free shotgun proteomics. 
Appendix Table IV.3 
Appendix Table IV.3 can be accessed via the URL: 
https://goo.gl/hoz76i 
Appendix Table IV.3 – List of primers and oligonucleotides. 
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Appendix File IV.1 
Appendix File IV.1 can be accessed via the URL: 
https://goo.gl/hoz76i 
Appendix File IV.1 - BED file of peptides identified in the “custom database” search of the 
HCT116 label-free shotgun proteomics data mapped onto the human GRCh38 reference 
genome (Ensembl annotation bundle 82). 
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